MXPA01000399A - Disubstituted bicyclic heterocycles having, in particular, a thrombin inhibitive effect - Google Patents
Disubstituted bicyclic heterocycles having, in particular, a thrombin inhibitive effectInfo
- Publication number
- MXPA01000399A MXPA01000399A MXPA/A/2001/000399A MXPA01000399A MXPA01000399A MX PA01000399 A MXPA01000399 A MX PA01000399A MX PA01000399 A MXPA01000399 A MX PA01000399A MX PA01000399 A MXPA01000399 A MX PA01000399A
- Authority
- MX
- Mexico
- Prior art keywords
- group
- alkyl
- general formula
- methyl
- compound
- Prior art date
Links
- NKCXQMYPWXSLIZ-PSRDDEIFSA-N (2S)-2-[[(2S)-1-[(2S)-5-amino-2-[[2-[[(2S)-6-amino-2-[[2-[[(2S)-2-[[(2S)-4-amino-2-[[(2S)-2-[[(2S,3R)-2-[[(2S)-2-[[(2S,3R)-2-amino-3-hydroxybutanoyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-3-hydroxybutanoyl]amino]propanoyl]amino]-4-oxobutanoyl]amino]-3-m Chemical compound O=C([C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@@H](N)[C@@H](C)O)[C@@H](C)O)C(C)C)N1CCC[C@H]1C(=O)N[C@@H](CO)C(O)=O NKCXQMYPWXSLIZ-PSRDDEIFSA-N 0.000 title claims abstract description 15
- 108090000190 Thrombin Proteins 0.000 title claims abstract description 15
- 229960004072 thrombin Drugs 0.000 title claims abstract description 15
- 125000002618 bicyclic heterocycle group Chemical group 0.000 title claims abstract description 12
- 230000002401 inhibitory effect Effects 0.000 title claims abstract description 8
- 150000001875 compounds Chemical class 0.000 claims abstract description 109
- 239000011780 sodium chloride Substances 0.000 claims abstract description 40
- 150000003839 salts Chemical class 0.000 claims abstract description 32
- 125000004093 cyano group Chemical group *C#N 0.000 claims abstract description 21
- 125000001841 imino group Chemical group [H]N=* 0.000 claims abstract description 15
- 239000003814 drug Substances 0.000 claims abstract description 6
- 230000000694 effects Effects 0.000 claims abstract description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 393
- -1 nicotinoyl Chemical group 0.000 claims description 252
- 239000002253 acid Substances 0.000 claims description 72
- 125000000217 alkyl group Chemical group 0.000 claims description 69
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 53
- 229910052757 nitrogen Inorganic materials 0.000 claims description 52
- 238000002360 preparation method Methods 0.000 claims description 37
- 238000006243 chemical reaction Methods 0.000 claims description 35
- 125000004435 hydrogen atoms Chemical group [H]* 0.000 claims description 30
- 229910052740 iodine Inorganic materials 0.000 claims description 28
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 27
- 125000003277 amino group Chemical group 0.000 claims description 22
- 239000001257 hydrogen Substances 0.000 claims description 22
- 229910052739 hydrogen Inorganic materials 0.000 claims description 22
- 229910052799 carbon Inorganic materials 0.000 claims description 21
- 125000006273 (C1-C3) alkyl group Chemical group 0.000 claims description 19
- OKTJSMMVPCPJKN-UHFFFAOYSA-N carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 19
- 125000000816 ethylene group Chemical group [H]C([H])([*:1])C([H])([H])[*:2] 0.000 claims description 18
- 125000001570 methylene group Chemical group [H]C([H])([*:1])[*:2] 0.000 claims description 18
- 239000011541 reaction mixture Substances 0.000 claims description 18
- 125000003545 alkoxy group Chemical group 0.000 claims description 17
- 238000007792 addition Methods 0.000 claims description 16
- 230000000875 corresponding Effects 0.000 claims description 16
- 238000006460 hydrolysis reaction Methods 0.000 claims description 14
- 239000000126 substance Substances 0.000 claims description 14
- QGZKDVFQNNGYKY-UHFFFAOYSA-N ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 claims description 13
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims description 13
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 13
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 claims description 12
- 229910052717 sulfur Inorganic materials 0.000 claims description 12
- 150000001412 amines Chemical class 0.000 claims description 11
- QVGXLLKOCUKJST-UHFFFAOYSA-N oxygen atom Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 11
- 230000001681 protective Effects 0.000 claims description 11
- 125000004434 sulfur atoms Chemical group 0.000 claims description 11
- 238000001149 thermolysis Methods 0.000 claims description 11
- 125000006272 (C3-C7) cycloalkyl group Chemical group 0.000 claims description 10
- WKBOTKDWSSQWDR-UHFFFAOYSA-N bromine atom Chemical group [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims description 10
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 claims description 10
- ZAMOUSCENKQFHK-UHFFFAOYSA-N chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims description 10
- 125000003831 tetrazolyl group Chemical group 0.000 claims description 10
- 238000007327 hydrogenolysis reaction Methods 0.000 claims description 9
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 9
- QDXQAOGNBCOEQX-UHFFFAOYSA-N 1-methylcyclohexa-1,4-diene Chemical compound CC1=CCC=CC1 QDXQAOGNBCOEQX-UHFFFAOYSA-N 0.000 claims description 8
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 claims description 8
- 125000004453 alkoxycarbonyl group Chemical group 0.000 claims description 6
- 125000000051 benzyloxy group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])O* 0.000 claims description 6
- 125000005956 isoquinolyl group Chemical group 0.000 claims description 6
- 125000000843 phenylene group Chemical group C1(=C(C=CC=C1)*)* 0.000 claims description 6
- 125000004076 pyridyl group Chemical group 0.000 claims description 6
- 125000005556 thienylene group Chemical group 0.000 claims description 6
- YCKRFDGAMUMZLT-UHFFFAOYSA-N fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 claims description 5
- 125000000623 heterocyclic group Chemical group 0.000 claims description 5
- 125000001434 methanylylidene group Chemical group [H]C#[*] 0.000 claims description 5
- 238000000034 method Methods 0.000 claims description 5
- 230000000269 nucleophilic Effects 0.000 claims description 5
- 125000004430 oxygen atoms Chemical group O* 0.000 claims description 5
- 125000005493 quinolyl group Chemical group 0.000 claims description 5
- 125000002619 bicyclic group Chemical group 0.000 claims description 4
- 239000003795 chemical substances by application Substances 0.000 claims description 4
- 125000000753 cycloalkyl group Chemical group 0.000 claims description 4
- 125000004185 ester group Chemical group 0.000 claims description 4
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims description 4
- QQONPFPTGQHPMA-UHFFFAOYSA-N propene Chemical group CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 claims description 4
- 125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 claims description 4
- 125000006698 (C1-C3) dialkylamino group Chemical group 0.000 claims description 3
- 125000006705 (C5-C7) cycloalkyl group Chemical group 0.000 claims description 3
- XCZKKZXWDBOGPA-UHFFFAOYSA-N 2-phenylbenzene-1,4-diol Chemical compound OC1=CC=C(O)C(C=2C=CC=CC=2)=C1 XCZKKZXWDBOGPA-UHFFFAOYSA-N 0.000 claims description 3
- 125000003739 carbamimidoyl group Chemical group C(N)(=N)* 0.000 claims description 3
- 239000003701 inert diluent Substances 0.000 claims description 3
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 claims description 2
- 101710005805 CYCS Proteins 0.000 claims description 2
- 125000004414 alkyl thio group Chemical group 0.000 claims description 2
- 125000002947 alkylene group Chemical group 0.000 claims description 2
- 125000004659 aryl alkyl thio group Chemical group 0.000 claims description 2
- 125000001164 benzothiazolyl group Chemical group S1C(=NC2=C1C=CC=C2)* 0.000 claims description 2
- 125000001624 naphthyl group Chemical group 0.000 claims description 2
- 125000004957 naphthylene group Chemical group 0.000 claims description 2
- 150000002828 nitro derivatives Chemical class 0.000 claims description 2
- 125000005551 pyridylene group Chemical group 0.000 claims description 2
- 125000001424 substituent group Chemical group 0.000 claims description 2
- 125000005557 thiazolylene group Chemical group 0.000 claims description 2
- 229910052727 yttrium Inorganic materials 0.000 claims description 2
- 125000004433 nitrogen atoms Chemical group N* 0.000 claims 17
- JUJWROOIHBZHMG-UHFFFAOYSA-O Pyridinium Chemical compound C1=CC=[NH+]C=C1 JUJWROOIHBZHMG-UHFFFAOYSA-O 0.000 claims 1
- 210000002356 Skeleton Anatomy 0.000 claims 1
- 125000005055 alkyl alkoxy group Chemical group 0.000 claims 1
- 125000000837 carbohydrate group Chemical group 0.000 claims 1
- 101710044204 cyp165C4 Proteins 0.000 claims 1
- 125000000714 pyrimidinyl group Chemical group 0.000 claims 1
- 125000000475 sulfinyl group Chemical group [*:2]S([*:1])=O 0.000 claims 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims 1
- 239000000203 mixture Substances 0.000 abstract description 40
- 230000000144 pharmacologic effect Effects 0.000 abstract description 4
- YMWUJEATGCHHMB-UHFFFAOYSA-N methylene dichloride Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 299
- VEXZGXHMUGYJMC-UHFFFAOYSA-N HCl Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 173
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 163
- 239000000741 silica gel Substances 0.000 description 161
- 229910002027 silica gel Inorganic materials 0.000 description 161
- OKKJLVBELUTLKV-UHFFFAOYSA-N methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 148
- 239000011734 sodium Substances 0.000 description 131
- 238000001819 mass spectrum Methods 0.000 description 129
- HEMHJVSKTPXQMS-UHFFFAOYSA-M sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 108
- XEKOWRVHYACXOJ-UHFFFAOYSA-N acetic acid ethyl ester Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 98
- 239000002904 solvent Substances 0.000 description 64
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 63
- PRKQVKDSMLBJBJ-UHFFFAOYSA-N Ammonium carbonate Chemical compound N.N.OC(O)=O PRKQVKDSMLBJBJ-UHFFFAOYSA-N 0.000 description 61
- 239000001099 ammonium carbonate Substances 0.000 description 61
- 235000012501 ammonium carbonate Nutrition 0.000 description 60
- RTZKZFJDLAIYFH-UHFFFAOYSA-N diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 58
- 125000004801 4-cyanophenyl group Chemical group [H]C1=C([H])C(C#N)=C([H])C([H])=C1* 0.000 description 55
- QTBSBXVTEAMEQO-UHFFFAOYSA-N acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 51
- 235000011121 sodium hydroxide Nutrition 0.000 description 46
- 239000000243 solution Substances 0.000 description 45
- JUJWROOIHBZHMG-UHFFFAOYSA-N pyridine Substances C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 42
- CSCPPACGZOOCGX-UHFFFAOYSA-N acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 40
- WYURNTSHIVDZCO-UHFFFAOYSA-N tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 36
- 229960000583 Acetic Acid Drugs 0.000 description 33
- 235000019439 ethyl acetate Nutrition 0.000 description 32
- 238000001704 evaporation Methods 0.000 description 32
- 150000003254 radicals Chemical class 0.000 description 31
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 28
- 239000012362 glacial acetic acid Substances 0.000 description 26
- YXFVVABEGXRONW-UHFFFAOYSA-N toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 26
- VEXZGXHMUGYJMC-UHFFFAOYSA-M chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 24
- 239000002585 base Substances 0.000 description 22
- KDLHZDBZIXYQEI-UHFFFAOYSA-N palladium Substances [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 22
- 238000000926 separation method Methods 0.000 description 22
- 239000012043 crude product Substances 0.000 description 18
- FAPWRFPIFSIZLT-UHFFFAOYSA-M sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 18
- 102100010976 SLC39A2 Human genes 0.000 description 17
- 101710017106 SLC39A2 Proteins 0.000 description 17
- UFHFLCQGNIYNRP-UHFFFAOYSA-N hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 17
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 16
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 16
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 16
- UHOVQNZJYSORNB-UHFFFAOYSA-N benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 16
- 150000002829 nitrogen Chemical group 0.000 description 16
- 238000002844 melting Methods 0.000 description 15
- 239000002244 precipitate Substances 0.000 description 15
- BZKBCQXYZZXSCO-UHFFFAOYSA-N sodium hydride Chemical compound [H-].[Na+] BZKBCQXYZZXSCO-UHFFFAOYSA-N 0.000 description 15
- WEVYAHXRMPXWCK-UHFFFAOYSA-N acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 14
- 239000004480 active ingredient Substances 0.000 description 14
- PMZURENOXWZQFD-UHFFFAOYSA-L na2so4 Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 14
- 239000001184 potassium carbonate Substances 0.000 description 14
- 229910000027 potassium carbonate Inorganic materials 0.000 description 14
- UIIMBOGNXHQVGW-UHFFFAOYSA-M buffer Substances [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 13
- 238000001816 cooling Methods 0.000 description 13
- LAPGMTOHOQPDGI-UHFFFAOYSA-N 4-amino-2,5-difluorobenzonitrile Chemical group NC1=CC(F)=C(C#N)C=C1F LAPGMTOHOQPDGI-UHFFFAOYSA-N 0.000 description 12
- 150000002148 esters Chemical class 0.000 description 12
- 125000004494 ethyl ester group Chemical group 0.000 description 12
- KWYUFKZDYYNOTN-UHFFFAOYSA-M potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 12
- 238000010992 reflux Methods 0.000 description 12
- ZMANZCXQSJIPKH-UHFFFAOYSA-N triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 12
- QTBSBXVTEAMEQO-UHFFFAOYSA-M acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 11
- QGZKDVFQNNGYKY-UHFFFAOYSA-O ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 11
- 238000003818 flash chromatography Methods 0.000 description 11
- 229910052938 sodium sulfate Inorganic materials 0.000 description 11
- 235000011152 sodium sulphate Nutrition 0.000 description 11
- MVPPADPHJFYWMZ-UHFFFAOYSA-N Chlorobenzene Chemical compound ClC1=CC=CC=C1 MVPPADPHJFYWMZ-UHFFFAOYSA-N 0.000 description 10
- 239000003054 catalyst Substances 0.000 description 10
- 239000003208 petroleum Substances 0.000 description 10
- DTQVDTLACAAQTR-UHFFFAOYSA-N trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 10
- BVKZGUZCCUSVTD-UHFFFAOYSA-N Carbonic acid Chemical compound OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 description 9
- 238000009835 boiling Methods 0.000 description 9
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 9
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 9
- QOSSAOTZNIDXMA-UHFFFAOYSA-N Carbodicyclohexylimide Chemical compound C1CCCCC1N=C=NC1CCCCC1 QOSSAOTZNIDXMA-UHFFFAOYSA-N 0.000 description 8
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate dianion Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 8
- XHXFXVLFKHQFAL-UHFFFAOYSA-N Phosphoryl chloride Chemical compound ClP(Cl)(Cl)=O XHXFXVLFKHQFAL-UHFFFAOYSA-N 0.000 description 8
- 239000012074 organic phase Substances 0.000 description 8
- 229910052763 palladium Inorganic materials 0.000 description 8
- NBIIXXVUZAFLBC-UHFFFAOYSA-N phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 8
- 238000003756 stirring Methods 0.000 description 8
- 125000003006 2-dimethylaminoethyl group Chemical group [H]C([H])([H])N(C([H])([H])[H])C([H])([H])C([H])([H])* 0.000 description 7
- DGEZNRSVGBDHLK-UHFFFAOYSA-N [1,10]phenanthroline Chemical compound C1=CN=C2C3=NC=CC=C3C=CC2=C1 DGEZNRSVGBDHLK-UHFFFAOYSA-N 0.000 description 7
- 150000001408 amides Chemical class 0.000 description 7
- 239000002775 capsule Substances 0.000 description 7
- WMFOQBRAJBCJND-UHFFFAOYSA-M lithium hydroxide Chemical compound [Li+].[OH-] WMFOQBRAJBCJND-UHFFFAOYSA-M 0.000 description 7
- DLYUQMMRRRQYAE-UHFFFAOYSA-N Phosphorus pentoxide Chemical compound O1P(O2)(=O)OP3(=O)OP1(=O)OP2(=O)O3 DLYUQMMRRRQYAE-UHFFFAOYSA-N 0.000 description 6
- FYSNRJHAOHDILO-UHFFFAOYSA-N Thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 6
- 125000004432 carbon atoms Chemical group C* 0.000 description 6
- 150000007530 organic bases Chemical group 0.000 description 6
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 6
- 239000011591 potassium Substances 0.000 description 6
- 229910052700 potassium Inorganic materials 0.000 description 6
- 238000001228 spectrum Methods 0.000 description 6
- KDPAWGWELVVRCH-UHFFFAOYSA-N Bromoacetic acid Chemical compound OC(=O)CBr KDPAWGWELVVRCH-UHFFFAOYSA-N 0.000 description 5
- 229920002261 Corn starch Polymers 0.000 description 5
- GUBGYTABKSRVRQ-UUNJERMWSA-N Lactose Natural products O([C@@H]1[C@H](O)[C@H](O)[C@H](O)O[C@@H]1CO)[C@H]1[C@@H](O)[C@@H](O)[C@H](O)[C@H](CO)O1 GUBGYTABKSRVRQ-UUNJERMWSA-N 0.000 description 5
- 230000003197 catalytic Effects 0.000 description 5
- 239000008120 corn starch Substances 0.000 description 5
- LCGLNKUTAGEVQW-UHFFFAOYSA-N dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 5
- 239000000706 filtrate Substances 0.000 description 5
- 238000005984 hydrogenation reaction Methods 0.000 description 5
- 239000008101 lactose Substances 0.000 description 5
- GUBGYTABKSRVRQ-XLOQQCSPSA-N lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 5
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 5
- 239000000725 suspension Substances 0.000 description 5
- JYZIHLWOWKMNNX-UHFFFAOYSA-N Benzimidazole Chemical compound C1=C[CH]C2=NC=NC2=C1 JYZIHLWOWKMNNX-UHFFFAOYSA-N 0.000 description 4
- FBPFZTCFMRRESA-KAZBKCHUSA-N D-Mannitol Natural products OC[C@@H](O)[C@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KAZBKCHUSA-N 0.000 description 4
- FBPFZTCFMRRESA-KVTDHHQDSA-N Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 4
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 4
- 125000002252 acyl group Chemical group 0.000 description 4
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 4
- 210000000436 anus Anatomy 0.000 description 4
- HEDRZPFGACZZDS-UHFFFAOYSA-N chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- OTMSDBZUPAUEDD-UHFFFAOYSA-N ethane Chemical compound CC OTMSDBZUPAUEDD-UHFFFAOYSA-N 0.000 description 4
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 4
- 125000005843 halogen group Chemical group 0.000 description 4
- OAKJQQAXSVQMHS-UHFFFAOYSA-N hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 description 4
- XEEYBQQBJWHFJM-UHFFFAOYSA-N iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 4
- 235000019359 magnesium stearate Nutrition 0.000 description 4
- 239000000594 mannitol Substances 0.000 description 4
- 235000010355 mannitol Nutrition 0.000 description 4
- BAVYZALUXZFZLV-UHFFFAOYSA-N methylamine Chemical compound NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 description 4
- 125000002816 methylsulfanyl group Chemical group [H]C([H])([H])S[*] 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- 239000000829 suppository Substances 0.000 description 4
- 239000008215 water for injection Substances 0.000 description 4
- OKTJSMMVPCPJKN-BJUDXGSMSA-N (11)6C Chemical compound [11C] OKTJSMMVPCPJKN-BJUDXGSMSA-N 0.000 description 3
- ASOKPJOREAFHNY-UHFFFAOYSA-N 1-hydroxybenzotriazole Chemical compound C1=CC=C2N(O)N=NC2=C1 ASOKPJOREAFHNY-UHFFFAOYSA-N 0.000 description 3
- PPJYSSNKSXAVDB-UHFFFAOYSA-N 2-[4-(4-hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl]acetic acid Chemical compound IC1=CC(CC(=O)O)=CC(I)=C1OC1=CC(I)=C(O)C(I)=C1 PPJYSSNKSXAVDB-UHFFFAOYSA-N 0.000 description 3
- CVNOWLNNPYYEOH-UHFFFAOYSA-N 4-cyanophenol Chemical compound OC1=CC=C(C#N)C=C1 CVNOWLNNPYYEOH-UHFFFAOYSA-N 0.000 description 3
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonium chloride Substances [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 3
- 101700027981 CCNC Proteins 0.000 description 3
- 229940087671 Icar Drugs 0.000 description 3
- GJRQTCIYDGXPES-UHFFFAOYSA-N Isobutyl acetate Chemical compound CC(C)COC(C)=O GJRQTCIYDGXPES-UHFFFAOYSA-N 0.000 description 3
- FEWJPZIEWOKRBE-XIXRPRMCSA-N Mesotartaric acid Chemical compound OC(=O)[C@@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-XIXRPRMCSA-N 0.000 description 3
- FAIAAWCVCHQXDN-UHFFFAOYSA-N Phosphorus trichloride Chemical compound ClP(Cl)Cl FAIAAWCVCHQXDN-UHFFFAOYSA-N 0.000 description 3
- NLKNQRATVPKPDG-UHFFFAOYSA-M Potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 3
- 230000002378 acidificating Effects 0.000 description 3
- 150000007513 acids Chemical class 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- 239000007844 bleaching agent Substances 0.000 description 3
- 238000004587 chromatography analysis Methods 0.000 description 3
- 235000015165 citric acid Nutrition 0.000 description 3
- 230000015271 coagulation Effects 0.000 description 3
- 239000012141 concentrate Substances 0.000 description 3
- ROSDSFDQCJNGOL-UHFFFAOYSA-N dimethylamine Chemical compound CNC ROSDSFDQCJNGOL-UHFFFAOYSA-N 0.000 description 3
- 238000004821 distillation Methods 0.000 description 3
- 239000000284 extract Substances 0.000 description 3
- 238000011049 filling Methods 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- BDAGIHXWWSANSR-UHFFFAOYSA-N formic acid Chemical compound OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 3
- 239000000499 gel Substances 0.000 description 3
- 150000002431 hydrogen Chemical class 0.000 description 3
- CPELXLSAUQHCOX-UHFFFAOYSA-N hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 3
- 150000007529 inorganic bases Chemical class 0.000 description 3
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N iodine atom Chemical group [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N iso-propanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
- 150000007524 organic acids Chemical class 0.000 description 3
- 239000007800 oxidant agent Substances 0.000 description 3
- 230000002265 prevention Effects 0.000 description 3
- JUYUYCIJACTHMK-UHFFFAOYSA-N quinoline-8-sulfonyl chloride Chemical compound C1=CN=C2C(S(=O)(=O)Cl)=CC=CC2=C1 JUYUYCIJACTHMK-UHFFFAOYSA-N 0.000 description 3
- 235000017557 sodium bicarbonate Nutrition 0.000 description 3
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 3
- FVAUCKIRQBBSSJ-UHFFFAOYSA-M sodium iodide Inorganic materials [Na+].[I-] FVAUCKIRQBBSSJ-UHFFFAOYSA-M 0.000 description 3
- 239000011975 tartaric acid Substances 0.000 description 3
- 229960001367 tartaric acid Drugs 0.000 description 3
- 235000002906 tartaric acid Nutrition 0.000 description 3
- ODGCEQLVLXJUCC-UHFFFAOYSA-N tetrafluoroborate Chemical compound F[B-](F)(F)F ODGCEQLVLXJUCC-UHFFFAOYSA-N 0.000 description 3
- NOOLISFMXDJSKH-KXUCPTDWSA-N (-)-(1R,3R,4S)-menthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1O NOOLISFMXDJSKH-KXUCPTDWSA-N 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N (E)-but-2-enedioate;hydron Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- GQHTUMJGOHRCHB-UHFFFAOYSA-N 2,3,4,6,7,8,9,10-octahydropyrimido[1,2-a]azepine Chemical compound C1CCCCN2CCCN=C21 GQHTUMJGOHRCHB-UHFFFAOYSA-N 0.000 description 2
- SLRMQYXOBQWXCR-UHFFFAOYSA-N 2154-56-5 Chemical compound [CH2]C1=CC=CC=C1 SLRMQYXOBQWXCR-UHFFFAOYSA-N 0.000 description 2
- MVORUGPDSUKHFR-UHFFFAOYSA-N 3-[5-(bromomethyl)tetrazol-1-yl]propanenitrile Chemical compound BrCC1=NN=NN1CCC#N MVORUGPDSUKHFR-UHFFFAOYSA-N 0.000 description 2
- LCZDCKMQSBGXAH-AWEZNQCLSA-N 3-[[3-[(2S)-2-amino-2-carboxyethyl]-5-methyl-2,6-dioxopyrimidin-1-yl]methyl]-5-phenylthiophene-2-carboxylic acid Chemical compound O=C1C(C)=CN(C[C@H](N)C(O)=O)C(=O)N1CC1=C(C(O)=O)SC(C=2C=CC=CC=2)=C1 LCZDCKMQSBGXAH-AWEZNQCLSA-N 0.000 description 2
- VSCWAEJMTAWNJL-UHFFFAOYSA-K Aluminium chloride Chemical compound Cl[Al](Cl)Cl VSCWAEJMTAWNJL-UHFFFAOYSA-K 0.000 description 2
- DVARTQFDIMZBAA-UHFFFAOYSA-O Ammonium nitrate Chemical compound [NH4+].[O-][N+]([O-])=O DVARTQFDIMZBAA-UHFFFAOYSA-O 0.000 description 2
- RDOXTESZEPMUJZ-UHFFFAOYSA-N Anisole Chemical compound COC1=CC=CC=C1 RDOXTESZEPMUJZ-UHFFFAOYSA-N 0.000 description 2
- 206010003791 Aura Diseases 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N Benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- IOJUPLGTWVMSFF-UHFFFAOYSA-N Benzothiazole Chemical compound C1=CC=C2SC=NC2=C1 IOJUPLGTWVMSFF-UHFFFAOYSA-N 0.000 description 2
- PASDCCFISLVPSO-UHFFFAOYSA-N Benzoyl chloride Chemical compound ClC(=O)C1=CC=CC=C1 PASDCCFISLVPSO-UHFFFAOYSA-N 0.000 description 2
- VZGDMQKNWNREIO-UHFFFAOYSA-N Carbon tetrachloride Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 2
- PFKFTWBEEFSNDU-UHFFFAOYSA-N Carbonyldiimidazole Chemical compound C1=CN=CN1C(=O)N1C=CN=C1 PFKFTWBEEFSNDU-UHFFFAOYSA-N 0.000 description 2
- PAFZNILMFXTMIY-UHFFFAOYSA-N Cyclohexylamine Chemical compound NC1CCCCC1 PAFZNILMFXTMIY-UHFFFAOYSA-N 0.000 description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N DMSO Substances CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- 108010010803 Gelatin Proteins 0.000 description 2
- 229940093915 Gynecological Organic acids Drugs 0.000 description 2
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Natural products C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 description 2
- 241000764238 Isis Species 0.000 description 2
- RXCVUXLCNLVYIA-UHFFFAOYSA-N Orthocarbonic acid Chemical compound OC(O)(O)O RXCVUXLCNLVYIA-UHFFFAOYSA-N 0.000 description 2
- LGRFSURHDFAFJT-UHFFFAOYSA-N Phthalic anhydride Chemical compound C1=CC=C2C(=O)OC(=O)C2=C1 LGRFSURHDFAFJT-UHFFFAOYSA-N 0.000 description 2
- 210000002381 Plasma Anatomy 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- FGIUAXJPYTZDNR-UHFFFAOYSA-N Potassium nitrate Chemical compound [K+].[O-][N+]([O-])=O FGIUAXJPYTZDNR-UHFFFAOYSA-N 0.000 description 2
- LPNYRYFBWFDTMA-UHFFFAOYSA-N Potassium tert-butoxide Chemical compound [K+].CC(C)(C)[O-] LPNYRYFBWFDTMA-UHFFFAOYSA-N 0.000 description 2
- NDVLTYZPCACLMA-UHFFFAOYSA-N Silver oxide Chemical compound [O-2].[Ag+].[Ag+] NDVLTYZPCACLMA-UHFFFAOYSA-N 0.000 description 2
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 2
- BOTDANWDWHJENH-UHFFFAOYSA-N Tetraethyl orthosilicate Chemical compound CCO[Si](OCC)(OCC)OCC BOTDANWDWHJENH-UHFFFAOYSA-N 0.000 description 2
- RIOQSEWOXXDEQQ-UHFFFAOYSA-N Triphenylphosphine Chemical compound C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-N 0.000 description 2
- 230000001154 acute Effects 0.000 description 2
- 229910052783 alkali metal Inorganic materials 0.000 description 2
- 150000001340 alkali metals Chemical class 0.000 description 2
- 125000003282 alkyl amino group Chemical group 0.000 description 2
- 125000004202 aminomethyl group Chemical group [H]N([H])C([H])([H])* 0.000 description 2
- 235000019270 ammonium chloride Nutrition 0.000 description 2
- 239000003708 ampul Substances 0.000 description 2
- 239000008346 aqueous phase Substances 0.000 description 2
- 239000003125 aqueous solvent Substances 0.000 description 2
- 125000001584 benzyloxycarbonyl group Chemical group C(=O)(OCC1=CC=CC=C1)* 0.000 description 2
- UGFAIRIUMAVXCW-UHFFFAOYSA-N carbon monoxide Chemical compound [O+]#[C-] UGFAIRIUMAVXCW-UHFFFAOYSA-N 0.000 description 2
- 238000005345 coagulation Methods 0.000 description 2
- 230000001419 dependent Effects 0.000 description 2
- 150000001993 dienes Chemical class 0.000 description 2
- GPIMMWSXKZSSDN-UHFFFAOYSA-N ethyl 2-[[2-[2-(4-carbamimidoylphenyl)ethyl]-1,3-benzoxazol-5-yl]-quinolin-8-ylsulfonylamino]acetate Chemical compound C=1C=CC2=CC=CN=C2C=1S(=O)(=O)N(CC(=O)OCC)C(C=C1N=2)=CC=C1OC=2CCC1=CC=C(C(N)=N)C=C1 GPIMMWSXKZSSDN-UHFFFAOYSA-N 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 239000008273 gelatin Substances 0.000 description 2
- 229920000159 gelatin Polymers 0.000 description 2
- 235000019322 gelatine Nutrition 0.000 description 2
- 235000011852 gelatine desserts Nutrition 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 238000000227 grinding Methods 0.000 description 2
- 150000004820 halides Chemical class 0.000 description 2
- 125000004356 hydroxy functional group Chemical group O* 0.000 description 2
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Substances C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 2
- 150000007928 imidazolide derivatives Chemical class 0.000 description 2
- 239000011261 inert gas Substances 0.000 description 2
- 239000000543 intermediate Substances 0.000 description 2
- 229910052742 iron Inorganic materials 0.000 description 2
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 2
- UZKWTJUDCOPSNM-UHFFFAOYSA-N methoxybenzene Substances CCCCOC=C UZKWTJUDCOPSNM-UHFFFAOYSA-N 0.000 description 2
- 239000002480 mineral oil Substances 0.000 description 2
- 235000010446 mineral oil Nutrition 0.000 description 2
- 150000007522 mineralic acids Chemical class 0.000 description 2
- QDHHCQZDFGDHMP-UHFFFAOYSA-N monochloramine Chemical compound ClN QDHHCQZDFGDHMP-UHFFFAOYSA-N 0.000 description 2
- 150000002825 nitriles Chemical class 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 235000005985 organic acids Nutrition 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 150000003141 primary amines Chemical class 0.000 description 2
- BDERNNFJNOPAEC-UHFFFAOYSA-N propanol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 2
- 230000000069 prophylaxis Effects 0.000 description 2
- SMWDFEZZVXVKRB-UHFFFAOYSA-N quinoline Chemical compound N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 description 2
- KEAYESYHFKHZAL-UHFFFAOYSA-N sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 238000001665 trituration Methods 0.000 description 2
- 229940075966 (+)- menthol Drugs 0.000 description 1
- YONLFQNRGZXBBF-ZIAGYGMSSA-N (2R,3R)-2,3-dibenzoyloxybutanedioic acid Chemical compound O([C@@H](C(=O)O)[C@@H](OC(=O)C=1C=CC=CC=1)C(O)=O)C(=O)C1=CC=CC=C1 YONLFQNRGZXBBF-ZIAGYGMSSA-N 0.000 description 1
- CVCQAQVBOPNTFI-AAONGDSNSA-N (3R,4R,5S,6R)-3-amino-6-(hydroxymethyl)oxane-2,4,5-triol;sulfuric acid Chemical compound OS(O)(=O)=O.N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O.N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O CVCQAQVBOPNTFI-AAONGDSNSA-N 0.000 description 1
- 125000006559 (C1-C3) alkylamino group Chemical group 0.000 description 1
- 125000006274 (C1-C3)alkoxy group Chemical group 0.000 description 1
- HCUOEKSZWPGJIM-YBRHCDHNSA-N (E,2E)-2-hydroxyimino-6-methoxy-4-methyl-5-nitrohex-3-enamide Chemical compound COCC([N+]([O-])=O)\C(C)=C\C(=N/O)\C(N)=O HCUOEKSZWPGJIM-YBRHCDHNSA-N 0.000 description 1
- HDPNBNXLBDFELL-UHFFFAOYSA-N 1,1,1-trimethoxyethane Chemical compound COC(C)(OC)OC HDPNBNXLBDFELL-UHFFFAOYSA-N 0.000 description 1
- WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 description 1
- SVLPCVGRPXRCHR-UHFFFAOYSA-M 2,2-dimethoxypropanoate Chemical compound COC(C)(OC)C([O-])=O SVLPCVGRPXRCHR-UHFFFAOYSA-M 0.000 description 1
- LNSCNEJNLACZPA-UHFFFAOYSA-N 2,3-dihydroxy-2,3-bis(2-methylphenyl)butanedioic acid Chemical compound CC1=CC=CC=C1C(O)(C(O)=O)C(O)(C(O)=O)C1=CC=CC=C1C LNSCNEJNLACZPA-UHFFFAOYSA-N 0.000 description 1
- MTJBQUIPLXBANG-UHFFFAOYSA-N 2-(3-methyl-1-benzofuran-6-yl)isoindole-1,3-dione Chemical compound O=C1C2=CC=CC=C2C(=O)N1C1=CC=C2C(C)=COC2=C1 MTJBQUIPLXBANG-UHFFFAOYSA-N 0.000 description 1
- SKQCVALOUXCHFP-UHFFFAOYSA-N 2-(chloromethyl)-5-nitroimidazo[1,2-a]pyridine Chemical compound [O-][N+](=O)C1=CC=CC2=NC(CCl)=CN12 SKQCVALOUXCHFP-UHFFFAOYSA-N 0.000 description 1
- AUABZJZJXPSZCN-UHFFFAOYSA-N 2-(dimethylamino)phenol Chemical compound CN(C)C1=CC=CC=C1O AUABZJZJXPSZCN-UHFFFAOYSA-N 0.000 description 1
- FOBHMFIRHHEYSW-UHFFFAOYSA-N 2-[2-[(4-carbamimidoylphenoxy)methyl]-5-(quinolin-8-ylsulfonylamino)benzimidazol-1-yl]acetic acid Chemical compound C1=CC(C(=N)N)=CC=C1OCC1=NC2=CC(NS(=O)(=O)C=3C4=NC=CC=C4C=CC=3)=CC=C2N1CC(O)=O FOBHMFIRHHEYSW-UHFFFAOYSA-N 0.000 description 1
- FERPNCIVWFVRTL-UHFFFAOYSA-N 2-[[2-[(4-carbamimidoylanilino)methyl]-4-methylquinolin-7-yl]-quinolin-8-ylsulfonylamino]acetic acid Chemical compound N=1C2=CC(N(CC(O)=O)S(=O)(=O)C=3C4=NC=CC=C4C=CC=3)=CC=C2C(C)=CC=1CNC1=CC=C(C(N)=N)C=C1 FERPNCIVWFVRTL-UHFFFAOYSA-N 0.000 description 1
- PMGKHTKKLFCKLL-UHFFFAOYSA-N 2-[[2-[2-(4-carbamimidoylphenyl)ethyl]-1,3-benzoxazol-5-yl]-quinolin-8-ylsulfonylamino]acetic acid Chemical compound C1=CC(C(=N)N)=CC=C1CCC1=NC2=CC(N(CC(O)=O)S(=O)(=O)C=3C4=NC=CC=C4C=CC=3)=CC=C2O1 PMGKHTKKLFCKLL-UHFFFAOYSA-N 0.000 description 1
- MIUJICXPDWWSQF-UHFFFAOYSA-N 2-[[2-[2-(4-carbamimidoylphenyl)ethyl]-1,3-benzoxazol-6-yl]-quinolin-8-ylsulfonylamino]acetic acid Chemical compound C1=CC(C(=N)N)=CC=C1CCC1=NC2=CC=C(N(CC(O)=O)S(=O)(=O)C=3C4=NC=CC=C4C=CC=3)C=C2O1 MIUJICXPDWWSQF-UHFFFAOYSA-N 0.000 description 1
- IEOAZMGWAKWHCE-UHFFFAOYSA-N 2-[[2-[2-(4-carbamimidoylphenyl)ethyl]-3-methyl-1-benzofuran-6-yl]-quinolin-8-ylsulfonylamino]acetic acid Chemical compound O1C2=CC(N(CC(O)=O)S(=O)(=O)C=3C4=NC=CC=C4C=CC=3)=CC=C2C(C)=C1CCC1=CC=C(C(N)=N)C=C1 IEOAZMGWAKWHCE-UHFFFAOYSA-N 0.000 description 1
- 125000001731 2-cyanoethyl group Chemical group [H]C([H])(*)C([H])([H])C#N 0.000 description 1
- CZPWVGJYEJSRLH-UHFFFAOYSA-N 289-95-2 Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 description 1
- HTIWHBWVGNIJCR-UHFFFAOYSA-N 3-(2-cyanophenyl)propanoyl chloride Chemical compound ClC(=O)CCC1=CC=CC=C1C#N HTIWHBWVGNIJCR-UHFFFAOYSA-N 0.000 description 1
- BXFPVGRYWPIBAY-UHFFFAOYSA-N 3-(4-cyanophenyl)propanoyl chloride Chemical compound ClC(=O)CCC1=CC=C(C#N)C=C1 BXFPVGRYWPIBAY-UHFFFAOYSA-N 0.000 description 1
- UZFMOKQJFYMBGY-UHFFFAOYSA-N 4-Hydroxy-TEMPO Chemical compound CC1(C)CC(O)CC(C)(C)N1[O] UZFMOKQJFYMBGY-UHFFFAOYSA-N 0.000 description 1
- YYROPELSRYBVMQ-UHFFFAOYSA-N 4-Toluenesulfonyl chloride Chemical compound CC1=CC=C(S(Cl)(=O)=O)C=C1 YYROPELSRYBVMQ-UHFFFAOYSA-N 0.000 description 1
- JTPASDVCKCDKNJ-UHFFFAOYSA-N 4-[(5-nitro-1,3-benzothiazol-2-yl)methoxy]benzonitrile Chemical compound N=1C2=CC([N+](=O)[O-])=CC=C2SC=1COC1=CC=C(C#N)C=C1 JTPASDVCKCDKNJ-UHFFFAOYSA-N 0.000 description 1
- CVUMMOHQIRAQSY-UHFFFAOYSA-N 4-[(6-amino-3-methyl-1-benzofuran-2-yl)methylamino]benzonitrile Chemical compound O1C2=CC(N)=CC=C2C(C)=C1CNC1=CC=C(C#N)C=C1 CVUMMOHQIRAQSY-UHFFFAOYSA-N 0.000 description 1
- RNCDZELNWQHSNO-UHFFFAOYSA-N 4-[(7-amino-4-methylquinolin-2-yl)methoxy]benzonitrile Chemical compound N=1C2=CC(N)=CC=C2C(C)=CC=1COC1=CC=C(C#N)C=C1 RNCDZELNWQHSNO-UHFFFAOYSA-N 0.000 description 1
- DDVIXVRHAFYFLO-ZHACJKMWSA-N 4-[(E)-2-(1-methylindol-2-yl)ethenyl]benzonitrile Chemical compound C=1C2=CC=CC=C2N(C)C=1\C=C\C1=CC=C(C#N)C=C1 DDVIXVRHAFYFLO-ZHACJKMWSA-N 0.000 description 1
- PDTYVYRIGGLENE-UHFFFAOYSA-N 4-[2-(5-nitro-1,3-benzoxazol-2-yl)ethyl]benzonitrile Chemical compound N=1C2=CC([N+](=O)[O-])=CC=C2OC=1CCC1=CC=C(C#N)C=C1 PDTYVYRIGGLENE-UHFFFAOYSA-N 0.000 description 1
- XPWJMAZBDLDGHU-UHFFFAOYSA-N 4-[2-[1-methyl-6-(quinolin-8-ylsulfonylamino)imidazo[4,5-b]pyridin-2-yl]ethyl]benzenecarboximidamide;hydrochloride Chemical compound Cl.N=1C2=NC=C(NS(=O)(=O)C=3C4=NC=CC=C4C=CC=3)C=C2N(C)C=1CCC1=CC=C(C(N)=N)C=C1 XPWJMAZBDLDGHU-UHFFFAOYSA-N 0.000 description 1
- AQKGLSWKNCDYMY-UHFFFAOYSA-N 4-[2-[4-methyl-7-[quinolin-8-ylsulfonyl(2H-tetrazol-5-ylmethyl)amino]quinolin-2-yl]ethyl]benzenecarboximidamide Chemical compound N=1C2=CC(N(CC3=NNN=N3)S(=O)(=O)C=3C4=NC=CC=C4C=CC=3)=CC=C2C(C)=CC=1CCC1=CC=C(C(N)=N)C=C1 AQKGLSWKNCDYMY-UHFFFAOYSA-N 0.000 description 1
- FDRCKRXNJSGZCF-UHFFFAOYSA-N 4-[2-[6-(1,3-dioxoisoindol-2-yl)-1H-imidazo[4,5-b]pyridin-2-yl]ethyl]benzonitrile Chemical compound O=C1C2=CC=CC=C2C(=O)N1C(C=C1N2)=CN=C1N=C2CCC1=CC=C(C#N)C=C1 FDRCKRXNJSGZCF-UHFFFAOYSA-N 0.000 description 1
- QXKVMUGTJASXFT-UHFFFAOYSA-N 4-[[4-methyl-7-(quinolin-8-ylsulfonylamino)quinolin-2-yl]methoxy]benzenecarboximidamide Chemical compound N=1C2=CC(NS(=O)(=O)C=3C4=NC=CC=C4C=CC=3)=CC=C2C(C)=CC=1COC1=CC=C(C(N)=N)C=C1 QXKVMUGTJASXFT-UHFFFAOYSA-N 0.000 description 1
- XRZWVSXEDRYQGC-UHFFFAOYSA-N 4-cyclohexylpyrrolidin-1-ium-2-carboxylate Chemical compound C1NC(C(=O)O)CC1C1CCCCC1 XRZWVSXEDRYQGC-UHFFFAOYSA-N 0.000 description 1
- MNIKERWISBANET-FIBGUPNXSA-N 4-nitro-1-N-(trideuteriomethyl)benzene-1,2-diamine Chemical compound [2H]C([2H])([2H])NC1=CC=C([N+]([O-])=O)C=C1N MNIKERWISBANET-FIBGUPNXSA-N 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N 5-methyl-2-(propan-2-yl)cyclohexan-1-ol Chemical compound CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- XTZCHWLRMWSSDU-UHFFFAOYSA-N 7a-(chloromethyl)-6-methyl-2-quinolin-2-yl-3aH-isoindole-1,3-dione Chemical compound C1=CC=CC2=NC(N3C(=O)C4C(C3=O)(CCl)C=C(C=C4)C)=CC=C21 XTZCHWLRMWSSDU-UHFFFAOYSA-N 0.000 description 1
- 101710034857 ATIC Proteins 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- WETWJCDKMRHUPV-UHFFFAOYSA-N Acetyl chloride Chemical compound CC(Cl)=O WETWJCDKMRHUPV-UHFFFAOYSA-N 0.000 description 1
- 229910000013 Ammonium bicarbonate Inorganic materials 0.000 description 1
- IAOZJIPTCAWIRG-QWRGUYRKSA-N Aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 1
- 229960005261 Aspartic Acid Drugs 0.000 description 1
- HNYOPLTXPVRDBG-UHFFFAOYSA-N Barbituric acid Chemical compound O=C1CC(=O)NC(=O)N1 HNYOPLTXPVRDBG-UHFFFAOYSA-N 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- JFDZBHWFFUWGJE-UHFFFAOYSA-N Benzonitrile Chemical compound N#CC1=CC=CC=C1 JFDZBHWFFUWGJE-UHFFFAOYSA-N 0.000 description 1
- BCMCBBGGLRIHSE-UHFFFAOYSA-N Benzoxazole Chemical compound C1=CC=C2OC=NC2=C1 BCMCBBGGLRIHSE-UHFFFAOYSA-N 0.000 description 1
- SESFRYSPDFLNCH-UHFFFAOYSA-N Benzyl benzoate Chemical compound C=1C=CC=CC=1C(=O)OCC1=CC=CC=C1 SESFRYSPDFLNCH-UHFFFAOYSA-N 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 1
- 210000004369 Blood Anatomy 0.000 description 1
- 210000001772 Blood Platelets Anatomy 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 229910000906 Bronze Inorganic materials 0.000 description 1
- CEDVDXBPXYDIRD-UHFFFAOYSA-M C=C1OCCC1.[Cl-] Chemical compound C=C1OCCC1.[Cl-] CEDVDXBPXYDIRD-UHFFFAOYSA-M 0.000 description 1
- MIOPJNTWMNEORI-UHFFFAOYSA-N Camphorsulfonic acid Chemical compound C1CC2(CS(O)(=O)=O)C(=O)CC1C2(C)C MIOPJNTWMNEORI-UHFFFAOYSA-N 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- AOGYCOYQMAVAFD-UHFFFAOYSA-N Chloroformic acid Chemical compound OC(Cl)=O AOGYCOYQMAVAFD-UHFFFAOYSA-N 0.000 description 1
- NEHMKBQYUWJMIP-UHFFFAOYSA-N Chloromethane Chemical compound ClC NEHMKBQYUWJMIP-UHFFFAOYSA-N 0.000 description 1
- FZUJWWOKDIGOKH-UHFFFAOYSA-N Cl.OS(O)(=O)=O Chemical compound Cl.OS(O)(=O)=O FZUJWWOKDIGOKH-UHFFFAOYSA-N 0.000 description 1
- 206010009802 Coagulopathy Diseases 0.000 description 1
- 208000002881 Colic Diseases 0.000 description 1
- 208000002528 Coronary Thrombosis Diseases 0.000 description 1
- 206010011091 Coronary artery thrombosis Diseases 0.000 description 1
- MTCFGRXMJLQNBG-UWTATZPHSA-N D-serine Chemical compound OC[C@@H](N)C(O)=O MTCFGRXMJLQNBG-UWTATZPHSA-N 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N D-sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- ZBCBWPMODOFKDW-UHFFFAOYSA-N Diethanolamine Chemical compound OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 description 1
- 241001649081 Dina Species 0.000 description 1
- HDWLUGYOLUHEMN-UHFFFAOYSA-N Dinobuton Chemical compound CCC(C)C1=CC([N+]([O-])=O)=CC([N+]([O-])=O)=C1OC(=O)OC(C)C HDWLUGYOLUHEMN-UHFFFAOYSA-N 0.000 description 1
- 208000009190 Disseminated Intravascular Coagulation Diseases 0.000 description 1
- AEOCXXJPGCBFJA-UHFFFAOYSA-N Ethionamide Chemical compound CCC1=CC(C(N)=S)=CC=N1 AEOCXXJPGCBFJA-UHFFFAOYSA-N 0.000 description 1
- 239000005977 Ethylene Substances 0.000 description 1
- 102100006624 F9 Human genes 0.000 description 1
- 229950003499 FIBRIN Drugs 0.000 description 1
- 108010076282 Factor IX Proteins 0.000 description 1
- 108010074864 Factor XI Proteins 0.000 description 1
- 108010080865 Factor XII Proteins 0.000 description 1
- 102000000429 Factor XII Human genes 0.000 description 1
- 108010074860 Factor Xa Proteins 0.000 description 1
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 1
- 102000009123 Fibrin Human genes 0.000 description 1
- 108010073385 Fibrin Proteins 0.000 description 1
- 239000004606 Fillers/Extenders Substances 0.000 description 1
- 229960002989 Glutamic Acid Drugs 0.000 description 1
- 101710017531 H4C15 Proteins 0.000 description 1
- KRHYYFGTRYWZRS-UHFFFAOYSA-N HF Chemical compound F KRHYYFGTRYWZRS-UHFFFAOYSA-N 0.000 description 1
- 240000001812 Hyssopus officinalis Species 0.000 description 1
- 235000010650 Hyssopus officinalis Nutrition 0.000 description 1
- AWJUIBRHMBBTKR-UHFFFAOYSA-N Isoquinoline Chemical compound C1=NC=CC2=CC=CC=C21 AWJUIBRHMBBTKR-UHFFFAOYSA-N 0.000 description 1
- 241001520820 Joinvillea ascendens Species 0.000 description 1
- TYQCGQRIZGCHNB-JLAZNSOCSA-N L-ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(O)=C(O)C1=O TYQCGQRIZGCHNB-JLAZNSOCSA-N 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- 229960004873 LEVOMENTHOL Drugs 0.000 description 1
- 101710034456 MT-CO1 Proteins 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N Malic acid Chemical compound OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- IWYDHOAUDWTVEP-UHFFFAOYSA-N Mandelic acid Chemical compound OC(=O)C(O)C1=CC=CC=C1 IWYDHOAUDWTVEP-UHFFFAOYSA-N 0.000 description 1
- INQOMBQAUSQDDS-UHFFFAOYSA-N Methyl iodide Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 1
- UVJGSUXLKIUQLT-UHFFFAOYSA-N N-[2-[(4-cyanoanilino)methyl]-3-methyl-1-benzofuran-6-yl]quinoline-8-sulfonamide Chemical compound O1C2=CC(NS(=O)(=O)C=3C4=NC=CC=C4C=CC=3)=CC=C2C(C)=C1CNC1=CC=C(C#N)C=C1 UVJGSUXLKIUQLT-UHFFFAOYSA-N 0.000 description 1
- HVVRZYUNXLEYQG-UHFFFAOYSA-N N-[2-[(4-cyanophenoxy)methyl]-1,3-benzothiazol-5-yl]quinoline-8-sulfonamide Chemical compound C=1C=CC2=CC=CN=C2C=1S(=O)(=O)NC(C=C1N=2)=CC=C1SC=2COC1=CC=C(C#N)C=C1 HVVRZYUNXLEYQG-UHFFFAOYSA-N 0.000 description 1
- CIFHHDGDOYHVRV-UHFFFAOYSA-N N-[2-[(4-cyanophenyl)methylsulfanyl]-1,3-benzothiazol-6-yl]quinoline-8-sulfonamide Chemical compound C=1C=CC2=CC=CN=C2C=1S(=O)(=O)NC(C=C1S2)=CC=C1N=C2SCC1=CC=C(C#N)C=C1 CIFHHDGDOYHVRV-UHFFFAOYSA-N 0.000 description 1
- LUFCGQYHBRAREN-UHFFFAOYSA-N N-[2-[2-(4-cyanophenyl)ethyl]-1,3-benzoxazol-6-yl]quinoline-8-sulfonamide Chemical compound C=1C=CC2=CC=CN=C2C=1S(=O)(=O)NC(C=C1O2)=CC=C1N=C2CCC1=CC=C(C#N)C=C1 LUFCGQYHBRAREN-UHFFFAOYSA-N 0.000 description 1
- XRQJINLUYDJEMB-UHFFFAOYSA-N N-[2-[2-(4-cyanophenyl)ethyl]-3-methylimidazo[4,5-b]pyridin-6-yl]quinoline-8-sulfonamide Chemical compound N=1C2=CC(NS(=O)(=O)C=3C4=NC=CC=C4C=CC=3)=CN=C2N(C)C=1CCC1=CC=C(C#N)C=C1 XRQJINLUYDJEMB-UHFFFAOYSA-N 0.000 description 1
- NQTADLQHYWFPDB-UHFFFAOYSA-N N-hydroxy-Succinimide Chemical compound ON1C(=O)CCC1=O NQTADLQHYWFPDB-UHFFFAOYSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 241000169439 Nocar Species 0.000 description 1
- TVMXDCGIABBOFY-UHFFFAOYSA-N Octane Chemical compound CCCCCCCC TVMXDCGIABBOFY-UHFFFAOYSA-N 0.000 description 1
- MAYUCBCSAVDUKG-UHFFFAOYSA-N Orthoacetic acid Chemical compound CC(O)(O)O MAYUCBCSAVDUKG-UHFFFAOYSA-N 0.000 description 1
- 101710040931 PTGS1 Proteins 0.000 description 1
- 108091005771 Peptidases Proteins 0.000 description 1
- 102000035443 Peptidases Human genes 0.000 description 1
- 208000005764 Peripheral Arterial Disease Diseases 0.000 description 1
- 229960004838 Phosphoric acid Drugs 0.000 description 1
- XNGIFLGASWRNHJ-UHFFFAOYSA-N Phthalic acid Chemical compound OC(=O)C1=CC=CC=C1C(O)=O XNGIFLGASWRNHJ-UHFFFAOYSA-N 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 208000010378 Pulmonary Embolism Diseases 0.000 description 1
- 208000005069 Pulmonary Fibrosis Diseases 0.000 description 1
- NZASCBIBXNPDMH-UHFFFAOYSA-N Pyrithyldione Chemical compound CCC1(CC)C(=O)NC=CC1=O NZASCBIBXNPDMH-UHFFFAOYSA-N 0.000 description 1
- 101710030983 RNF138 Proteins 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 206010038563 Reocclusion Diseases 0.000 description 1
- 101700058207 SPP1 Proteins 0.000 description 1
- 240000003670 Sesamum indicum Species 0.000 description 1
- JVBXVOWTABLYPX-UHFFFAOYSA-L Sodium dithionite Chemical compound [Na+].[Na+].[O-]S(=O)S([O-])=O JVBXVOWTABLYPX-UHFFFAOYSA-L 0.000 description 1
- 229960005202 Streptokinase Drugs 0.000 description 1
- 108010023197 Streptokinase Proteins 0.000 description 1
- CZMRCDWAGMRECN-GDQSFJPYSA-N Sucrose Natural products O([C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O1)[C@@]1(CO)[C@H](O)[C@@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-GDQSFJPYSA-N 0.000 description 1
- 229940032330 Sulfuric acid Drugs 0.000 description 1
- 101710029702 TICAM1 Proteins 0.000 description 1
- 101710021425 TRIM69 Proteins 0.000 description 1
- 102100003447 TRIM69 Human genes 0.000 description 1
- UWYZHKAOTLEWKK-UHFFFAOYSA-N Tetrahydroisoquinoline Chemical compound C1=CC=C2CNCCC2=C1 UWYZHKAOTLEWKK-UHFFFAOYSA-N 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 229910010320 TiS Inorganic materials 0.000 description 1
- 229960004319 Trichloroacetic Acid Drugs 0.000 description 1
- YNJBWRMUSHSURL-UHFFFAOYSA-N Trichloroacetic acid Chemical compound OC(=O)C(Cl)(Cl)Cl YNJBWRMUSHSURL-UHFFFAOYSA-N 0.000 description 1
- IYDQMLLDOVRSJJ-UHFFFAOYSA-N Triethyloxonium tetrafluoroborate Chemical compound F[B-](F)(F)F.CC[O+](CC)CC IYDQMLLDOVRSJJ-UHFFFAOYSA-N 0.000 description 1
- QAEDZJGFFMLHHQ-UHFFFAOYSA-N Trifluoroacetic anhydride Chemical compound FC(F)(F)C(=O)OC(=O)C(F)(F)F QAEDZJGFFMLHHQ-UHFFFAOYSA-N 0.000 description 1
- WVLBCYQITXONBZ-UHFFFAOYSA-N Trimethyl phosphate Chemical compound COP(=O)(OC)OC WVLBCYQITXONBZ-UHFFFAOYSA-N 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Tris Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- 229960005356 Urokinase Drugs 0.000 description 1
- 108090000435 Urokinase-type plasminogen activator Proteins 0.000 description 1
- 102000003990 Urokinase-type plasminogen activator Human genes 0.000 description 1
- 210000003462 Veins Anatomy 0.000 description 1
- MRAHIVCBBZNVHV-UHFFFAOYSA-M [Br-].N#CC1=CC=CC=C1 Chemical compound [Br-].N#CC1=CC=CC=C1 MRAHIVCBBZNVHV-UHFFFAOYSA-M 0.000 description 1
- WWNGFIHAFUDJBO-UHFFFAOYSA-O [amino(hydroxy)methylidene]-ethylazanium;tetrafluoroborate Chemical compound F[B-](F)(F)F.CC[NH+]=C(N)O WWNGFIHAFUDJBO-UHFFFAOYSA-O 0.000 description 1
- CLZISMQKJZCZDN-UHFFFAOYSA-N [benzotriazol-1-yloxy(dimethylamino)methylidene]-dimethylazanium Chemical compound C1=CC=C2N(OC(N(C)C)=[N+](C)C)N=NC2=C1 CLZISMQKJZCZDN-UHFFFAOYSA-N 0.000 description 1
- CDXSJGDDABYYJV-UHFFFAOYSA-N acetic acid;ethanol Chemical compound CCO.CC(O)=O CDXSJGDDABYYJV-UHFFFAOYSA-N 0.000 description 1
- DBJUEJCZPKMDPA-UHFFFAOYSA-N acetic acid;zinc Chemical compound [Zn].CC(O)=O DBJUEJCZPKMDPA-UHFFFAOYSA-N 0.000 description 1
- 239000012346 acetyl chloride Substances 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N al2o3 Chemical compound [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 125000003158 alcohol group Chemical group 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 238000005804 alkylation reaction Methods 0.000 description 1
- 125000004397 aminosulfonyl group Chemical group NS(=O)(=O)* 0.000 description 1
- 235000012538 ammonium bicarbonate Nutrition 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- 235000011114 ammonium hydroxide Nutrition 0.000 description 1
- 238000002399 angioplasty Methods 0.000 description 1
- 150000008064 anhydrides Chemical class 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 235000010357 aspartame Nutrition 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 125000004429 atoms Chemical group 0.000 description 1
- 125000000477 aza group Chemical group 0.000 description 1
- ZXVOCOLRQJZVBW-UHFFFAOYSA-N azane;ethanol Chemical compound N.CCO ZXVOCOLRQJZVBW-UHFFFAOYSA-N 0.000 description 1
- BCTILSWHJRTUIE-UHFFFAOYSA-N azanium;4-[4-[bis[4-(dimethylamino)phenyl]-hydroxymethyl]-3-methyl-5-oxo-4H-pyrazol-1-yl]benzenesulfonate Chemical compound [NH4+].C1=CC(N(C)C)=CC=C1C(O)(C=1C=CC(=CC=1)N(C)C)C1C(=O)N(C=2C=CC(=CC=2)S([O-])(=O)=O)N=C1C BCTILSWHJRTUIE-UHFFFAOYSA-N 0.000 description 1
- PCCNIENXBRUYFK-UHFFFAOYSA-O azanium;cerium(4+);pentanitrate Chemical compound [NH4+].[Ce+4].[O-][N+]([O-])=O.[O-][N+]([O-])=O.[O-][N+]([O-])=O.[O-][N+]([O-])=O.[O-][N+]([O-])=O PCCNIENXBRUYFK-UHFFFAOYSA-O 0.000 description 1
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N benzohydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 239000010974 bronze Substances 0.000 description 1
- 125000004063 butyryl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- CURLTUGMZLYLDI-UHFFFAOYSA-N carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- LKZMBDSASOBTPN-UHFFFAOYSA-N carbonic acid;silver Chemical compound [Ag].OC(O)=O LKZMBDSASOBTPN-UHFFFAOYSA-N 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 125000004181 carboxyalkyl group Chemical group 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- DRWMGJONTCWKES-UHFFFAOYSA-M chloroform;chloride Chemical compound [Cl-].ClC(Cl)Cl DRWMGJONTCWKES-UHFFFAOYSA-M 0.000 description 1
- 230000035602 clotting Effects 0.000 description 1
- 230000001143 conditioned Effects 0.000 description 1
- XLJMAIOERFSOGZ-UHFFFAOYSA-M cyanate Chemical compound [O-]C#N XLJMAIOERFSOGZ-UHFFFAOYSA-M 0.000 description 1
- UKJLNMAFNRKWGR-UHFFFAOYSA-N cyclohexatrienamine Chemical group NC1=CC=C=C[CH]1 UKJLNMAFNRKWGR-UHFFFAOYSA-N 0.000 description 1
- VUJGDEMTTYDVTB-UHFFFAOYSA-N diazanium;ethanol;carbonate Chemical compound [NH4+].[NH4+].CCO.[O-]C([O-])=O VUJGDEMTTYDVTB-UHFFFAOYSA-N 0.000 description 1
- MHDVGSVTJDSBDK-UHFFFAOYSA-N dibenzyl ether Chemical compound C=1C=CC=CC=1COCC1=CC=CC=C1 MHDVGSVTJDSBDK-UHFFFAOYSA-N 0.000 description 1
- RWSOTUBLDIXVET-UHFFFAOYSA-N dihydrogen sulfide Chemical compound S RWSOTUBLDIXVET-UHFFFAOYSA-N 0.000 description 1
- HRKQOINLCJTGBK-UHFFFAOYSA-N dihydroxidosulfur Chemical compound OSO HRKQOINLCJTGBK-UHFFFAOYSA-N 0.000 description 1
- 239000000539 dimer Substances 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 239000008298 dragée Substances 0.000 description 1
- HZAXFHJVJLSVMW-UHFFFAOYSA-N ethanolamine Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 1
- VGGSQFUCUMXWEO-UHFFFAOYSA-N ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 1
- 125000003754 ethoxycarbonyl group Chemical group C(=O)(OCC)* 0.000 description 1
- GKTHZSUTDPZKAF-UHFFFAOYSA-N ethyl 2-[5-amino-2-[(4-cyanophenoxy)methyl]benzimidazol-1-yl]acetate Chemical compound N=1C2=CC(N)=CC=C2N(CC(=O)OCC)C=1COC1=CC=C(C#N)C=C1 GKTHZSUTDPZKAF-UHFFFAOYSA-N 0.000 description 1
- KCDRUSRAFNSFCD-UHFFFAOYSA-N ethyl 2-[6-[benzenesulfonyl-[2-(dimethylamino)ethyl]amino]-2-[(4-cyanophenoxy)methyl]benzimidazol-1-yl]acetate Chemical compound N=1C2=CC=C(N(CCN(C)C)S(=O)(=O)C=3C=CC=CC=3)C=C2N(CC(=O)OCC)C=1COC1=CC=C(C#N)C=C1 KCDRUSRAFNSFCD-UHFFFAOYSA-N 0.000 description 1
- IKRKHOPNHCZJOO-UHFFFAOYSA-N ethyl 2-[6-amino-2-[(4-cyanophenoxy)methyl]benzimidazol-1-yl]acetate Chemical compound N=1C2=CC=C(N)C=C2N(CC(=O)OCC)C=1COC1=CC=C(C#N)C=C1 IKRKHOPNHCZJOO-UHFFFAOYSA-N 0.000 description 1
- HDTYMPYMKGMFMG-UHFFFAOYSA-N ethyl 2-[[2-[(4-carbamimidoylanilino)methyl]-3-methyl-1-benzofuran-6-yl]-quinolin-8-ylsulfonylamino]acetate;hydrochloride Chemical compound Cl.C=1C=CC2=CC=CN=C2C=1S(=O)(=O)N(CC(=O)OCC)C(C=C1O2)=CC=C1C(C)=C2CNC1=CC=C(C(N)=N)C=C1 HDTYMPYMKGMFMG-UHFFFAOYSA-N 0.000 description 1
- ZRUQGQBLBCUDNQ-UHFFFAOYSA-N ethyl 2-[[2-[(4-carbamimidoylphenoxy)methyl]-3H-benzimidazol-5-yl]-quinolin-8-ylsulfonylamino]acetate Chemical compound C=1C=CC2=CC=CN=C2C=1S(=O)(=O)N(CC(=O)OCC)C(C=C1N2)=CC=C1N=C2COC1=CC=C(C(N)=N)C=C1 ZRUQGQBLBCUDNQ-UHFFFAOYSA-N 0.000 description 1
- YWKVLDDDLFHTPM-UHFFFAOYSA-N ethyl 2-[[2-[(4-carbamimidoylphenoxy)methyl]-4-methylquinolin-7-yl]-quinolin-8-ylsulfonylamino]acetate;hydrochloride Chemical compound Cl.C=1C=CC2=CC=CN=C2C=1S(=O)(=O)N(CC(=O)OCC)C(C=C1N=2)=CC=C1C(C)=CC=2COC1=CC=C(C(N)=N)C=C1 YWKVLDDDLFHTPM-UHFFFAOYSA-N 0.000 description 1
- WTUNHBFAIGBNFS-UHFFFAOYSA-N ethyl 2-[[2-[(4-cyanoanilino)methyl]-3-methyl-1-benzofuran-6-yl]-quinolin-8-ylsulfonylamino]acetate Chemical compound C=1C=CC2=CC=CN=C2C=1S(=O)(=O)N(CC(=O)OCC)C(C=C1O2)=CC=C1C(C)=C2CNC1=CC=C(C#N)C=C1 WTUNHBFAIGBNFS-UHFFFAOYSA-N 0.000 description 1
- QUSNBJAOOMFDIB-UHFFFAOYSA-N ethyl amine Chemical compound CCN QUSNBJAOOMFDIB-UHFFFAOYSA-N 0.000 description 1
- 229960004222 factor IX Drugs 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 125000001153 fluoro group Chemical group F* 0.000 description 1
- 238000005187 foaming Methods 0.000 description 1
- YVUBWJOBCFNMES-UHFFFAOYSA-N formamide;pyridine Chemical compound NC=O.C1=CC=NC=C1 YVUBWJOBCFNMES-UHFFFAOYSA-N 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 description 1
- 238000001640 fractional crystallisation Methods 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N fumaric acid Chemical compound OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 125000003104 hexanoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- KLGZELKXQMTEMM-UHFFFAOYSA-N hydride Chemical compound [H-] KLGZELKXQMTEMM-UHFFFAOYSA-N 0.000 description 1
- 229960000443 hydrochloric acid Drugs 0.000 description 1
- YZCKVEUIGOORGS-UHFFFAOYSA-N hydrogen atom Chemical compound [H] YZCKVEUIGOORGS-UHFFFAOYSA-N 0.000 description 1
- 229910000042 hydrogen bromide Inorganic materials 0.000 description 1
- 229910000037 hydrogen sulfide Inorganic materials 0.000 description 1
- FUKUFMFMCZIRNT-UHFFFAOYSA-N hydron;methanol;chloride Chemical compound Cl.OC FUKUFMFMCZIRNT-UHFFFAOYSA-N 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxyl anion Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 description 1
- 125000004029 hydroxymethyl group Chemical group [H]OC([H])([H])* 0.000 description 1
- UTCSSFWDNNEEBH-UHFFFAOYSA-N imidazo[1,2-a]pyridine Chemical compound C1=CC=CC2=NC=CN21 UTCSSFWDNNEEBH-UHFFFAOYSA-N 0.000 description 1
- 150000003949 imides Chemical class 0.000 description 1
- 239000012442 inert solvent Substances 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- XMBWDFGMSWQBCA-UHFFFAOYSA-M iodide Chemical compound [I-] XMBWDFGMSWQBCA-UHFFFAOYSA-M 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 229940099690 malic acid Drugs 0.000 description 1
- 229960002510 mandelic acid Drugs 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000000155 melt Substances 0.000 description 1
- CERQOIWHTDAKMF-UHFFFAOYSA-M methacrylate Chemical compound CC(=C)C([O-])=O CERQOIWHTDAKMF-UHFFFAOYSA-M 0.000 description 1
- YDCHPLOFQATIDS-UHFFFAOYSA-N methyl 2-bromoacetate Chemical compound COC(=O)CBr YDCHPLOFQATIDS-UHFFFAOYSA-N 0.000 description 1
- GZUXJHMPEANEGY-UHFFFAOYSA-N methyl bromide Substances BrC GZUXJHMPEANEGY-UHFFFAOYSA-N 0.000 description 1
- 239000008108 microcrystalline cellulose Substances 0.000 description 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 1
- 229940016286 microcrystalline cellulose Drugs 0.000 description 1
- YNAVUWVOSKDBBP-UHFFFAOYSA-N morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 description 1
- 229940113083 morpholine Drugs 0.000 description 1
- 125000001280 n-hexyl group Chemical group C(CCCCC)* 0.000 description 1
- NHNBFGGVMKEFGY-UHFFFAOYSA-N nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 1
- 239000012299 nitrogen atmosphere Substances 0.000 description 1
- GQPLMRYTRLFLPF-UHFFFAOYSA-N nitrous oxide Inorganic materials [O-][N+]#N GQPLMRYTRLFLPF-UHFFFAOYSA-N 0.000 description 1
- 230000003000 nontoxic Effects 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 230000003287 optical Effects 0.000 description 1
- 150000002905 orthoesters Chemical class 0.000 description 1
- 150000002923 oximes Chemical class 0.000 description 1
- 238000002496 oximetry Methods 0.000 description 1
- 125000001820 oxy group Chemical group [*:1]O[*:2] 0.000 description 1
- 230000020477 pH reduction Effects 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- RLZZZVKAURTHCP-UHFFFAOYSA-N phenanthrene-3,4-diol Chemical compound C1=CC=C2C3=C(O)C(O)=CC=C3C=CC2=C1 RLZZZVKAURTHCP-UHFFFAOYSA-N 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 125000002071 phenylalkoxy group Chemical group 0.000 description 1
- XYFCBTPGUUZFHI-UHFFFAOYSA-N phosphine Chemical compound P XYFCBTPGUUZFHI-UHFFFAOYSA-N 0.000 description 1
- XYFCBTPGUUZFHI-UHFFFAOYSA-O phosphonium Chemical compound [PH4+] XYFCBTPGUUZFHI-UHFFFAOYSA-O 0.000 description 1
- 229910000073 phosphorus hydride Inorganic materials 0.000 description 1
- 125000001557 phthalyl group Chemical group C(=O)(O)C1=C(C(=O)*)C=CC=C1 0.000 description 1
- 229920000137 polyphosphoric acid Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 239000004323 potassium nitrate Substances 0.000 description 1
- 235000010333 potassium nitrate Nutrition 0.000 description 1
- 125000001501 propionyl group Chemical group O=C([*])C([H])([H])C([H])([H])[H] 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- SHNUBALDGXWUJI-UHFFFAOYSA-N pyridin-2-ylmethanol Chemical compound OCC1=CC=CC=N1 SHNUBALDGXWUJI-UHFFFAOYSA-N 0.000 description 1
- AOJFQRQNPXYVLM-UHFFFAOYSA-N pyridine hydrochloride Substances [Cl-].C1=CC=[NH+]C=C1 AOJFQRQNPXYVLM-UHFFFAOYSA-N 0.000 description 1
- KAESVJOAVNADME-UHFFFAOYSA-N pyrrole Chemical compound C=1C=CNC=1 KAESVJOAVNADME-UHFFFAOYSA-N 0.000 description 1
- 239000002516 radical scavenger Substances 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 200000000008 restenosis Diseases 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- LKZMBDSASOBTPN-UHFFFAOYSA-L silver carbonate Substances [Ag].[O-]C([O-])=O LKZMBDSASOBTPN-UHFFFAOYSA-L 0.000 description 1
- 229910001958 silver carbonate Inorganic materials 0.000 description 1
- 229910001923 silver oxide Inorganic materials 0.000 description 1
- 235000009518 sodium iodide Nutrition 0.000 description 1
- POECFFCNUXZPJT-UHFFFAOYSA-M sodium;carbonic acid;hydrogen carbonate Chemical compound [Na+].OC(O)=O.OC([O-])=O POECFFCNUXZPJT-UHFFFAOYSA-M 0.000 description 1
- OTNVGWMVOULBFZ-UHFFFAOYSA-N sodium;hydrochloride Chemical compound [Na].Cl OTNVGWMVOULBFZ-UHFFFAOYSA-N 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 239000001384 succinic acid Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 125000000446 sulfanediyl group Chemical group *S* 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-N sulfonic acid Chemical compound OS(O)=O LSNNMFCWUKXFEE-UHFFFAOYSA-N 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 125000005931 tert-butyloxycarbonyl group Chemical group [H]C([H])([H])C(OC(*)=O)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 150000003509 tertiary alcohols Chemical class 0.000 description 1
- 150000007970 thio esters Chemical class 0.000 description 1
- 230000002537 thrombolytic Effects 0.000 description 1
- 230000001732 thrombotic Effects 0.000 description 1
- 230000001550 time effect Effects 0.000 description 1
- 231100000224 toxic side effect Toxicity 0.000 description 1
- 230000001131 transforming Effects 0.000 description 1
- 125000004044 trifluoroacetyl group Chemical group FC(C(=O)*)(F)F 0.000 description 1
- 125000000876 trifluoromethoxy group Chemical group FC(F)(F)O* 0.000 description 1
- 229960001322 trypsin Drugs 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
- JABYJIQOLGWMQW-UHFFFAOYSA-N undec-4-ene Chemical compound CCCCCCC=CCCC JABYJIQOLGWMQW-UHFFFAOYSA-N 0.000 description 1
- 238000005292 vacuum distillation Methods 0.000 description 1
- 125000003774 valeryl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Abstract
The invention relates to disubstituted bicyclic heterocycles of general formula (I) Ra - Het - B - Ar - E, in which Ra, Ar, B, Het and E are defined as in Claim No. 1, to their tautomers, their stereoisomers, their mixtures, their salts, and to the production thereof. The invention also relates to the medicaments containing the pharmacologically active compounds and to their application. The compounds of the general formula (I), in which E represents a cyano group, depict valuable intermediate products for producing the remaining compounds of general formula (I), and the compounds of said general formula (I), in which E represents an RbNH-C(=NH) group, comprise valuable pharmacological properties, in particular, a thrombin inhibitive and thrombin time prolonging effect.
Description
BICICLIC HETEROCICLES D I REPLACED ITS PREPARATION AND ITS EMPLOYMENT AS A MEDICATION
DESCRIPTION OF THE INVENTION The object of the present invention are new bicyclic di-substituted heterocycles of the general formula Ra-Het-B-Ar-E, (I) their tautomers, their stereoisomers, their mixtures and their salts, in particular their salts physiologically compatible with inorganic or organic acids or bases, which have valuable properties. The compounds of the general formula I above, in which E represents a cyano group, represent valuable intermediates for the preparation of the remaining compounds of the general formula I, and the compounds of the general formula I above in which E represents a grupc RbNH-C (= NH), as well as its tautomers and its eisomers, have valuable pharmacological properties, in particular an inhibitory effect of thrombin and thrombin time extender. Accordingly, the new compounds of formula I above, as well as their preparation, the medicaments containing the pharmacologically active compounds and their use are subject of the present application. In the above general formula, B means an ethylene group, optionally substituted with one or two two C? _3 alkyl groups, a methylene group of the ethylene group, which is linked to the Het or Ar radical, may be replaced by an oxygen atom or sulfur, by a sulfamyl, sulfonyl, carbonyl or -NRi group, Ri representing a hydrogen atom or a C? -6 alkyl group, or B also means a straight chain C3_5 alkylene group, in which a methylene group, which is not linked to the radical Het or to the radical Ar, is replaced by a group -NRX, in which Ri is defined as mentioned above, E means a cyano group or RbNH-C (= NH), in wherein Rb represents a hydrogen atom, a hydroxy group, a C1-3 alkyl group or an in vivo cleavable radical, Ar means a phenylene or naphthylene group, sometimes substituted with a fluorine atom,
chlorine or bromine, with a group t r i f 1 u or r ome t 11 o,
C3_3alkyl or C1-3alkoxy, means a thienylene, thiazolylene, pyridinylene, pyrimidine, pyridinylidene group, optionally substituted on the carbon skeleton with a C1_alkyl group; 3, Het means a bicyclic heterocycle of
the f or rmu 1 to X represents a nitrogen atom or a methino group, optionally substituted with a C 1-3 alkyl group, and Y represents an imino group, optionally substituted with a C 1-5 alkyl or C 3-7 cycloalkyl group, An oxygen or sulfur atom or X represents a nitrogen atom and represents an imino group substituted with a C 1-5 alkyl or C 3-7 cycloalkyl group, the alkyl and cycloalkyl substituent being in each case substituted with a carboxy group or with a group transformable in vivo in a carboxy group, being able
to be replaced in one of the above-mentioned heterocycles additionally a group
.- «^ sa» a ^ & - ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^^^^^^^^^^^^^^^^ ~ & *. r. $ r # * > # ü & * non-angular methine for a nitrogen atom, or Het means a group of the formulas.
Ri being defined as mentioned above, and Ra, means a phenyl-C1-3 alkoxy group, an amino group, a C3_3-amino alkyl group which is substituted at the nitrogen atom additionally with a phenol group 1 - a 1 qu i 1 or C1-3, a group R3-CO-R4N c R3-SO2-R4N, wherein R3 represents a C1-5 alkyl group, phenylC1-3 alkyl, C3-7 cycloalkyl, phenyl, naphthyl, pyridyl, quinolyl, isoquinolyl, tetrahi dr oqu i no 1 i 1 ootetr ah i dr o 1 s oqu i no 1 i 1 oy
R 4 represents a hydrogen atom, a C 1 _ 5 alkyl group of 1 to 1 1 to 1 to 1 to 3 to 3, which in each case is substituted on the alkyl part with a group which can be converted in vivo into a carboxy group; with a carboxy or tetrazolyl group, with an aminocarbonyl group or C 1 _ 3 -aminocarbonyl group, which in each case are additionally substituted on the nitrogen atom with a group which can be transformed in vivo into a carboxymethyl group; 1 qu i 1 o C? -3, or with a
The carboxy group represents a C2-s alkyl group substituted in the terminal position with a di- (C1-3 alkyl) -araino group, or a C3-7 cycloalkyl group. By a group which can be converted in vivo into a carboxy group, it is to be understood, for example,
The hydroxymethyl group, a carboxy group esterified with an alcohol in which the alcohol part is preferably a Ci-e alkanol, a 1-to-1-cycloalkanol C1-3, a cycloalkanol 03-9, and a C5-cycloalkanol may be substituted. -8 additionally with one or two
C 1-3 alkyl groups, a C 5 -s cycloalkanol in which a methylene group in the 3 or 4 position is replaced by an oxygen atom or by an imino group, optionally substituted with a C 1-3 alkyl group, phenyl 1 - at 1 qu i 1 or C 1 _ 3, phenyl-C 1 _ 3 -25 alkoxycarbonyl or C 2-6 alkanoyl. and the part of
The cycloalkanol may be further substituted with one or two C1-3 alkyl groups, a C1 1 or a 1 that is not 1 C4-7, a C3-5 alkenol, a f in i1-a1 which does not 1 C3-.5, a C3-5 alkynol of ofin 1 - a 1 qui not 1 C3-5, with the proviso that no bond in the oxygen atom starts from a carbon atom carrying a double or triple bond, a C3-C3-β-alkanol C1-3 cycloalkyl, a bicyclic 1 or a ca 1 with a total of 8 to 10 carbon atoms that in the bicyclic part 1 or 1 that is additionally substituted with one or two alkyl groups C1-3, a 1,3-dihydro or -3-oxo-1-is obe nzofura no 1 or an alcohol of the formula R 5 -CO-O- (R 6CR 7) -OH, wherein R 5 represents a group Ci-a alkyl, C 5 7 cycloalkyl, phenyl 1 to 1 a 1 to 1 to C 1 to 3 phenyl, Rg represents a hydrogen atom, a C 1-3 alkyl group, C 5-7 cycloalkyl or phenyl and R 7 represents a hydrogen atom or ur C 1 _ 3 alkyl group, or by a separable radical i The imino or amino group of uri is to be understood, for example, as a hydroxy group, an acyl group such as the benzoyl or pyridinoyl group or a C?-α6 alkanoyl group, such as the formyl, acetyl, propionyl group,
»« Aanatfaem butanoyl, pentanoyl or hexanoyl, a group at 111 oxycarbon 11, or an alkoxy group C x _ j_ 6- car bon i 1 o such as the group me t ox i ca r bo n 11 o, et ox icar bo n 11 o, pr opox icar bon i 1 o, is op r opox icarb on i 1, butoxicar-bonyl, tert-bu t oxi car bon i 1, pen toxi-car bon i 1, he xo xi ca rb on i 1 o, oc ti 1 ox icar bon i 1 o, non i 1 ox icarbo -rulo, de ci 1 ox i ca rboni 1 o, unde ci 1 ox i ca rb on i 1, dode ci 1 oxi ca r bon i 1 oo hexade ci 1 ox i ca r bon i 1 o, a phenyl-alkoxy group C i? - ca r bon i 1 o such as the benzyloxycarbonyl group, f in i 1 et ox i-carb on i 1 oopheni lp r oppo xicar bon i 1, a C1-3 alkyl group-su 1 f on i 1 a 1 cox 1 C2-4 - ca r bon i 1, C 1 -C 3 alkoxy C 2-4 alkoxy C 2-4 alkoxy -carbonyl or R 5 CO-O- (R 6CR 7) -O-CO, wherein R 5 to R7 are defined as mentioned above. Furthermore, in the definition of the aforementioned alkyl and alkoxy saturated portions containing more than 2 carbon atoms, as well as the unsaturated alkanoyl and alkyl parts, containing more than 3 carbon atoms, are also included their branched isomers such as, for example, the isopropyl, tere-butyl, isobutyl group, etc. Preferred compounds of general formula I above are those in which
£ ¿ Fe-B means an ethylene group, optionally substituted by one or two methyl groups, a methylene group of the ethylene group, which is linked to the radical Het or Ar, may be replaced by an oxygen or sulfur atom, by a carbonyl group or -NRi, Ri representing a hydrogen atom or a methyl group, or B also means an n-propylene group, in which the central methylene group is replaced by a group ~ NR ?, in which Ri is defined as mentioned above, E means a cyano group or RbNH-C (= NH), in which Rb represents a hydrogen atom, a C?-8 alkyloxy group, -carbonyl group, a cyc 1 or a 1 qu i 1 ox i C group 5 -7 - car bon i 1, benzoyl, nicotinoyl or 1 s on icoti no i 1, Ar means a phenylene group, sometimes substituted with a fluorine, chlorine or bromine atom, with a trifluoromethyl, methyl or methoxy group , or a thienylene group, optionally substituted with a methyl group, Het means a bicyclo heterocycle or colic of f r mu 1
• - XU * - * r * -, -, X represents a nitrogen atom or a methine group, optionally substituted with a methyl group, and Y represents an immo group optionally substituted with a C1-3 alkyl group or C3- cycloalkyl group 7, an oxygen or sulfur atom, or X represents a nitrogen atom and Y represents an amino group substituted with a C3-3 alkyl group, the alkyl part being substituted ad 1 c 1 on at the most with a carboxy group. C 1 - 3 alkyloxy-ca rb on 11 o, or Het means a group of the formulas
& amp; & < > i with Ri being defined as mentioned above, and R2 represents a 'C3_3 alkyl group substituted with a carboxy or C1-3-alkoxycarbonyl group, and Ra, means a benzyloxy group, an amino group, an alkylC group? -3-amino which is substituted on the nitrogen atom ad 1 c 1 on at least with a benzyl group, a group R 3 -CO-R 4 N or R 3 -SO 2 -R 4 N, wherein R 3 represents a C 1-4 alkyl group , benzyl, C5-7 cycloalkyl phenyl, pyridyl, qumolyl, isoquinolyl, tetrahi dr oqu 1 not 111 ootetrah 1 drois oqu i no 1 i 1 o and R4 represents a hydrogen atom, a C1-3 alkyl group, which is substituted with a carboxy group, C 1 -3 alkoxycarbonyl or, tetrazolyl, ami nocar bon i 1 oo C 1-3 alkyl-ami no car bon 11 or, the aminocarbonyl and the C 1-3 alkylamino groups being substituted rbon 11 or, in each case at the nitrogen atom, ad 1 cyan ate with a carboxy-C 3 -C 3 alkyl or C 1 -C 3 -alkoxy 11-a 1 group or 11 or C1-3, or a C2-3 alkyl group substituted in terminal position with a di- (C1-3 alkyl) -am group, its isomers and its salts.
Particularly preferred compounds of general formula I above are those in which B means an ethylene group optionally substituted by one or two methyl groups, a methylene group of the ethylene group, which is linked to the radical Het, can be replaced. or Ar, for an oxygen or sulfur atom, for a carbonyl group or -NRlf representing Ri a hydrogen atom or a methyl group, or B also means an n-propylene group, in which the central methylene group is replaced by a group -NRi, in which Ri is defined as mentioned above, E means a group RbNH-C (= NH), in which R represents a hydrogen atom, an alkyloxy group CI-B, -carbonyl, a group cic 1 or 1 qu 11 axi Cs -? - ca r boni 1 oo benzoyl, Ar means a phenylene group, optionally substituted by a fluorine, chlorine or bromine atom, with a trif 1 or r or 111 group, methyl or methoxy, or a thienylene group, optionally substituted with a methyl group in the carbon skeleton, Het means a bicyclic heterocycle of the fo rmu 1 a
X represents a nitrogen atom or a methino group, optionally substituted with a methyl group, and Y represents an imino group, optionally substituted by a C 1-3 alkyl or C 3-7 cycloalkyl group, an oxygen or sulfur atom, or X represents a nitrogen atom and Y represents an imino group substituted with a C.-3 alkyl group. the alkyl part being further substituted with a carboxy or C 1 -C 3 alkyloxycarbonyl group, and Ra means a benzyloxy group, an amino group, a C alqu-3-amino alkyl group which is substituted on the atom of nitrogen ad 1 c 1 ona lme nte with a benzyl group, a group R3-CO-R4N or R3-SO2-R4N, in which R3 represents a C 1 -4 alkyl, benzyl, C5.7 cycloalkyl group, phenyl, pyridyl, quinolyl, isoquinolyl, tetrahydroquio 1 i 1 octetrahidroiso qu ino 1 i 1 oy
JBto ^ asac R4 represents a hydrogen atom, a C1-3 alkyl group, which is substituted with a carboxy group, C1-.3-alkoxycarbonyl, tetrazolyl, aminocarbonyl or C1-3 alkyl-ami no car bo ni 1 o, the aminocarbonyl and C ?3-aminocarbonyl alkyl groups being substituted, in each case at the nitrogen atom, additionally with a C3-3 carboxyalkyl group or C1-3 alkoxy-ca r bon i 1-a 1 qu i 1 o C1-3or a C2-3 alkyl group substituted in terminal position with di- (C 1-3 alkyl) -amino group, in particular those compounds of the above general formula, in which Ra in position 5 means a group R3-CO -R4N or R3-SO2-R4N, which R3 and R4 are defined as mentioned above, their isomers and their salts. Very particularly preferred compounds are those of the general formula
wherein X means a methino group or a nitrogen atom, B means an ethylene group, the methylene group being replaced with Ar being replaced by an oxygen atom or an imino group, Ar means a group 1, 4-pheni 1 e not , E means an amidino group, Ri means a methyl group and Ra, means a group R3-CO-R4N or R3-SO2-R4N, R4 representing a methyl group substituted with a carboxy group, C 1-3 alkoxy - ca r boni 1, car box ime ti 1 ami non -carbonyl or C 1-3 alkoxy - ca rbon i lme ti 1 ami noca r bon i 1 o, and R represents an iso qu io group 11 n - 8 - i 1 o, in particular those compounds of the above-mentioned general formula, in which Ra represents a group R3-CO-R4N, their isomers and their salts. As particularly preferred compounds of the general formula I above, there can be mentioned, for example, the following: (a) l-methyl-2- [(4-amidinophenyl) -oxymethyl] -5- [N- (hydroxycarbonylmethyl) -quinolin- 8-Sulfonylamino] -benzimidazole, (b) l-methyl-2- [2- (4-amidinofenyl) -ethyl] -5- [N- (NT- (hydroxycarbonylmethyl) -aminocarbonylmethyl) -quinolin-8-sulfonylamino] -benzimidazole, (c) l-methyl-2- [N- (4-amidinophenyl) -aminomethyl] -5- [N - (hydroxy-carbonylmethyl) -quinolm-8-sulfonylamino] -benzimidazole and (d) 1 -me ti 1 - 2 - [N - (4-amidi no f eni 1) - aminome ti 1] - 5 - [N - (hydroxycarbonylmethyl) -quinolin-8-sulfonylamino] -indol, as well as their salts. The new compounds can be prepared according to methods known per se, for example according to the following procedures: a. For the preparation of a compound of the general formula I, in which E means a group RbNH-C (= NH), in which Rb represents a hydrogen atom, a hydroxy group or C1_3 alkyl: reaction of a compound, eve tually formed in the reaction mixture, of the general formula Ra - Het - B - Ar - C (= NH) - Z lf (II) wherein B, Ar, Het and Ra are defined as mentioned at the beginning and Zi represents an alkoxy or aralkoxy group such as the methoxy, ethoxy, n-propoxy, isopropoxy or benzyloxy group, or an alkylthio or aralkylthio group such as the methylthio, ethylthio, n-propylthio or benzylthio group, with an amine of the general formula H2N-b ', (III) in which Rb' represents a hydrogen atom, a hydroxy group or C1-3 alkyl. The reaction is conveniently carried out in a solvent such as methanol, ethanol, n-propanol, water, methanol / water, tetrahydrofura or dioxane, at temperatures between 0 and 150 ° C, preferably at temperatures between 20 and 120 ° C, with a compound of the general formula III or with a corresponding salt by addition of acids such as, for example, ammonium carbonate. A compound of the general formula II is obtained, for example, by reaction of a compound of the general formula I, in which E represents a cyano group, with a corresponding alcohol such as methanol, ethanol, n-propanol, isopropanol and alcohol benzyl, in the presence of an acid such as hydrochloric acid, or by reaction of a corresponding amide with a trialkyxonium salt such as triethyloxonium tetrafluoroborate, in a solvent such as methylene chloride, tetrahydrofuran or dioxane,
. soasaste * ..A-. ? temperatures between 0 and 50 ° C, but preferably at 20 ° C, or a corresponding nitrile with hydrogen sulfide, conveniently in a solvent such as pyridine or dimethylformamide and in the presence of a base such as triethylamine and subsequent alkylation of the thioamide formed with a corresponding alkyl or aralkyl halide. b. For the preparation of a compound of the general formula I, in which the group Ra and E are defined as mentioned at the beginning, with the proviso that the group Ra contains a carboxy group and E is defined as at the beginning, or the group Ra, is defined as at the beginning and E represents a group NH2-C (= NH), or the group Ra contains a carboxy group and E represents a group NH2-C (= NH): transformation of a compound of the formula general - Het B - Ar IV in which A, B, Ar and Het are defined as at the beginning and the group Ra 'and E' possess the meanings mentioned at the beginning for the group Ra, and E, with the condition that the group Ra ', contains a group transformable into a carboxyl group by
hydrolysis, treatment with an acid or base, thermolysis or hydrogenolysis, and E is defined as at the beginning, or E 'represents a group which can be transformed into an NH2 -C (= NH) group by hydrolysis, treatment with an acid or base, thermolysis or hydrogenolysis and the group Ra »present the meanings mentioned at the beginning for the group Ra, or the group Ra ', contain a group which can be converted into a carboxyl group by hydrolysis, treatment with an acid or base, thermolysis or hydrogenolysis, and E' represents a group transformable in a NH2-C group (= NH) by hydrolysis, treatment with an acid or a base, thermolysis oh 1 dr ogenol isis, by hydrolysis, treatment with an acid or base, thermolysis oh 1 drogen or 1 is 1 s in a compound of the general formula I, in which the group Ra, and E are defined as mentioned at the beginning, with the proviso that the group Ra contains a carboxy group and E is defined as at the beginning, or the group Ra, present the meanings mentioned at the beginning and E represents a group NH2-C (= NH), or the group Ra, contain a carboxy group and E represents a group NH2-C (= NH).
As a group which can be converted into a carboxy group, for example, a carboxyl group protected by a protective radical, such as its functional derivatives, for example its amides, esters, thioesters, trimer esters, esters, ortho esters, can be used. or imino esters unsubstituted or substituted, conveniently, are transformed into a carboxyl group by hydrolysis, esters thereof with tertiary alcohols, for example the tert-butyl ester, which is transformed into a conveniently carboxyl group by treatment with an acid or thermolysis, and its esters with aralkanols, for example the benzyl ester, which are conveniently converted to a carboxyl group by means of hi drge or 1 isis. The hydrolysis is conveniently carried out in the presence of an acid such as hydrochloric acid, sulfuric acid, phosphoric acid, acetic acid, trichloroacetic acid, trifluoroacetic acid or mixtures thereof, or in the presence of a base such as lithium hydroxide, sodium hydroxide or potassium hydroxide in a suitable solvent such as water, water / water no. 1, water / ethanol, water / water, alcohol, ethanol, water / ethanol / dioxane, to
- ff lte & aifeisá-jü *.
temperatures between -10 and 120 ° C, for example at temperatures between room temperature and the boiling temperature of the reaction mixture. If the group Ra ', and / or E' in a compound of the formula IV contains, for example, the tere-butyl or tert-butyloxycarbonyl group; then these can also be separated by treatment with an acid such as trifluoroacetic acid, formic acid, p-to-1 acid, not its 1-ion, sulfuric acid, hydrochloric acid, phosphoric acid or po-phosphonic acid, optionally in an inert dioxane, preferably at temperatures between -10 and 120 ° C, for example at temperatures between 0 and 60 ° C, or also thermally, optionally solvent such as methylene chloride, chloroform, benzene, toluene, diethyl ether, tetrahydrofuran or in a inert solvent such as methylene chloride, chloroform, benzene, toluene, tetrahydrofuran or dioxane and preferably in the presence of a catalytic amount of an acid such as p -t 1 ue not its 1f ng ico, sulfuric acid, phosphoric acid or polyphosphoric acid, preferably at the boiling point of the solvent used, for example at temperatures between 40 and 120 ° C.
If the group Ra ', and / or E' in a compound of the formula IV contains, for example, the benzyloxy or be cycloxycarbonyl group, then these can also be separated by hydrogenation in the presence of a hydrogenation catalyst such as 1 a di / car bon in a suitable solvent such as methanol, ethanol, ethanol / water, glacial acetic acid, ethyl acetate, dioxane or dimethylene, preferably at temperatures between 0 and 50 ° C, for example at room temperature, and a hydrogen pressure of 1 to 5 bars. c. For the preparation of a compound of the general formula I, in which the group Ra contains one of the ester groups mentioned at the beginning in the definition of the group Ra: reaction of a compound of the general formula Ra "- Het - B - Ar - E, (V) in which B, E, Ar and Het are defined as at the beginning and the group Ra "has the meanings mentioned at the beginning for the group Ra, with the proviso that the group Ra" contains a carboxyl group or a group which can be converted into a corresponding ester group by an alcohol, with an alcohol of the general formula HO-R8, (VI) in which Rβ represents the alkyl part of one of the in vivo separable radicals mentioned at the beginning, exception of the group R5-C0-0- (R5 CR7) for a carboxyl group, or with its formamidoacetals or with a compound of the general formula Z2-R9, (VII) in which Rg represents the alkyl part of one of the in vivo separable radicals mentioned at the beginning, with the exception of the group R5-CO-O- (R5CR7) for a carboxyl group and Z2 represents a leaving group such as a halogen atom, for example a chlorine or bromine atom. The reaction with an alcohol of the general formula VI is conveniently carried out in a solvent or mixture of solvents such as methylene chloride, benzene, toluene, chlorobenzene or, tetrahydrofuran, benzene / tetrahydrofuran or dioxane, but preferably in an alcohol of the general formula VI, optionally in the presence of an acid such as hydrochloric acid in the presence of a water subtracting agent, for example in the presence of isobutyl ester of c 1 oroformate, thionyl chloride, tr ime ti 1 c 1 orosi 1 ano, hydrochloric acid, sulfuric acid, metanic acid, ionic acid, non-ionic acid, phosphorus trichloride, phosphorus pentoxide, N, N '- di cic 1 ohex i 1 ca rb odi imi da, N, N '-dicic 1 ohe xicarb odi imi da / N -hi dr ox is uc cin imi da, N, N'-carbonyldiimidazole or N, N' - ti on 11 di imi da zo 1, trifei 1 fosfi na / tetrac 1 oruro de carbon otrifeni 1 phosphine / diethyl ether of aza di car bo bo x 11 co, optionally in the presence of a base such as potassium carbonate, N-ethyl-di is op r op i 1 amine or N, N-dimime ti 1-ami not -pyridine, conveniently at temperatures between 0 and 150 ° C, preferably at temperatures between 0 and 80 ° C. With a compound of the general formula VII, the reaction is conveniently carried out in a solvent such as methylene chloride, tetrahydrofuran, dioxane, dimethyl ether, dimethylamine or acetone, optionally the presence of a reaction accelerator such as sodium or potassium iodide and, preferably, in the presence of a base such as sodium carbonate or potassium carbonate or in the presence of a tertiary organic base such as -e 1 1 -di is op r op i 1 amine or N-eti 1 -mo rfo 1 i na which, at the same time, can also serve as solvents, or possibly in the presence of silver carbonate or silver oxide, at temperatures between -30 and 100 ° C, but preferably at temperatures between -10 and 80 ° C. d. For the preparation of a compound of 0 the general formula I, in which Rb represents a radical that can be separated in vivo: reaction of a compound of the general formula Ra-Het-B-Ar-C (= NH) -NH2, (VII ) In which Ra, Het, B and Ar are defined as in the beginning, with a compound of the general formula Z3-Rio, (IX) wherein 0 Rio means a radical that can be separated in vivo and Z3 means a nucleophilic leaving group such as a halogen atom, for example a chlorine, bromine or iodine atom. The reaction is carried out advantageously in a solvent such as methanol, ethanol, chloride
Methylene, tetrahydrofuran, toluene, dioxane, dimer, its 1-oxide or dimethylformamide, optionally in the presence of an inorganic base or a tertiary organic base, preferably at temperatures between 20 ° C and 20 ° C. boiling temperature of the solvent used. With a compound of the general formula IX, in which Z3 represents a nucleophilic leaving group, the reaction is preferably carried out in a
The solvent, such as methylene chloride, aceton on 11 r 11, tetrahydrofuran, toluene, dimethylformamide or dimethylamine, optionally in the presence of a base such as sodium hydride, potassium carbonate, tert. bu 111 potassium or N - 15 and 111 - di 1 s op r op 11 ami na, at temperatures between 0 and 60 ° C. and. For the preparation of a compound of the general formula I, in which Ra represents an amino group and E represents a cyano group: reduction of a nitro compound of the general formula N02 - Het - B - Ar - CN, (X ) where B, Ar and Het are defined as
mentioned at the beginning.
The reduction is preferably carried out by hydrogenolysis, for example with hydrogen, in the presence of a catalyst such as pa 1 a di / / car bon, in a solvent such as methanol, ethanol, acetic acid ethyl ester, dimethylformamide, tell me The reaction is carried out with glacial acetic acid, optionally with the addition of an acid such as hydrochloric acid, at temperatures between 0 and 50 ° C, but preferably at room temperature and at a hydrogen pressure of 1 to 7. Bars, but preferably from 3 to 5 bars. This can also be carried out with nascent hydrogen, for example with zinc / glacial acetic acid, zinc / hydrochloric acid or iron or their suitable salts with hydrochloric acid. f. For the preparation of a compound of the general formula I, in which Ra represents an amino group and E represents a cyano group: separation of a protective radical for an amino group of a compound of the general formula Ra "- Het - B - Ar - CN, (XI) in which B, Ar and Het are defined as mentioned at the beginning and
«To adftaia & - < - r:, z. ^ 2; -j ?? "Ra" means an amino group protected by a protective radical, as the protective radical for an amino group, for example, the acetyl group, trifluoroacetyl, benzoyl, ethoxycarbonyl, tert-bu t ox i ca r boni 1 o, benzyloxycarbonyl, benzyl, me t ox i be nc i 1, 2, 4-d ime t ox ibenci 1 oof such ilo. The separation of a protective radical used is preferably carried out by hydrolysis in an aqueous solvent, for example in water, isop ripa no 1 / a gua, tetrahydrofuran / gua odi oxa no / a gu a, in the presence of an acid such as trifluoroacetic acid, hydrochloric acid or sulfuric acid, or in the presence of an alkali metal base such such as lithium hydroxide, sodium hydroxide or potassium hydroxide, or by separation of the ether, for example in the presence of and with a temperature of 1 to 1, at temperatures between 0 and 100 ° C, preferably at temperatures between 10 and 50 ° C, the separation d A benzyl radical, a methoxybenzyl radical, or an oxycarbon radical, is preferably carried out by hydrogenation, for example with hydrogen in the presence of a catalyst such as carbon dioxide, in a solvent such as methanol, ethanol, acetic acid ethyl ester, dimethylaminophenone, dime ti 1 fo rmami a / a cetane or glacial acetic acid, possibly with acidic acid such as hydrochloric acid, at temperatures between 0 and 50 ° C, but preferably at room temperature, and at a hydrogen pressure of 1 to 7 bar, but preferably 3 to 5 bar, the separation of a me t ox i be nci 1 group is also effected in the presence of an oxidizing agent such as nitrous (IV) ammonium nitrate, in a solvent such as methylene chloride, acetonitrile or acetonitrile / water, at temperatures between 0 and 50 ° C, but preferably at room temperature, the separation of a 2, 4-d-methyl or oxenc-11 radical is preferably carried out in trifluoroacetic acid in the presence of anisole, the separation of a radical tere -butyl orbit-1-butylated oxycarbonate is preferably carried out by treatment with an acid such as trifluoric acid or hydrochloric acid, optionally with the use of a solvent such as methylene chloride, dioxane or ether, the separation of a phthalyl radical is preferably carried out in the presence of hydrazine or of a primary amine such as methylamine,
The solvent is obtained in a solvent such as methanol, ethanol, isopropanol, toluene / water or dioxane, at temperatures between 20 and 50 ° C, the separation of a radical from The oximetry is also carried out by treatment with a catalytic amount of tetrakis- (triphenylphosphma) -palladium (O), preferably in a solvent such as tetrahydrofuran and preferably in the presence of an excess of such a base. as morphol or 1,3-dimedone, at temperatures between 0 and 100 ° C, preferably at room temperature and under inert gas, or by treatment with a catalytic amount of tris- (triphenylphosphine) -rod chloride or (I) in a solvent such as aqueous ethanol and, optionally, in the presence of a base such as 1, 4-diaz ab icic 1 or [2.2.2] or t, at temperatures between 20 and 70 ° C. g. For the preparation of a compound of the general formula I, in which Ra represents a group R3-CO-R4N or R3-SO2-R4N and E represents a cyano group: reaction of a compound of the general formula R4NH-Het-B - Ar - CN, (XII) in which
.- «& mSn > aHS. *.-..- »< ,, R4, Het, B and Ar are defined as mentioned at the beginning, with a compound of the general formula R3-X-Z4, (XIII) wherein R3 is defined as mentioned at the beginning, X means a carbonyl or sulfonyl group and Z4 means a nucleophobic leaving group such as a halogen atom, for example a chlorine, bromine or iodine atom or, also, in the case where X represents a carbonyl group, means, together with another carbon atom. hydrogen of the contiguous nitrogen atom, another bond bond - n 11 r oge no. The reaction is preferably carried out in a solvent such as methanol, ethanol, methylene chloride, tetrahydrofuran, toluene, dioxane, dιme 111 its 1-fold or dime-111 foaming, optionally in the presence of of an inorganic base or a tertiary organic base, preferably at temperatures between 20 ° C and the boiling temperature of the solvent employed. With a compound of the general formula XIII, in which Z4 represents a nucleophobic leaving group, the reaction is preferably carried out in a solvent such as methylene chloride, acetonitrile, tetrahydrofuran, toluene, 1-methyl bromide or dimethyl ether. 111 its 1-oxime, 5 optionally in the presence of a base such as sodium hydride, potassium carbonate, pyridine, potassium tert-bu 111 potassium or N-eti 1-di is op r op 11 amine, a temperatures between 0 and 60 ° C. h. For the preparation of a compound of the
General formula I, in which Ra represents a group R3-CO-R4N or R3-S02-R4N and E represents a cyano group, where R4 is defined as mentioned at the beginning, with the exception of the hydrogen atom: reaction of a compound of the general formula R3-X-NH-Het-B-Ar-CN, (XIV) wherein R3, Het, B, Ar and X are defined as mentioned at the beginning, with a compound of the formula general R4 '- Z5, (XV) in which R4' possesses, with the exception of the hydrogen atom, the meanings mentioned at the beginning for R4 and
l ~ ^.? - fcfefe3aíÍÉfe-¿- ** - > Z5 means a nucleophilic leaving group such as a halogen atom, for example a chlorine, bromine or iodine atom. The reaction is preferably carried out in a solvent such as methylene chloride, acet on 11 r 11, acetone, tetrahydrofura no, toluene, dime 111 fo rmami da odime 111 su xix, suitably in the presence of a base such as sodium hydride, potassium carbonate, pyridine, 1, 8-diaz ab icic 1 or [5.4.0] unde c-7-ene, tert -bu 111 ato potassium or N-e 111-di is op r op 11 ami na, at temperatures between 0 and 60 ° C. i. For the preparation of a compound of the general formula I, in which R 4 represents a C alquilo-5 alkyl group ofen 11 - a 1 qu 11 or C _ 3, which is substituted in each case in the alkyl part with a group transformable in vivo in a carboxy group, with a tetrazolyl group, with a group ami no car bon 11 oo alkyl C 1-3 - ami ocar bon 11 or, which in each case are substituted at the nitrogen atom, di c 1 ona lme nte, with a group transformable in vivo in a ca box group 1 - to 1 qu 11 or C1-3, and E represents a cyano group: reaction of a compound of the general formula R3 - X - NR4 '- Het - B - Ar - CN, (XVI) e that R 3, Het, B, Ar and X are defined as mentioned at the beginning and R 'means a C 1-5 alkyl or phenyl-C 1 -C 3 alkyl group, which in each case is substituted the alkyl part with a group which can be transformed in vivo into a carboxy group, with a tetrazolyl group, with an aminocarbonyl group or C C-3-amino-carbonyl alkyl which, in each case, is substituted at the nitrogen atom, additionally with a group transformable in vivo in a car box group i-a 1 qu i 1 or C1-3, or its derivatives reactive with a compound of the general formula Rn-H, (XVII) in which R4 'possesses the of the abovementioned for R4, with the exception of the hydrogen atom, and R11 represents a substituent mentioned at the beginning in the definition of the radical R, of the C? _5 alkyl group ofeni 1 - a 1 qu i 1 or C1-3, which is bound with the radical Rxl through a carbonyl group. The reaction of a carboxylic acid of the general formula XVI is optionally carried out in a solvent or mixture of solvents such as methylene chloride, dimethylformamide, benzene, toluene, chlorobenzene, tetrahydrofuran, benzene / tetr ah i dr of ur ano or dioxane, optionally in the presence of a water-scavenging agent, for example in the presence of isobutyl ester of organic acid, orthocarbonate tetraethyl ester, ortho-acetic acid trimethyl ester, 2, 2 - tell me t oxip r opane, tetr ame t ox isi 1 a no, thionyl chloride, tr ime ti 1 c 1 orosi 1 ano, phosphorus trichloride, phosphorus pentoxide, N, N'-dicyclohexylcarbodiimide, N, N '- dicyclohexylcarbodi-imide / N-hydroxysuccinimide, N, N '-di-cyclohexylcarbo-d ?? m? da / 1-hydroxybenzotriazole, 2- (lH-benzatriazole-1-yl) -l tetrafluoroborate , 3, 3-tetramethyl-uronium, 2 - (1 H -be nzotriazo 1 - 1 -yl) -1, 1, 3, 3-tetram tetrafluoroborate ethyluronium / l-hydroxybenzotriazole, N, N'-ca r bon 11 di imi da zo 1 otrifeni 1 fosfino / tetrac 1 carbon oruro, and optionally with the addition of a base such as pyridine, 4 - d íme ti 1 ami nop iri di na, N -me ti 1 -mo rfo 1 inaotrie 111 ami na, conveniently at temperatures between 0 and 150 ° C, preferably at temperatures between 0 and 100 ° C. The reaction of a corresponding reactive compound of the general formula XVI such as its esters, imidazolides or halides with an amine of the general formula XVII is preferably carried out in a corresponding amine as solvent, optionally in the presence of another solvent such as methylene or ether and, preferably, in the presence of a tertiary organic base such as triethylamine, N-ethyl- d 11 s op r op i 1 amine or N -me thi 1 -mo rfo 1 i na, at temperatures between 0 and 150 ° C, preferably at
temperatures between 50 and 100 ° C. j. For the preparation of a benzothiazolyl or benzoxazolyl benzothiazolyl or benzthiazolyl compound of the general formula I, in which B represents an ethylene group: reaction of a compound, optionally formed in the reaction mixture, of the formula general
wherein Ra and Y are defined as mentioned at the beginning, with a compound of the general formula HO-CO-B '- Ar - E, (XIX
wherein Ar and E are defined as mentioned at the beginning and B 'means an ethylene group, optionally substituted with one or two C? _3 alkyl groups. The reaction is conveniently carried out in a solvent or mixture of solvents such as methylene chloride, dimethylformamide, benzene, toluene, chlorobenzene, tetrahydrofuran, be nc ene / tetrahydrofura no or dioxane, optionally in the presence of a water subtracting agent, example in the presence of isobutyl ester of c 1 oroformic acid, tetraethyl ester of orthocarbonic acid, trimethyl ester of orthoacetic acid, 2,2-dimethoxypropionate, tetrimethoxane 11 to not, chloride Thionyl, triamote 1 c 1 orosi 1 a, phosphorus trichloride, phosphorus pentoxide, N, N'-dicyclohexylcarbodiimide, N, N'-dicyclohexicarbo-d i imi da / N - hi dr oxisuccin imi da, N, N'-dicyclohexylcarbodiimide / 1-hydroxy-benzotriazole, tetrafluoroborate of 2- (1 H -b in zotriazo 1 - 1 - i 1) -1, 1, 3, 3 - tetr ame ti 1 ur on io, tetrafluoroborate of 2- (lH-benzotriazol-1-yl) -1, 1, 3, 3-tetramethyluronium / l- Hydrogen ox i - benzotriazo 1, N, N '- car bon i ldi imi da zo 1 ctrifeni 1 fosfine / tetrac 1 or ur or carbon, and eventually under the addition of a base such as pyridine, 4 - d íme ti 1 ami nop iri dina, N -me ti 1 -mo rfo 1 i na or triethylamine, conveniently at temperatures between 0 and 150 ° C, preferably at temperatures between 0 and 100 ° C. The reaction of a corresponding reactive compound of the general formula XIX, such as its esters, imidazolides or halides with an amine
of the general formula XVIII is preferably carried out in a solvent such as methylene chloride, ether or tetrahydrofuran and, preferably, in the presence of a tertiary organic base such as triethylamine, N-ethyl- 15 diis op r op 1 ami nao N -me ti 1 -mo rfo 1 i na which, at the same time, can serve as solvents, at temperatures between 0 and 150 ° C, preferably at temperatures between 50 and 100 ° C. k. For the preparation of a compound of
the general formula I, which contains one of the radicals t e t r ah i dr o - qui no 1 i na or -isoquinoline mentioned at the beginning: hydrogenation of a compound of the general formula I which contains one of the radicals
quinoline or isoquinoline mentioned at the beginning.
The hydrogenation is preferably carried out in the presence of an acid such as hydrochloric acid with hydrogen in the presence of a catalyst such as palladium or car bon or in a solvent such as methanol, ethanol, ethyl ester of acetic acid, dimethylformamide , d ime ti 1 fo rmami da / a ce t ona or glacial acetic acid, at temperatures between 0 and 50 ° C, but preferably at room temperature and at a pressure of
hydrogen from 1 to 7 bar, but preferably from 3 to 5 bar. In the case of the reactions described above, reactive groups optionally present, such as hydroxy groups,
The carboxy, amino, alkylamino or imino can be protected during the reaction by customary protective groups which, after the reaction, are separated again. For example, as a protective radical for a
The hydroxy group comes into consideration the group trimeti 1 if 1 i 1, acetyl, benzoyl, tere-butyl, trifly, benzyl or tetrahydride or, as protective radicals for a carboxyl group, the trimide group is considered. 1 if 1 i 1,
methyl, ethyl, tere-butyl or benzyl and as radical
For an amino, alkylamino or imino group, the acetyl, hydroxy, trifluoride, or benzoyl, oxocar bon 11 or, tert-bu t oxicar bon i 1, ben ci 1 ox, benzyl, or oxocarbon group may be considered. icarb on 11 o, benzyl, 5 me t ox i be nc i 1 oo 2, 4 - dime t ox i be nci 1 o and, for the amino group, add the phthalyl group. The optionally subsequent separation of a protective radical used is effected, for example, by hydrolysis in an aqueous solvent,
for example in water, is op rpa no 1 / a gua, tetrahydrofura no / a gua or di oxa no / a gua, in the presence of an acid such as trifluoric acid or hydrochloric acid or hydrochloric acid sulfuric acid, or in the presence of an alkali metal base such as hydroxide
lithium, sodium hydroxide or potassium hydroxide, or by separation of the ether, for example in the presence of and at the same time 11 s, at temperatures between 0 and 100 ° C, preferably at temperatures between 10 and 50 ° C . The separation of a hydroxy, benzyl, me t ox and benzyl radical or oxide is carried out, however, for example by hydrogenolysis, for example with hydrogen, in the presence of a catalyst such as
p a 1 a d i o / ca r b on o, in a solvent such as methanol,
lfcfe f ^ £ - S? aii- ^ H 'ethanol, acetic acid ethyl ester, tell me the title, tell me 1 / or amide / acet on or glacial acetic acid, possibly with the addition of an acid such as hydrochloric acid, at temperatures between 0 and 50 ° C, but preferably at room temperature, and at a hydrogen pressure of 1 to 7 bar, but preferably 3 to 5 bar. The separation of a non-oxidizable group can also be effected in the presence of an oxidizing agent such as cerium (IV) ammonium nitrate in a solvent such as methylene chloride, acetonitrile or acetonitrile / water, at temperatures between 0 and 50 ° C, but preferably at room temperature. The separation of a hydroxy, benzyl, methyl or benzethyloxycarbonyl radical is carried out, however, for example by hydrogenolysis, for example with hydrogen, in the presence of a catalyst such as pa 1 a di o / car bon or, in a solvent such as methanol, ethanol, acetic acid ethyl ester, dimethylether, dimethylaminophenol, acetic acid or glacial acetic acid, optionally with the addition of an acid such as hydrochloric acid, temperatures between 0 and 50 ° C, but preferably at room temperature, and at a hydrogen pressure of 1 to 7 bar, but preferably 3 to 5 bar. The separation of a non-toxic group can also be carried out in the presence of an oxidizing agent such as nitrate (IV) ammonium nitrate in a solvent such as methylene chloride, acetonitrile or acetonitrile / water, at temperatures between 0.degree. and 50 ° C, but preferably at room temperature. The separation of a 2,4-d ime t oxibene radical is, however, preferably carried out in the presence of anisole. The separation of a tere-butyl radical of cterc-buyl-1-oxycarbide is preferably effected by treatment with an acid such as trifluoroacetic acid, hydrochloric acid, optionally with the use of a solvent such as methylene chloride, dioxane or ether. . The separation of a phthalyl radical is preferably carried out in the presence of hydrazine C of a primary amine such as methylamine, ethylamine or n-b u t i 1 amine, in a solvent such as methanol,
This is ethanol, isopropanol, toluene / water or dioxane, at temperatures between 20 and 50 ° C. The separation of an allyloxycarbon radical is effected by treatment with a catalytic amount of t-t r a k i s - (t r i f in 11 f or s f i na) -palladium (O), preferably in a solvent such as tetrahydrofuran and, preferably, in the presence of an excess of a base such as morpholine or 1,3-dαmone, at temperatures between 0 and 100 ° C, preferably at room temperature and under an inert gas, or by treatment with a catalytic amount of tris- (tr? phen? lphosphine) -rod? chloride or (I) in a solvent such as aqueous ethanol and, optionally, in the presence of a base such as 1,4-d? azab? c? [2.2.2] octane, at temperatures between 20 and 70 ° C. The compounds of the general formulas I] to XIX, used as starting substances, which are partly known from the literature, are obtained according to methods known from the literature and, moreover, their preparation is described in the appendices. Thus, for example, a compound of the general formula II is obtained by reaction of a corresponding nitrile, which, for its part, is conveniently obtained according to the processes 3: ah, with a corresponding thioalcohol or alcohol, in the presence of sodium chloride. hydrogen or hydrogen bromide. 5 A compound of the general formulas IV,
V, VIII, X, XI and XIX, used as starting material, is conveniently obtained according to a process of the present invention. In addition, the compounds of the formula
General I obtained, can be separated into their enantiomers and / or diastereoisomers. Thus, for example, the compounds of the general formula I obtained, which are manifested in racemates, can be separated according to known methods: see Allinger NL and Eliel EL in "Topics in Stereochemistry", Vol. 6, Wiley Interscience, 1971) in their optical antipodes, and compounds of the general formula I with at least 2 asymmetric carbon atoms can be separated, in
By virtue of their physico-chemical differences, according to methods known per se, for example by chromatography and / or fractional crystallization, in their diastereoisomers which, if they result in racemic form, can then be separated into
The enantiomers, as mentioned above.
The separation into the enantiomers is preferably effected by column separation in chiral phases or by recrystallization in an optically active solvent, or by reaction with an optically active substance which forms with the racemic compound salts or derivatives such as, for example, esters or amides, in particular acids and their activated derivatives or alcohols, and separation of the mixture of salts or the diastereomeric derivative
obtained in this way, for example by virtue of the different solubilities, it being possible to liberate the antipodal fibers from the pure salts or derivatives d i a s t e r e or i s orme s by the action of suitable agents. Optically acidic
Particularly common active substances are, for example, the D and L forms of tartaric acid or dibenzoyltartaric acid, di-o-tolyltartaric acid, malic acid, mandelic acid, camphorsulfonic acid, glutamic acid, aspartic acid or quinaic acid. Eat
The optically active alcohol is, for example, (+) - or (-) - menthol, and as optically active acyl radical in amides, for example, the (+) - or (-) - menthyloxycarbonyl radical comes into consideration.
Furthermore, the compounds of the formula I obtained can be converted into their salts, in particular for the pharmaceutical application, into their physiologically compatible salts with inorganic or organic acids. Suitable acids are, for example, hydrochloric acid, hydrobromic acid, sulfuric acid, phosphoric acid, fumaric acid, succinic acid, lactic acid, citric acid, tartaric acid, maleic acid, benzoic acid, methacid not their f ón icoo acid to 1 ue not your 1 f óni co. In addition, the novel compounds of formula I, thus obtained, if they contain a carboxy group, can then be converted, if desired, into their salts with inorganic or organic bases, in particular for the pharmaceutical application, in their physiologically compatible salts. Suitable bases are, for example, sodium hydroxide, potassium hydroxide, cyclohexylamine, ethanolamine, diethanolamine and triethanolamine. As already mentioned at the beginning, the new compounds of the general formula I and their salts have valuable properties. Thus, the compounds of the general formula I, in which E represents a cyano group or Ra represents an amino group and E represents a cyano group, represent valuable intermediate products for the preparation of the remaining compounds of the general formula I, and compounds of the general formula I, in which 1 E represents a group RbNH-C (= NH), as well as its tautomers, its stereoisomers, its physiologically compatible salts, have valuable pharmacological properties, in particular an inhibitory effect of thrombin, an extended thrombin time effect and an inhibitory effect on serine-related proteases such as, for example, trypsin, urokinase, factor Vlla, factor Xa, factor IX, factor XI and factor XII, also presenting some compounds such as, for example, the compound of Example 16, at the same time ur inhibiting effect of thrombocyte aggregation. For example, the compounds A = l-methyl-2- [(4-amid-n-phenyl) -oxymethyl] -5- [N- (hydroxycarbonylmethyl) -quinolin-8-sulfonylamino] -benzimidazole, B = 1-methyl- 2 - [2 - (4-amidinofenyl) -e] - 5 - [N - ('- (hydroxycarbonylmethyl) -aminocarbonylmethyl) -quinolin-8-sulfonylamino] -benzimidazole, C = 1 -methyl 1 - 2 - [N- (4-midi not f in i 1) - ami no-metí 1] -5- [N- (hydroxy-carbonylmethyl) -quinolin-8-su 1 f on i 1 ami no] - be nc imi da zo 1 and 'D = l-methyl-2 - [N- (4-amidinofenyl) -aminomethyl] -5- [N- (hydroxycarbonylmethyl) -quinolin-8-sulfonylamino] -indole were examined for their effect on thrombin time as follows: Material: plasma, human coded blood, test thrombin (bovine), 3C U / ml, Behringwerke, Marburg buffer barbiturate - diethyl acetate, ORWH 60/61, Be ringwer e, Marburg Biomatic BIO coagulometer, Sars tedt Realization: The determination of thrombin time was carried out with a Biom coagulometer BIO atic Sarstedt. The test substance was added to the test containers prescribed by the manufacturer1 with 0.1 ml of human coded plasma and 0.1 ml of diethyl barbiturate buffer (DBA buffer). The batch was incubated for one minute at 37 ° C. By adding 0.3 U test thrombin in 0.1 ml of:
S- * A -j¡aaÉB agw ..
DBA buffer the coagulation reaction was started. Conditioned by the device, with the introduction of thrombin the measurement of the time until the clotting of the batch begins. As a control, batches were added to which 0.1 ml of DBA buffer was added. According to the definition, the concentration of effective substance at which the thrombin time was doubled with respect to the control was calculated by means of a curve of do s i - e f e c t o. The following table contains the values found:
Substance T ostime of t r omb ina (DE2oo e n μM) A 0, 015 B 0, 016 C 0, 031 D 0, 054
For example, in rats no acute toxic side effects could be observed in the application of the compounds in the above dose range. Accordingly, these compounds. They are very compatible.
By virtue of their pharmacological properties, the novel compounds and their physiologically compatible salts are suitable for the prevention and treatment of venous and arterial thrombotic diseases such as, for example, the treatment of acute thrombosis of the leg veins, the prevention of reocclusions after arterial bypass operations or angioplasty (PT (C) A), as well as in the occlusion of peripheral arterial diseases such as pulmonary embolism, disseminated intravascular coagulation, prophylaxis of coronary thrombosis, stroke prophylaxis and Prevention of occlusion of vascular channels or Stents. Additionally, the compounds according to the invention are suitable for an anosomal support in the case of a thrombolytic treatment such as, for example, with rt-PA or streptokinase, to prevent long-term restenosis after of PT (C) A, to prevent metastasisation and the development of coagulation-dependent tumors and of fibrin-dependent inflammatory processes, for example in the treatment of pulmonary fibrosis.
The dosage necessary to achieve a corresponding effect is conveniently in the case of intravenous administration at 0.01 to 10 mg / kg, preferably 0.03 to 3 mg / kg and, in the case of oral administration at 0 , 1 to 10 mg / kg, preferably 0.3 to 5 mg / kg, in each case 1 to 4 times a day. For this purpose, the compounds of the formula I prepared according to the invention can be incorporated into conventional galenical preparations such as tablets, dragees, capsules, powders, suspensions or suppositories, optionally in combination with other active substances, together with one or more substances of support and / or customary inert diluents, for example with corn starch, lactose, sucrose, microcrystalline cellulose, magnesium stearate, polyvinylpyrrolidone, citric acid, tartaric acid, water, water / ethanol, water / g 1 icero 1, water / sor bi ta, a gua / po 1 ieti 1 e ng 1 ico 1, pr op 11 e ng 1 ico 1, alcohol ceti 1 es-teari 11 co, carboxymethylcellulose, or substances with fat content such as fat aura or mixtures thereof adequate. The following examples have to explain the invention in more detail:
- s. ? ÁkSü r Preliminary observations In the case of the determination of the Rf values, 1-Polygram gel plates from E. Merck, Darmstadt, were always used, insofar as not indicated otherwise. The spectra of EKA tables (mass spectra of e 1 e c t r opu 1 ve r i z ation of cations) are described, for example, in Chemie unserer Zeit 6_, 308-316 (1991).
Example 1 l-Methyl-2- [2- (4-amidinofenyl) -ethyl] -5- [N- (ethoxycarbonylmethyl) -methanesulfonylamino] -benzimidazole a. l-ethyl-2- [2- (4-cyanophenyl) -ethyl] -5-nitro-benzimidazole 2.3 g (0.014 mol) of 2-methyl-amino-5-nitro-aniline and 2.7 g ( 0.0154 mol) of 4-cyano-non-phenol-1-acetic acid are heated at reflux for 1 hour in 25 ml of phosphorus oxychloride. After cooling, it is mixed with water and alkalized with ammonia. The precipitate is filtered with suction, washed with water and dried. Yield: 3.8 g (89% of theory), R value: 0.28 (silica gel); dichloromethane / methanol b. l-Methyl-2- [2 - (4-cyanophenyl) -ethyl] -5-amino-benzimidazole 3.8 g (0.0124 mol) 'of 1-methyl-2 - [2 - (4-cyn. feni 1) - eti 1] - 5 - nitro-be nc imi da zo 1 dissolve 5 in 100 ml of methanol and 100 ml of di c 1 or ome ta and, after the addition of 0.5 g of palladium at 10% on active carbon, they are hydrogenated with water. Then, the catalyst is filtered off and concentrated by evaporation. 10 Yield: 3.2 g (93% of theory), R value: 0.38 (silica gel, dichloromethane / methanol = 9: 1) c. l-methyl-2- [2- (4-cyanophenyl) -ethyl] -5-methano-sulphonylamino-benzimidazole; 1.6 g (5.8 mmol) of 1 -me 111-2 - [2 - ( 4 - cyanopheni 1) - and 111] - 5 - ami non-benzimide zo 1 and 0.66 c (5.8 mmol) of methacrylate and not its 1-ion are stirred in 30 ml of pipdin for 3 hours at room temperature. Next, 1 ml is added
water and concentrated by evaporation. The residue is diluted with ethyl acetate and water and the crystalline product is filtered off with suction and dried. Yield: 1.4 g (68% of theory), R value: 0.70 (silica gel, dichloromethane / methanol
= 9: 1)
d. l-Methyl-2 - [2- (4-cyanophenyl) -ethyl] -5- [N- (ethoxycarbonylmethyl) -methylammonium] -benzimidazole 1.4 g (3.95 mmol) of 1-methyl - 2 - [2 - (4-cyano-phenyl) -ethyl] -5-methanesulfon-lane-benzimidazole, 0.73 g (4.4 mmol) of (ethyl ester of bromoacetic acid and 2.8 g (20 g. mmol) of potassium carbonate are dissolved in 200 ml of acetone and refluxed for 2 hours, then filtered off and the solution is concentrated by evaporation Yield: 1.6 g (92% of theory) , Rf value: 0.76 (silica gel; dichloromethane / methane)
= 9: 1) e. l-methyl-2- [2- (4-amidinophen-1-yl) -ethyl] -5- [N- (ethoxy- • carbonylmethyl) -me tanosulfonylamino] -benzimidazole 1.6 g (3.63 mmol) of 1 -me 111-2- [2 - (4-cyano-phenyl) -ethyl] -5- [N- (ethoxycarbonylmethyl) -methane-sulphomlamino] -benzipudazole are dissolved in 50 ml of saturated ethanolic hydrochloric acid and stirred for 5 hours at room temperature. Next, the solvent is distilled off, the residue is dissolved in 30 ml of absolute ethanol and 3.5 g (3.63 mmol) of ammonium carbonate are added. After 18 hours at room temperature, it is evaporated to dryness and the residue is chromatographed on silica gel (methylene chloride / me t a no = 5: 1). The corresponding fractions are concentrated and the mixture is mixed by trituration with ether and filtered with suction. Yield: 0.9 g (50% of theory), R value: 0.36 (silica gel, dichloromethane / methanol = 5: 1) C22H27N5O4S (457.55) 10 mass spectrum: (M + H) + = 458 (M + Na) + = 480
EXAMPLE 2 l-Methyl-2 - [2- (4-amidinophenyl) -ethyl] -5- [N- (ethoxy-15 carbonylmethyl) -benzenesulfonyl] amino] -benzimidazole
to . l-methyl-2- 2- (4-cyanophenyl) -etill-5- [N- (ethoxy-carbonyl-methyl) -benzenesulfonyl] amino] -begaimide zol Prepared analogously to Example Id, starting from 1 -me 111 - 2 - [2 - (4 - c 1 to no phen 11) - and 111] - 5 - be nce not its 1 f on 11 ami no -bencimide zo 1, ethyl ester of bromoacetic acid and carbonate of potassium er acetone. Performance: 54% of the theoretical,
R f value: 0.84 (silica gel, dichloromethane / methanol = 9: 1) b. l-methyl-2 - [2- (4-amidinophenyl) -ethyl] -5- N- (ethoxycarbonylmethyl) -benzenesulfonylamino] -benzimidazole Prepared analogously to Example le, from l-met? l-2- [2- (4-c? Anophen?) -et? L] -5- [N- (ethoxycarbonylmethyl) -benzenesulfonylamino] -benzimidazole, and hydrochloric acid / ammonium carbonate in ethanol. Yield: 59% of theory, Rf value: 0.38 (silica gel, dichloromethane / methane = 5: 1) mass spectrum: (M + H) + = 520 (M + Na) + = 542
EXAMPLE 3 l-Methyl-2- [2- (4-amidinophenyl) -ethyl] -5- N- (hydroxycarbonyl-methyl) -benzenesulfoni-lamino] -benzimidazole 0.52 g (0.93 mmol) of 1 -me 111 - 2 - [2 - (4-amidinophenyl) -ethyl] -5- [N- (ethoxycarbonylmethyl) -be nce not su 1 f on 11 ami no] -ben c idem zo 1, and 0.4 g ( 0.01 mol) of sodium hydroxide are stirred in 5 ml of water and 10 ml of ethanol for three hours at room temperature. Then it is diluted with
&-i-faith ...
water and adjusted to pH 4 with glacial acetic acid. The crystalline precipitate is filtered off with suction and dried. Yield: 77% of theory, C25H25N504S (491.66) mass spectrum: (M + H) + = 492 (M + Na) + = 514 (M-H + 2Na) + = 536 (2M + H + Na) ++ = 503
Example 4 l-Methyl-2 - [2- (4-amidinophenyl) -ethyl] -5- [N- (hydroxycarbonylmethyl) -me tanosulfonylamino] -benzimidazole Prepared analogously to Example 3, from 1-methyl ti-2 - [2 - (4-ami di no f in 11) - and 111] - 5 - [N - (ethoxycarbonylmethyl) -methanesulfonylamino] -benzimidazole and soda lye. Yield: 97% of theory, C2oH23N5? 4S (429.5) mass spectrum: (M + H) + = 430 (M + Na) + = 452 (2M + H + Na 2 + = 441 (2M + 3Na) 3 + = 309
Example 5 1-Ethoxycarbonylmethyl 2 - [(4-amidinopheyl) -oxymethyl] -5- N- (2-dimethylaminoethyl) -benzenesulfonylamino] -benzimidazole a. Mixture based on 1-ethoxycarbonylmethyl -2 - (4-cyanophenyl) -oxymethyl] -5-n-ro-benzimidazole and l-ethoxycarbonylmethyl-2-f (4-cyano-phenyl) -oxymethyl] -6-nitro-benzimidazole Prepared analogously to Example Id, from 1 H-2 - [(4-cyano f in i 1) -ox ime ti 1] -5-nitro-benzimidazole, ethyl ester of bromoacetic acid and potassium carbonate in acetone. Yield: 3.6 g (95% of theory), R value: 0.56 (silica gel, dichloromethane / methanol = 19: 1) b. Mixture based on 1-e-toxicarbonylmethyl - 2 - [(4-cyanophenyl) -oxymethyl] -5-amino-benzimidazol and l-ethoxycarbonylmethyl-2 - [(4-cyanophenyl) -oxymethyl] -6-amino-benzimidazole 3.6 g (9.5 mmol) of the mixture based on 1-ethoxycarbonyl-methyl-2- [(.-Cyanophenyl) -oxymethyl] -5-nitro-benzimide zo 1 and l-ethoxycarbonylmethyl-2- [(4-cyanophenyl) -ox ime ti 1] -6-nitro-benz imi da zo 1 are dissolved in 20C ml of methanol and, after the addition of 0.5 g of 10% palladium on active carbon, Hydrogen with hydrogen. The catalyst is then filtered off and concentrated by evaporation. The residue is chromatographed on silica gel (methylene chloride + 1 to 5% ethanol). Yield: 1.2 g (36% of theory) of 1-ethoxycarbonylmethyl-2- [(4-cyanophenyl) -oxymethyl] -5-amino-benzimidazole R value: 0.10 (silica gel; dichloromethane / methanol
= 19: 1) Yield: 1.0 g (30% of theory) of 1-ethoxycarbonylmethyl-2- [(4-cyanophenyl) -oxymethyl] -6-amino-benzimidazole Rf value: 0.32 (silica gel; dichloromethane / methanol
= 19: 1) c. l-Ethoxycarbonylmethyl-2-r (4-cyanophenyl) -oxymethyl] -5-benzenesulfonyl-lamino-benzimidazole Prepared analogously to Example 1, from 1-ethoxycarboxymethyl 1 - 2 - [(4 - cia no feni 1) -ox ime ti 1] - 5 - ami no -benz imi da zo 1 and chloride of acid bence not its 1 ión ico in pyridine. Yield: 100% of theory, Rf value: 0.43 (silica gel, dichloromethane / methanol = 9: 1) d. 1-e-co-ylmethyl-2 - [(4-cyanophenyl) -oxymethyl] -5- [N- (2-dimethylaminoethyl) -benzenesul onyl-amino] -benzimidazole 1.65 g (3.4 mmol) 3 - et oxicar bo ni lme ti 1 -2- [(4-cyanophenyl-nil) -oxymethyl] -5-benzenesulfonylamino-benzimidazole and 518.4 mg (3.6 mmol) of 2-dimethyl chloride hydrochloride 1 ami no ti 1 or dissolve in 100 ml of acetone and, after the addition of 2.0 g of potassium carbonate and 737 mg (4.85 mmol) of 1,8-diazabicyclo [5.4.0] undec 7-ene, heated to reflux for 11 hours. It is then filtered off and concentrated by evaporation. The residue is chromatographed on silica gel (methylene chloride and not / 5-10% ethanol). Yield: 750 mg (39% of theory), Rf value: 0.21 (silica gel, dichloromethane / methanol = 9: 1) e. 1-E Toxycarbonylmethyl-2 - [(4-amidinophenyl) -oxymethyl] -5- [N- (2-dimethylaminoe-thi-1-benzenesulfonyl-amino] -benzimidazole Prepared analogously to Example 1, e from l-ethoxycarbonylmethyl -2- [(4-cyanophen? L) -oxymethyl] -5- [N- (2-dimethylaminoet? L) -benzenesulfonylamino] -benzimidazole, and c 1 orhydric acid / ammonium carbonate in ethanol.
i ^ Áik ^ & iii &X ^ Yield: 85% of theory, C29H34N605S (578.7) mass spectrum: (M + H) + 579 (M + 2H) ++ 290
Example 6 l-Ethoxycarbonylmethyl-2- (4-amidinophenyl) -oxymethyl] -6- [N- (2-dimethylaminoethyl) -benzenesulfonylamino] -benzimidazole a. l-Ethoxycarbonylmethyl-2- (4-cyano-phenyl) -oxymethyl] -6-benzene sulfonyl-lamino-benzimidazole Prepared analogously to Example LE, from l-ethoxycarbonylmethyl-2 - [(4-c? anophen? I) -ox? methylene] -6-ammo-benzimidazole and 1-ionic acid chloride in pyridine. Yield: 80% of theory, Rf value: 0.72 (silica gel, dichloromethane / methanol = 9: 1)
b. 1- ethoxycarbonylmethyl 2 - [(4-cyanophenyl) -oxymethyl] -6- [N- (2-dimethylamino-ethyl) -benzenesulfonylamino] -benzimidazole Prepared analogously to Example 5d, from l-ethoxycarbonylmethyl-2- [( 4-c? Anophen?) Oxymethyl] -6-benzenesul-fonylamino-imidazole, chloride -
• f *? ' ? ¡»« A *: a »* 2 & ^ ^ .f tSM h drocloruro 2 - 111 ami tell noe t i1 or potassium carbonate and 1, 8 - di z ab i c i c 1 or [5.4.0] undec-7-ene in acetone. Yield: 24% of theory, R value: 0.34 (silica gel, dichloromethane / methanol
= 9: 1)
c. l-ethoxycarbonylmethyl-2-f (4-amidinophenyl) -oxime-tl] -6- [N- (2-dimethylamino-tyl) -banzene-sulfonyl-amino] -benzimidazole Prepared analogously to Example 1, from l-ethoxycarbonylmet? l-2- [(4-c? anophen? l) -oxymethyl] -6- [N- (2-dimethylamino] -benzenesulfon on 11 ami] - b ene imi da zo 1 and acid c 1 orhydric / ammonium carbonate in ethanol. Yield: 67% of theory, C29H3 N605S (578.7) mass spectrum: (M + H) + = 579 (M + 2H) ++ = 290
E j emplo July 1 -hidroxicarbonilmetil -2-f (4-amidinophenyl) -oximetil] -5- [N- (2 tilaminoe Tell me til) -benzenesulfonyl-amino] benzimidazole
"A, ifi? --- &S5 Prepared analogously to Example 3, starting from 1-et ox i ca r bon i lme ti 1 - 2 - [(4-ami di no f in i 1) - oxymethyl] -5- [N- (2-dimethylaminoethyl) -benzenesulf on i 1 ami] -b ene imi da zo 1 and soda lye 5 Performance: 91% of theory, C27H30N6O5S (550, 65) mass spectrum (EKA): (M + H) + = 551 (M + 2H) ++ = 276
Example 8 1-Ethoxycarbonylmethyl -2-T (4-amidinophenyl) -oxymethyl] -5- [N- (2-dimethylaminoethyl) -me tanosulfonylamino] -benzimidazole Prepared analogously to Example 1, from 1-ethoxycarbonylmethyl. -2- [(4-cyanophenyl) -oxymethyl] -5- [N- (2-dimethylaminoetyl) -methanesulfonyl-ami no] -benzimide zo 1 with ethanolic hydrochloric acid and ammonium carbonate. Yield: 96% of theory, 20 C24H32N605S (516, 6) mass spectrum (EKA): (M + H) + = 517 (M + 2 H) + + = 2 5 9
E j emp l o 9
1 - . 1-ethoxycarbonylmethyl 2 - [(4-amidinophenyl) -oxymethyl] -6- [N- (2-dimethylaminoethyl) -me tanosulfonylamino] -benzimidazole Prepared analogously to Example le, from l-ethoxycarbonylmethyl-2- [ (4-cyanophenyl) -oxymethyl] -6- [N- (2-dimethylaminoetyl) -methanesulfonyl-ami no] -be nc idem 1 and ethanolic hydrochloric acid, ethanol and ammonium carbonate. Yield: 69% of theory, C24H32N605S (516.6) mass spectrum (EKA): (M + H) + = 517 (M + 2H) ++ = 259
Use 10 1 -hydroxycarbonylmethyl 2 - [(4-amidinophenyl) -oxymethyl] -6- [N- (2-dimethylaminoe ti 1) -me tanosulfonyl-amino] -benzimidazole Prepared analogously to Example 3, starting from 1 - oxy et ca rboni lme 111-2 - [(4 - amidi of in 11) -oximetil] -6- [N- (? 2-dimethylaminoeth l) -methanesulfonyl-ami no] -benzyl c imi da zo 1 and soda lye. Yield: 92% of theory, C22H28N605S (488, 67) mass spectrum (EKA): (M + H) + = 489 (M + 2H) ++ = 245 Example 11 1 -hydroxycarbonylmethyl 2- [(4 -amidinophenyl) -oxymethyl] -5- [N- (2-dimethylaminoethyl) -me tanosulfonyl-amino] -benzimidazole Prepared analogously to Example 3, from l-ethoxycarbonylmethyl-2- [(4-amidinophenyl) -oxymethyl ] -5- [N- (2-dimethylaminoethyl) -methanesulfonyl-ami no] -ne ncimide zo 1 and soda lye. Performance: 98% of the theoretical,
40 /// C22H28 6? 5S (488, 6) mass spectrum (EKA): (M + H) + = 489 (M + 2H) ++ = 245
Use 12 l-methyl-2- [(4-amidinophenyl) -oxymethyl] -5- [N- (e-oxycarbonylmethyl) -quinolin-8-sulfonylamino] -benzimidazole Prepared analogously to Example le, starting from 1 -me ti 1 - 2 - [(4-cyano f eni 1) -ox ime ti 1] - 5 - [N- (ethoxycarbonylmethyl) -quinolin-8-sulfonylamino] -benzimidazole and ethanolic hydrochloric acid, ethanol and ammonium carbonate. Yield: 70% of theory, C 29 H 28 N 6 O 5 S (572, 65) spectrum of EKA tables) M + H = 573 M + 2 H = 287 M + H + Na = 298
E j emplo 13 l-et l-2- [2- (4-amidinofenll) -ethyl] -5- [N- (ethoxycarbonylmethyl) -quinolin- 8 - sulfonylamino] - benzimidazole Prepared analogously to Example le, 10 from l-et l-2- [2- (4-c anofen l?) -ethyl] -5- [N- (etoxicarbonimetil) -quinolm-8-sulfon lam not?] - benzimidazole and hydrochloric acid ethanolic, ethanol and ammonium carbonate. Yield: 85% of theory, 15 C3? H32N604S (584, 71) R value: 0.32 (silica gel, dichloromethane / methanol = 5: 1) mass spectrum (EKA): (M + H) + = 585 (M + H + Na) ++ = 304 20 (M + 2H) ++ = 293
Example 14 l-Methyl-2- [2- (4-amidinophenyl) -ethyl] -5- [N- (ethoxycarbonylmethyl) -quinolin-8-sulphonyl] amino] benzimidazole
& fc¿ * 'w = Mt ^. . = fc ^ > ^^ Xm. »• S ?? i, prepared analogously to Example le, starting from 1 -me 111-2 - [2 - (4-cyanof in 11) -e 111] - 5 - [N - (ethoxycarbonimethyl) qumolm-8-sulfon? lam? no ] -benzimidazole and ethanolic hydrochloric acid, ethanol and ammonium carbonate. Yield: 71% of theory, C3oH3? 604S (570, 68) R value: 0.30 (silica gel, dichloromethane / methanol
= 5: 1) mass spectrum (EKA): (M + H) + = 571 (M + H + Na) ++ = 297 (M + 2H) ++ = 286
Use 15 lc? Clopropyl-2- [2- (4-amidinofeni 1) -ethyl] -5- [N- (ethoxycarbonylmethyl) -quinolin-8-sulfonylamino] -benzimidazole Prepared analogously to Example le, from 1 - ci clop r opi 1 - 2 - [2 - (4-ami di no f in 11) -ethyl] -5- [N- (ethoxycarbonylmethyl) -qumol? N-8-su 1 f on 11 ami no] -Beginning of zo 1 and ethanolic hydrochloric acid, ethanol and ammonium carbonate. Yield: 76% of theory, C32H32N6? 4S (596.72) R value: 0.34 (silica gel, dichloromethane / methanol = 5: 1) mass spectrum (EKA): (M + H) * = 597 (M + H + Na) ++ = 310 (M + 2H) ++ = 299
Example 16 l-Methyl-2- [(4-amidinophenyl) -oxymethyl] -5- [N- (hydroxycarbonylmethyl) -gui-or-8-sulfonylamino] -benzimidazole Prepared analogously to Example 3, starting from l- methyl-2- [(4-amidinofenyl) -oxymethyl] -5- [N- (methoxycarbonyl-methyl) -quinolin-8-su-1-foni-amyl] -b ene imi da z ol and soda lye. Yield: 43% of theory, C27H24N605S (544.6) mass spectrum EKA M + H) + = 545 M + Na) + = 567 MH) "= 543 2M + 2Na + H 3 + = 378.7 XH-NMR (d6-DMS0): d = 3.90 (s, 3 H), 5.05 (s, 2 H), 5.73 (s, 2 H), 7.09 (dd, 1 H), 7, 38 (d, 2 H), 7.52 (d, 1 H), 7.57-7.74 (m, 2 H), 7.80 (dd, 1 H), 7.92 (d, 2 H) ); 8.13 (d, 1 H);
8.31 (d, 1H); 8.61 (dd, 1 H); 9.12-9.30 (m, 3H); 9.38 (s, 2H) ppm
Ie 17 l-ethyl-2- [2- (4-amidinophenyl) -ethyl] -5- [N- (hydroxycarbonyl-methyl) -quinolin-8-sulfonylamino] -benzimidazole Prepared analogously to Example 3, starting from from 1 - e 111 - 2 - [2 - (4-ami di nofe ni 1) - e 111] - 5 - [N - (ethoxycarbonylmethyl) -qumol? n-8-sulfon? lam? no] - benzimidazole and soda lye. Yield: 74% of theory, C29H28 604S (556, 65) mass spectrum (EKA): (M + H) + = 557 (M + Na) + = 579
Use 18 l-methyl-2- [2- (4-amidinophenyl) -ethyl] -5- [N- (hydroxycarbonylmethyl) -quinolin-8-sulfonylamino] -benzimidazole Prepared analogously to Example 3, from 1 - me 111 - 2 - [2 - (4-ami dinofen 11) - and 111] -5- [N- (ethoxycarbonylmetyl) -quinoline-8-sulfonamino-benzimidazole and bleach soda. Performance: 96% of the theoretical,
C28H26N6? 4S (542.59) mass spectrum (EKA): (M + H) + = 543 (M + Na) + = 565 (2M + 3Na) 3"= 385
Use 19 l-cyclopropyl-2- [2- (4-amidinophenyl) -ethyl] -5- [N- (hydroxycarbonylmethyl) -quinolin-8-sulfonylamino] -benzimidazole. Prepared analogously to Example 3, starting from 1-cyc 1 op r op i 1 - 2 - [2 - (4-ami di nofeni 1) -ethyl] -5- [N- (ethoxycarbonylmethyl) -quinolin-8- su 1 f on i 1 ami no] - Be nc imi da z ol and lye of soda. Yield: 88% of theory, 15 C3oH28N604S (568, 66) mass spectrum (EKA): (M + H) + = 569 (M + Na) + = 591 2M + 3Na 3 + = 402
EXAMPLE 20 l-Ethyl-2- [(4-amidinophenyl) -oxymethyl] -5- [N- (ethoxycarbonylmethyl) -quinone 8-sulfonylaminobenzimidazole Prepared analogously to Example 1, from -ethyl-2- [(4-cyanophen? l) -oxymethyl] -5- [N-
(ethoxycarbonylmethyl) -quinolin-8-sulfonylamino] -benzimidazole and ethanolic hydrochloric acid, ethanol and ammonium carbonate. Yield: 81% of theory, 5 C30H30 6O5S (586.7) mass spectrum (EKA): (M + H) + = 587 (M + H + Na) ++ = 305 (M + 2H) ++ = 294
Example 21 l-Ethyl-2- [(4-amidinophenyl) -oxymethyl] -5- [N- (hydroxycarbonyl-methyl) -quinolin-8-sulfonylamino] -benzimidazole Prepared analogously to Example 3, starting from 1 - eti 1 - 2 - [(4-amidi no fe nor 1) - oxime ti 1] - 5 - [N- (ethoxycarbonylmethyl) -quinolin-8-sulfonylamino] -benzimidazole and soda lye. Yield: 96% of theory, C28H26N605S (558, 6) 20 mass spectrum (EKA): (M + H) + = 559 (M + Na) + = 581 (M-H) ~ = 557
E j us 22
l ^^^^ v ^^^^^^ l-methyl-2- [2- (4-amidi-ofenyl) -oxymethyl] -5- [N- (ethoxycarbonylmethyl) -benzenesulfonylamino] -benzimidazole Prepared analogously to Example le, from l-methyl-2- [(4-cyanophenyl) -oxymethyl] -5- [N- (ethoxycarbonylmethyl) -benzenesulfonylamino] -benzimidazole and ethanolic hydrochloric acid, ethanol and ammonium carbonate. Yield: 48% of theory, C26H27N5O5S (521.6) mass spectrum (EKA): (M + H) + = 522 (M + H + Na) ++ = 272.8
Example 23 L-methyl-2- [2- (4-amidinophenyl) ethyl] -5- [N- (Nf- (ethoxycarbonylmethyl) -aminocarbonylmethyl 1) -quinolin-8-sulphonamino] -benzimidazole a. l-Methyl-2- [2- (4-cyanophenyl) -ethyl] -5- [N- (hydroxycarbonyl-ill -quinolin-8-sulfonylamino] -benzimidazole Prepared analogously to Example 3, from 1-methyl-1 - 2 - [2 - (4 - cia no f in i 1) - eti 1] - 5 - [N - (ethoxycarbonylmethyl) -quinolin-8-sulfonylamino] -benzimidazole and sodium hydroxide in ethanol / water Yield: 92% of the theoretician,
• jfe.
R f value: 0.24 (silica gel, dichloromethane / methanol = 9: 1) b. l-Methyl-2- [2- (4-cyanophenyl) -ethyl] -5- [N- (N '- (ethoxycarbonylmethyl) -aminocarbonyl methyl) -quinolin-8-sulfonylamino] -becimidazole 2.1 g (0.004 mol) of l-methyl-2- [2- (4-cyanophenyl) -ethyl] -5- [N- (hydroxycarbonylmethyl) -quo 1 in-8-su 1 f on i 1 ami no] -be nc imi Zero 1 and 0.65 g (0.004 mol) of N, N'-ca r bon i 1 di imi da zo 1 are dissolved in 30 ml of dimethylformamide and stirred for 45 minutes at 80 ° C. Then, 0.71 g is added
(0.0046 mol) of ester g 1 i c i ne t í 1 i co and 0.51 g (0.005 mol) of triethylamine and stir for another four hours at 80 ° C. The solvent is concentrated by evaporation and the residue is chromatographed on silica gel (methylene chloride / ano 1 = 50: 1). Yield: 44% of theory, R value: 0.74 (silica gel, dichloromethane / methanol = 9: 1) c_. l-methyl-2- [2- (4-amidinophenyl) -ethyl] -5- [N- (N '- (ethoxycarbonylmethyl) -aminocarbonylmethyl) -quinolin-8-sulfonylamino] -benzimidazole Prepared analogously to Example 1, starting from 1 -me ti 1 - 2 - [2 - (4 - cia no fe ni 1) - eti 1] - 5 - [N - (N '- (ethoxycarbonylmethyl) -aminocarbonylmethyl) -qu? nolm-8-sulfonylamino ] -benzium zol and acid or ammonium hydrocarbon bonate in ethanol. Yield: 86% of theory, C32H33N705S (627, 73). Mass spectrum: (M + H) + = 628 (M + 2H) + = 314.8 (M + H + Na) ++ = 325.7
Example 24 l-Methyl-2- [2- (4-amidinophenyl) -ethyl] -5- [N- (N'- (e-toxycarbonylmethyl-N '-methyl-aminocarbonylmethyl) -quinolin-8-sulfonylamino ] -benzimidazole Prepared analogously to Example LE, starting from l-met? l-2- [2- (4-c? anophen? l) -et? l] -5- [N- ('-ethoxy? carbon? lmet? lN '-methyl-aminocarbonylmethyl) -quinolin-8-sulfonamino] -benz midazole and ethanolic hydrochloric acid, ethanol and ammonium carbonate Yield: 63% of theory, C33H35N7O5S (641.76) value Rf: 0.30 (silica gel, dichloromethane / methanol = 5: 1) mass spectrum (EKA): (M + H) + = 642 (M + H + Na) ++ = 332.8 (M + 2H ) ++ = 321.7 Use 25 l-methyl-2- [2- (4-amidinophenyl) -ethyl] -5- [N- (N '- (hydroxycarbonylmethyl) -aminocarbonylmethyl) -quinoline- - aul foni lamino] -benzimidazole Prepared analogously to Example 3, starting from 1-methyl ti 2 - [2 - (4-ami di no f in i 1) - eti 1] - 5 - [N - (N '- (ethoxycarbonylmethyl) -aminocarbonylmethyl) - qu i no 1 in - 8 - su 1 f oni 1 ami no] -be n ci da z o 1 and bleach
soda Yield: 87% of theory, C3oH29N705S (599.68) mass spectrum EKA 'M + H) = 600 M + H + Na) + + = 311.8 15 M + Na) + + = 622 M + 2H) + + = 300.8 2M + H + 2Na) 3 + = 415 2M + 3Na 3 + = 422.7 XH-NMR (d6-DMS0 + DC1): 20 d = 3.29 (t, 2H), 3.51 (t, 2 H); 3.80 (s, 2 H); 3.87 (s, 3 H); 5, 01 (s, 2 H); 7, 10 (dd, 1H); 7, 56-7, 90 (m, 8 H); 8, 17 (d, 1 H); 3, 28 (d, 1 H); 8, 68 (dd, 1 H); 9, 26 (dd, 1H) ppm
E n g ect 26
vattB l-methyl-2- [2- (4-midinophenyl) -ethyl] -5- [N- (N '-hydroxycarbonylmethyl-N' -methyl-1-aminocarbonylmethyl 1) -quinolin-8-sulfonylamino] - Benzimidazole Prepared analogously to Example 3, from 1 -me ti 1 - 2 - [2 - (4-ami di no pheni 1) - eti 1] - 5 - [N - (N '-ethoxycarbonylmethyl-N' -methyl-aminocarbonylmethyl) -quinolin- 8-sulfonylamino] -benzimidazole and soda lye. Yield: 97% of theory, C3? H3? N707s (613.71) mass spectrum (EKA) M + H) = 614 M + Na) + = 636 M + 2H) + + = 307.7 M + H + Na) + + = 318.6 M + 2Na = 329.6
Use 27 l-methyl-2- [(4-amidinophenyl) -oxymethyl] -5- [N- (hydroxycarbonylmethyl) -benzenesulfonylamino] -benzimidazole Prepared analogously to Example 3, starting from 1-methyl ti-2. - [(4-amidi no f eni 1) - oxime ti 1] - 5 - [N- (ethoxycarbonylmethyl) -benzenesulfonylamino] -benzimidazole and sodium hydroxide solution. Yield: 79% of theory, C24H23N5O5S (493, 6) mass spectrum (EKA M + H) = 494 M + Na) + = 516 M-H) "= 492
Example 28 l-Methyl-2- [N- (4-aminophenyl) -aminomethyl] -5- [N- (methoxycarbonylmethyl) -quinolin-8-sulfonilamino] -benzimidazole Prepared analogously to Example le, from 1 -me 111 - 2 - [N - (4 - c 1 anof in 11) - ami nome 111] -5- [N- (methoxycarbonyl-methyl) -qu? nol? n-8-su 1 f on 11 ami o ] -benzene, zo 1 and methanolic hydrochloric acid, ethanol and ammonium carbonate. Yield: 65% of theory, C28H27N7O4S (557, 64) Rf value: 0.33 (silica gel, dichloromethane / methanol = 5: 1) mass spectrum (EKA): (M + H) + = 558 (M + 2H) + + = 279.7 (M + H + Na) + = 290.7 E 299-methyl-2- [2- (4-amidinofeuyl) -ethyl] -5- [N- (methoxycarbonylmethyl)] -quinolin-8-sulfonylamino] benzimidazole Prepared analogously to Example LE, starting from 1-methyl 1-2 - [N - (4-cyn not f at 11) -e 111] - 5 - [N - (methoxycarbonylmethyl) -qu? nolin-8-sulfon? lamino] -benzimidazole and methanolic hydrochloric acid, methanol and ammonium carbonate. Yield: 78% of theory, C29H28N6? 4S (556, 65) R value: 0.29 (silica gel, dichloromethane / methanol = 5: 1) mass spectrum (EKA): (M + H) + = 557 (M + 2H) ++ = 579 (M + H + Na) ++ = 290.3 Use 30 l-methyl-2- [N- (4-amidinophenyl) -aminomethyl] -5- [N- 15 (hydroxycarbonylmethyl) -quinolin-8-sulfonylamino-benzimidazole Prepared analogously to Example 3, starting from 1-methyl 1-2 - [N - (4-ami di no phen 11) -amomomethyl] -5- [N- ( ethoxycarbonylmethyl) -quinolin-8- 20 its 1 foni 1 ami no - be nc imi da zo 1 and soda lye. Yield: 91% of theory, C27H25N7O4S (543; 62) mass spectrum (EKA): (M + H) + = 544 (M + Na) + = 566 25 (M + H + Na) ++ = 283.8
- * .., c-faith. ^ a ^^ - »^ ^ - ^? aiW» ítfea - «88« - 1 -,. -, ^ m (M + 2Na) ++ = 294.6 XH-NMR (d6-DMSO): d = 3.70 (s, 3 H); 4.60 (broad s, 4 H); 6.45 (dd, 1 H); 6.72 (d, 2 H); 7.09 (d, 1 H); 7.30-7.60 (m, 5 H); 7.73 (dd, 1 H); 8.08 (d, 1 H); 8.11-8.35 (m, 3 H); 8.53 (dd, 1H); 9.18 (dd, 1 H); 11.55 (broad s, 2 H) ppm
E n g lish 31 10 l-methyl-2- [2- (4- (N-ethoxycarbonylamino) phenyl) -ethyl] -5- [N- (mexycarbonylmethyl) -quinolin-8-sulfonylamino] -benzimidazole 0.8 g (1.34 mmol) of l-methyl-2- [2- (4-amidinophenyl) -ethyl] -5- [N- (methoxycarbonylmethyl) -15 qu i not 1 in-8-su 1 f on i 1 ami no] -benz imi da zo 1 is dissolved in 50 ml of tetrahydrofuran and 10 ml of water and, after the addition of 0.55 g (4.0 mmol) of potassium carbonate, is stirred for 10 minutes at room temperature. room temperature. Then they are added
0.17 g (1.6 mmol) of ethyl ester of chloroformic acid and stir for another 60 minutes at room temperature. Then, the organic phase is separated, dried and concentrated by evaporation. The residue is chromatographed on silica gel
(methylene chloride / methanol = 30: 1). The
"JA¿" .- * - ~ A3¿ d «% ¿3a £ &toJÍ - ~» -,. At the end, the corresponding fractions are concentrated, mixed by trituration with ether and filtered with suction. Yield: 0.41 g (49% of theory), R value: 0.57 (silica gel, dichloromethane / methanol
= 9: 1) C32H32N606S (628.71) mass spectrum: (M + H) + = 629 (M + Na) + = 651 10 (M + 2H) ++ = 315
Use 32 l-methyl-2- [1- (4-amidinophenoxy) -1-methyl-ethyl] -5- [N- (ethoxycarbonylmethyl) -benzenesulfonylamino] -15-benzimidazole Prepared analogously to Example 1, from 1 -me ti 1 - 2 - [1 - (4 - cia no fe nox i) - 1 -me thi 1 - ethyl] -5- [N- (ethoxycarbonylmethyl) - be nce not su 1 f on i 1 ami no] -be c imi da zo 1 and ethanolic hydrochloric acid, ethanol and ammonium carbonate. Yield: 31% of theory, C26H3? N505S (549, 7) mass spectrum (EKA): (M + H) + = 550 25 (M + Na) + = 572
** & L £ < For example 33 l-methyl-2- [N- (4-amidinophen-11) -aminomethyl] -5-benzyloxy-benzimidazole a. l-methyl-2- [N- (4-cyanophenyl) -aminomethyl] -5-benzyloxy-benz imidazole Prepared analogously to Example la, from 2-methyl-1-amino-5-benzyl-1-oxy-an i 1 inay 4-cia no feni 1 ami noa cé ti co in phosphorus oxychloride. Yield: 11% of theoretical, melting point: > 350 ° C value R f: 0.60 (silica gel, ethyl acetate) b. l-Methyl-2- [N- (4-amidinophenyl) -aminomethyl] -5-benzyloxy-benzimidazole Prepared analogously to Example LE, from 1-methyl ti-2 - [N - (4-cyanal) 1) - ami nome ti 1] - 5 -be nci 1 ox i -be nc imi zo zo 1 and acid c 1 orh idico / ca r bona to ammonium in ethanol. Yield: 66% of the theoretical, RF value: 0.23 (silica gel, dichloromethane / methanol = 4: 1) C23H23N50 (385.47) mass spectrum: (M + H) + = 386 (M + 2H) + + = 193, 5
XSt5¿. K., »f JÉfcwi- A» ~ AE j emplo 34 l-methyl-2- [(4-amidinopheni 1) -oxymethyl] -5- [N- (me tolocarbonylmethyl) -quinolin-8-sulfonylamino] -benzimidazole Prepared analogously to Example le, from 1 -me 111-2 - [(4-cyn not in 11) -oxime 111] -5 - [N- (methoxycarbonylmethyl) -quinolin-8-sulfonamino] -benzimidazole and methanolic hydrochloric acid, methanol and ammonium carbonate. Yield: 68% of theory, CsdHse gOsS (558, 6) mass spectrum (EKA): (M + H) + = 559 (M + 2H) ++ = 280 (M + H + Na) ++ = 291
EXAMPLE 35 l-Ethoxycarbonylmethyl-2- [(4-amidinophenyl) -oxymethyl] -5- (quinolin-8-sulfonylamino] -benzimidazole Prepared analogously to Example 1, starting from 1-et ox i ca r bon i lme ti 1 - 2 - [(4-cyanophen-11) -oxymethyl] -5- (quinolin-8-sulfonylamino) -benzimidazole and ethanolic hydrochloric acid, ethanol and ammonium carbonate Yield: 86% of theory, C28H26N6O5S (558, 6) mass spectrum (EKA): (M + H) + = 559. (M + Na) + = 581 (M + 2H) ++ = 280
Use 36 l-methyl-2- [(4- (N-ethoxycarbonylamido) phenyl) -oxim] -5- [N- (methoxycarbonylmethyl) -quinolin-8-sulfonylamino] -benzimidazole Prepared analogously to Example 31, a
from 1 -me ti 1 - 2 - [(-amidino f eni 1) - oxime ti 1] - 5 - [N- (methoxycarbonylmethyl) -quinol? N-8-sulfon? Lamino] -benz midazole and ethyl ester of acid c 1 oroformi co. Yield: 25% of theory, C3? H30N6O7S (630.7) 15 Rf value: 0.34 (silica gel, dichloromethane / ethanol = 19: 1) mass spectrum (EKA): (M + H) + = 631 (M + Na) + = 653 (M + H + Na) ++ = 327 20 Use 37 1- (3-ethoxycarbonylpropyl) -2- [(4-amidinophenyl) -oxymethyl] -5- (quinolin- 8) -sulfonylamino) - bbenzimidazole
Prepared analogously to Example 1, from 1 - (3-ethoxycarb on i lp r op 11) - 2 - [(4-cyano-phenyl) -oxymethyl] -5- (quinol-n-8-sulfonylamino) -benzimidazole and ethanolic hydrochloric acid, ethanol and ammonium carbonate. Yield: 63% of theory, C3oH30N5? 5S (586.7) mass spectrum (EKA): (M + H) + = 587 (M + Na) + = 609 (M + 2H) ++ = 294
Example 1 1-Hydroxycarbonylmethyl 2 - [(4-amidinophenyl) -oxymethyl] -5- (quinolin-8-sulfonylamino) -benzimidazole Prepared analogously to Example 3, starting with 1-et ox i ca r bon i lme 111) - 2 - [(4-amino di-not-phenyl) -oxymethyl] -5- (quinoline-8-sulfonylamm) -benzimidazole and sodium hydroxide solution. Yield: 97% of theory, C26H22N6O5S (530, 6) mass spectrum (EKA): (M + H) + = 531 (M + Na) + = 553
E n gle 39
** $ - '1- (3-hydroxycarbonylpropyl) -2- [(4-amidinophenyl) -oxymethyl] -5- (quinolin-8-sulfonilamino) -benzimidazole Prepared analogously to Example 3, starting with l- (3 -ethoxycarbonylpropyl) -2- [(4-amidinophenyl) -oxymethyl] -5 ^ (quinolin-8-su 1 foni 1 ami no) -benz imi da zo 1 and soda lye. Yield: 91% of theory, C28H26N605S (558, 6) mass spectrum (EXA): M + H) = 559 M + Na) + = 581 M + 2H) + + = 280 M + H + Na) + + = 291 M + H + K) + + = 299
Use 40 l-methyl-2- [(4- (N-cyclohexyloxycarbonylamino) phenyl) -oxymethyl] -5-N- (methoxycarbonylmethyl) -quinolin-8-sulfonylamino] -benzimidazole Prepared analogously to Example 31, starting from of 1 -me ti 1 - 2 - [(4-ami di no-phenyl-1) -ox ime ti 1] - 5 - [N- (methoxycarbonylmethyl) -quinol? n-8-sulfonylamino) -benzimidazole and ester cic 1 oh ex ico acid chloride chloroform. Performance: 44% of the theoretical,
"J S" a.
C35H36N607S (684.8) mass spectrum (EKA (M + H) + = 685 (M + Na) + = 707 (M + H + Na) + '= 354
Use 41 l-methyl-2- [(3-amidinophenyl) -oxymethyl] -5-benzenesulfonyl-lamino-benzimidazole Prepared analogously to Example 1, from 1-me 111-2 - [(3-cyan of 11) -oxime 111] - 5 - (be n ce nosu 1 f on 11 ami no) -benzium zo 1 and ethanolic hydrochloric acid, ethanol and ammonium carbonate. Yield: 65% of theory, C22H2? N503S (435, 52) mass spectrum (EKA): (M + H) + = 436 (M + Na) + = 458
Example 42 l-methyl-2- [(3-amidinophen? L) -oxymethyl] -5- (quin lin -8-sulfonylamino) -benzimidazole Prepared analogously to Example le, starting from 1-me 111-2 - [(3 - cyan f eni 1) - oxime 111] - 5 - (which is 11 n - 8 - its 1 f on 11 ami) -benzyme zo 1 and ethanolic hydrochloric acid, ethanol and ammonium carbonate. Yield: 89% of theory, C25H22N603S (486.57) R value: 0.16 (silica gel, dichloromethane / ethanol = 4: 1) mass spectrum (EKA): (M + H) + = 487 (M + Na) + = 509
Example 43 l-methyl-2- [N- (4-amidinophenyl) -N-methyl-aminomethyl] -5- [N- (methoxycarbonylmethyl) -quinolin-8-sulfonylamino] -benzimidazole Prepared analogously to Example 1, starting from 1 -me ti 1 - 2 - [N - (4-cyano-phen 11) -N -me-111-aminomethyl] -5- [N- (methoxycarbonylmethyl) -quinolin-8- su 1 f on i 1 ami no) -benc imi da zo 1 and methanolic hydrochloric acid, methanol and ammonium carbonate. Yield: 32% of theory, C29H29N7O4S (571, 67) Rf value: 0.28 (silica gel, dichloromethane / methanol = 5: 1) mass spectrum (EKA): (M + H) + = 572 (M + H + Na) ++ = 297.7
! 3W ^ &f? TiS? S3 &62g: «? & Yes?. ~ ** 'a .. < «-« ^ E ju 44 L-methyl-2- [N- (4- (Neocarbonylamidoino) -phenyl) -aminomethyl] -5- [N- (me-oxycarbonylmethyl) -quinolin-8-sulfonylamino] -benzimidazole Prepared analogously to Example 31, starting from l-methyl-2- [N- (4-amidinofenyl) -aminomethyl] -5- [N- (methoxycarbonylmethyl) -quinolin-8- su 1 f on i 1 ami no] - be nc imi da z ol and ethyl ester of acid c 1 orof órmi co. 0 Yield: 71% of theory, C3iH3? N706S (629.70) R value: 0.62 (silica gel, dichloromethane / methanol = 9: 1) mass spectrum (EKA): (M + H) + = 630 15 (M + H + Na) ++ = 326.6 (M + 2H) ++ = 315.6
E g 45 l-methyl-2- [N- (4- (N-cyclohexy lo i carboni 1 amidi-0 no) phenyl) -aminomethyl] -5- [N- (methoxycarbonylmethyl) -quinolin-8-sulfonylamino] -benzimidazole Prepared analogously to Example 31, starting from 1-methyl ti-2 - [N - (4-ami di no f in i 1) -aminomethyl] -5- [N- (methoxycarbonylmethyl) -quinolin-8-
sulphide lamino] -benzimide zol and ester c i c 1 oh e x i 11 c o of acid c 1 o r or f ormi c. Yield: 59% of theory, C35H37N7O6S (683, 79) R value: 0.66 (silica gel, dichloromethane / methanol = 9: 1) mass spectrum (EKA): (M + H) + = 684 (M + H + Na) ++ = 353, 7 (M + 2H) ++ = 342, 6 10 E xample 46 2- [2- (4-amidinophenyl) -ethyl] -6- [N- (motoxicarbonylmethyl ) -quinolin-8-sulfonylamino] -benzoxazole a. 2- [(4-aminocarbonylphenyl) -ethyl] -6-nitro-15-benzoxazole 2.64 g (15 mmol) of 4- c 1 to non-phenyl-1-pr op 1-ony and 2.31 g (15 mmol) of 2-amino-5-n-11 -three-1 are stirred for three hours at 130 ° C in 50 ml of po-1-acid under a nitrogen atmosphere. It is then poured into water, the precipitate is filtered off with suction, dissolved in methylene chloride / methanol and filtered on activated carbon. The filtrate is concentrated by evaporation in a vacuum, the crystalline residue is filtered off with suction and dried.
~ * «* I» "
• '-'iM &' ji & H ', Jfe * 33_Sfífe' t > »£ * Ü» »ta * í * ÍMI Yield: 3.0 g (64% of theory), R value: 0.43 (silica gel, dichloromethane / methanol = 19: 1) b. 2- [2- (4-C? Anophenyl) -ethyl] -6-n? Tro-benzoxazole 2.0 g (6.43 mmol) of 2- [(4-aminocarbonylphenyl) -ethyl] -6-n? tro-benzoxazole is heated for 60 minutes at reflux in 50 ml of phosphorus oxychloride. Then, it is distilled off in vacuo, the residue is mixed with ice / water, the crystalline product is filtered off with suction, washed and dried. The residue is chromatographed on silica gel (methylene chloride and no a 1 = 99.5: 0.5). The corresponding fractions are concentrated, mixed by triturating with ether, filtered with suction and dried. Yield: 1.25 g (66.5% of theory), Rf value: 0.40 (silica gel; dichloromethane / ethanol = 50: 1) c. 2- [2- (4-C? Anophenyl) -ethyl] -6-am-no-benzoxazole Prepared analogously to Example Ib, starting from 2 - [2 - (4-cyanophen-11) -e 111] -6 - n 11 ro - benzoxazole and palladium on active carbon in methanol / methylene chloride. Performance: 100% theoretical,
Rf value =: 0.59 (silica gel, dichloromethane / ethanol = 19: 1) d. 2 - [2- (4-cyano-phenyl) -ethyl] -6- (N-quinolin-8-sulfonylamino) -benzoxazole Prepared analogously to Example le, starting from 2 - [2 - (4-cyano-pheni-1) - eti 1] - 6 - ami non-benzoxazole and acid chloride 8 - qu i no 1 insu 1 f ón i co in pyridine. Yield: 57% of theory, Rf value: 0.61 (silica gel, dichloromethane / ethanol = 19: 1) e. 2 - [2- (4-cyanophenyl) -ethyl] -6- [N- (methoxycarbonylmethyl) -guiñol in-8-sulfonylamino] -benzoxazole Prepared analogously to Example Id from 2 - [2 - (4-cyano) f in i 1) - eti 1] - 6 - [N - qu i no 1 in - 8 - su 1 f on i 1 ami no] - b in z oxa zo 1, bromoacetic acid methyl ester and potassium carbonate in acetone Yield: 88.5% of the theoretical, Rf value: 0.30 (silica gel, ethyl ether or ethyl acetate = 1: 1)
f. 2 - [2 - (4-Amidino-enyl) -ethyl] -6- [N- (methoxycarbonylmethyl) -quinolin-8-sulfonylamino] -benzoxazole
HjS & r Prepared analogously to Example le, starting from 2 - [2 - (4-cia no fen 11) -e 111] - 6 - [N- (methoxycarbonylmethyl) -qu? Nol? N-8-sulfon? Lam ? no] - benzoxazole and ammonium chloride acid ammonium in methanol. Yield: 82% of theory, R value: 0.32 (silica gel, dichloromethane / ethanol = 4: 1) C28H25N5O5S (543.61) 10 mass spectrum: (M + H) + = 544 (M + 2H ) ++ = 272.7 (M + H + Na) ++ = 283.7
Use 47 15 2 - [2 - (4-amidinophenyl) -ethyl] -6- [N- (hydroxycarbonylmethyl) -quinolin-8-sulfonylamino] -benzoxazole Prepared analogously to Example 3, from 2- [2- (4-am? D? Nofen? L) -et? L] -6- [N- (methoxycarbonylmethyl) -qu? Nolm-8-sulfon? Lam] -20-benzoxazole and soda lye. Yield: 64% of theory, C27H23N5? 5S (529.59) R value: 0.11 (silica gel, dichloromethane / methanol = 4: 1) 25 mass spectrum (EKA): (M + H) + = 530
M + Na) + = 552 M + 2H) + + = 265.7 M + H + Na) + + = 276.7 2M + 3Na = 376
EXAMPLE 48 2- [(4-Amidinophenyl) -oxymethyl] -5- [N- (ethoxycarbonylmethyl) -quinolin-8-sulfonylamino] -lH-benzimidazole Prepared analogously to Example le, starting from 2- [(4-cyanophen ?) -ox? met? l] -5- [N- (ethoxycarbonylmethyl) -quinolin-8-sulfonylamino] -1H-benzimidazole and ethanolic hydrochloric acid, ethanol and ammonium carbonate. Yield: 79% of theory, 15 C28H26N6? 5S (558, 63) R value: 0.26 (silica gel, dichloromethane / methanol = 5: 1) mass spectrum (EKA): (M + H) + = 559 (M + 2H) ++ = 280 20 (M + H + Na) ++ = 291
Example 49 l-methyl-2- [N- (4-amidinobene i 1) -aminomethyl] -5 - [N- (ethoxycarbonylmethyl) -quinolin-8-sulfonylamino] -25-benzimidazole
-i ¿¿¿w.i .. l ^ 4 ....- ^ s & a ^ S »¡. ~. , ... «MU ...,.« ... - ^ - ». , - -á -? ^ -M ¿^ ^ it S £ ^ z & it. ^^, .jeJ &SSi Prepared analogously to Example le, from 1 -me 111 - 2 - [N- ( 4-cia nobe nc 11) - ami nome 111] -5- [N- (ethoxycarbonyl-methyl) -qu? Nol? N-8-sulphon? L-ami no] -benz bound zol and ethanolic hydrochloric acid, ethanol and ammonium carbonate. Yield: 82% of theory, C3oH3iN704S (585.70) R value: 0.30 (silica gel, dichloromethane / methanol = 5: 1) mass spectrum (EKA): (M + H) + = 586 (M + 2H) ++ = 293.7
E 3 emplo 50 l-methyl-2- [N- (4-amidinobenzyl) -aminomethyl] -5- [N- (hydroxycarbonylmethyl) -quinolin-8-sulfonylamino] -benzimidazole Prepared analogously to Example 3, from 1 -me 111 - 2 - [N - (4-amyl di nobenc 1) -aminomethyl] -5- [N- (ethoxycarbonylmethyl) -qu? nol? n-8-su 1 f on i 1 ami no] -ben c I'm in zo 1 and soda lye. Yield: 94% of theory, C28H27N7O4S (557, 64) mass spectrum (EKA): (M + H) + = 558 (M + Na) + = 580
.-, k- &!?? .. ..- .. ,, A¡¡ ^ E j emplo 51 2 - [2 - (4-amidinophenyl) -ethyl] -5- [ N- (ethoxycarbonylmethyl) -quinolin-8-sulfonylamino] -benzoxazole a. 2- [2- (4-Cyanophenyl) -ethyl] -5-nitro-benzoxazole 5 Prepared analogously to Example 46b, starting from 2 - [(4-amino-car bon-11-phe-11) -e 111] -5-n 11 ro - benzoxazole and phosphorus oxychloride. Yield: 36% of theory, value R f: 0.90 (silica gel; dichloromethane / methanol 10 = 19: 1) b. 2- [2- (4-C? Anophenyl) -ethyl] -5-amino-benzoxazole Prepared analogously to Example Ib, starting from 2 - [2 - (4-cynophen-11) -e 111] - 5 - n 11-benzoxazole and palladium on active carbon in methanol / methylene chloride. Yield: 100% of theory, R value: 0.36 (silica gel, dichloromethane / methanol = 19: 1) c. 2- [2- (4-cyanophenyl) -ethyl] -5- (N-quino-lin-8-sulphonylamino) -benzoxazole Prepared analogously to Example le, from 2 - [2 - (4-cyanophen-11) - and 111] -5-amino-benzoxazole and acid chloride 8-qui not 11 nsu 1 f ón i co in pyridine. 25 Performance: 27% of the theoretical,
t Rf value: 0.70 (silica gel, dichloromethane / methanol = 19: 1) d. 2- [2- (4-cyano-phenyl) -etill-5- [(N- (ethoxycarbonylmethyl) -quinolin-8-sulfonylamino] -benzoxazole Prepared analogously to Example Id, from 2 - [2 - (4-anophenol eni 1) -eti 1] - 5 - (N-quino 1 in-8 - su 1 f on i 1 ami no) -ben z oxa zo 1, ethyl ester of bromoacetic acid and potassium carbonate in acetone Yield: 100 % of theory, value R f: 0.78 (silica gel, dichloromethane / methanol = 50: 1) e 2- [2- (4-amidinophenyl) -ethyl] -5- [N- (ethoxycarbonylmethyl) -quinolin - 8 -silynylamino] -benzoxazole Prepared analogously to Example le, starting from 2 - [2 - (4 - cyano f in i 1) - eti 1] - 5 - [N - (et oxycarbonylmethyl) - quinolin-8-sulfonamino] -benzoxazole and acidic ammonium chloride in ethanol yield: 98% of theory, R value: 0.44 (silica gel, dichloromethane / methanol = 5: 1) C29H27 5O5S (557, 63) mass spectrum (EKA): (M + H) + = 558 (M + 2H) ++ = 279.7 (M + H + Na) ++ = 290, 7
Example 52 2- [2- (4-amidinophenyl) -ethyl] -5- [N- (hydroxycarbonylmethyl) -quinolin-8-sulfonylamino] -benzoxazole Prepared analogously to Example 3, from 2- [2- ( 4-amidinophenyl) -ethyl] -5- [N- (ethoxycarbonylmethyl) -quinolin-8-sulfonylamino] -benzoxazole and sodium hydroxide solution. Yield: 77% of theory, C27H23N5O5S (529.58) mass spectrum (EKA M + H) + = 530 M + Na) + = 552 M + H + Na) ++ = 276.6; M-H + 2Na ) + = 574; M + 2Na) ++ = 287.6
The solution was 53 L-methyl-2- [2- (2-amidinothiophen-5-yl) -ethyl] -5- [N- (ethoxycarbonylmethyl) -quinolin-8-sulfonylamino] -benzimidazole Prepared analogously to Example le, from 1 -me ti 1 - 2 - [2 - (2-cy without thiof en-5-i 1) - eti 1] - 5- [N- (ethoxycarbonylmethyl) -quinol? n-8- su 1 foi 1 ami no] - be nc imi da zo 1 and ethanolic hydrochloric acid, ethanol and ammonium carbonate. Performance: 42, of the theoretician,
-.--. "«: • »" ,, - »¿8Wft¿.,. ^, -.g-aS ^ Jed ^ á ^^ ga ^^ - ^^^ a ^ é ^^ »^: .. '.,' - ^ a¡ bb? B.
C28H28 6? 4S2 (576, 71) R f value: 0.36 (silica gel; dichloromethane / methanol
= 5: 1) mass spectrum (EKA): (M + H) + = 577 (M + 2H) ++ = 289 (M + H + Na) ++ = 300
E 3 emplo 54 l-met? L-2- [2- (2-a idinotiof en-5-? L) -ethyl] -5- [N- (hydroxycarbonylmethyl) quinolin-8-sulfoni lamino] -benzimidazole Prepared analogously to Example 3, from 1 -me 111-2 - [2 - (2-amidino 11 of en-5-l, 11) -ethyl] -5- [N- (ethoxycarbonyl-methyl) -qu? nol? n- 8- su 1 f on 11 ami no - be nc ími da zo 1 and lye of soda. Yield: 98% of theory, C26H24N604S2 (548, 66) mass spectrum (EKA): (M + H) + = 549 (M + Na) + = 571
E -j 55 l-met? L-2- [N- (4-amidinophenyl) -aminomethyl] -5- [N- (etoxycarbonylmethyl) -benzenesulfanthylamino] -benzimidazole
Prepared analogously to Example LE, starting from 1-methyl ti 2 - [N - (4-cyanof in i 1) - ami nome ti 1] - 5- [N- (ethoxycarbonylmethyl) -benzenesulfonylamino] -benzimidazole and acid ethanolic hydrochloride, ethanol and ammonium carbonate. Yield: 50% of theory, C26H28 6? 4S (520.62) R value: 0.34 (silica gel, dichloromethane / methanol = 5: 1) mass spectrum (EKA): (M + H) + = 521
Use 56 l-methyl-2- [N- (4-aminophenyl) -aminomethyl] -5- [N- (hydroxycarbonylmethyl) -benzenesulfonylamino] -benzimidazole Prepared analogously to Example 3, starting from 1-methyl-1 2 - [N - (4-amidino f eni 1) - aminomethyl] -5- [N- (ethoxycarbonylmethyl) -benzene sulphon i ami no] -be nc imi da zo 1 and soda lye. Yield: 97% of theory, C2.H24N6O4S (492.56) mass spectrum (EKA): (M + H) + = 493 (M + Na) + = 515 (M-H + 2Na) + = 537 (M + 2Na) ++ = 269
Example 57 l-methyl-2- [N- (4-amidinophenyl) -aminomethyl] -5- (N-benzyl-N-methylamino) -benzimidazole Prepared analogously to Example le, starting from 1-me 111 - 2 - [N- (4 - cia no fen 11) - ami n ome 111] - 5 - (- be nc 11 - -me 111 ami no) -be nc ím id zo 1 and ethanolic hydrochloric acid, ethanol and carbonate of ammon io. Yield: 85% of theory, 10 C2 H26N6 (398.51) R value: 0.27 (silica gel; dichloromethane / methanol = 4: 1) mass spectrum (EKA): (M + H) + = 399 (M + 2H) ++ = 200 15 E jmplo 58 l-methyl-2- [N- (4-amidinophenyl) ) -aminomethyl] -5- [N- (ethoxycarbonylmethyl) -n-bu-tanosulfonylamide] - benzyl zol Prepared analogously to Example LE, from 1 -me 111-2 - [N - (4-cynophen 11) - ami nome 111] - 5- [N- (ethoxycarbonylmethyl) -n-butanesulfonylammo] -benzimidazole and ethanolic hydrochloric acid, ethanol and ammonium carbonate. 25 Performance: 71% of the theoretical,
C24H32N604S (500, 63) Rf value: 0.32 (silica gel; dichloromethane / methanol
= 5: 1) mass spectrum (EKA): (M + H) + = 501 M + H + Na 262
Example 59 l-Methyl-2- [N- (4-amidinophenyl) -aminomethyl] -5- [N- (ethoxycarbonylmethyl) -benzoylamino] -benzimidazole Prepared analogously to Example le, from 1-methyl-1 - 2 - [N - (4 - cia no feni 1) - ami nome ti 1] -5- [N- (ethoxycarbonylmethyl) -benzoylamino] -benzimidazole and ethanolic hydrochloric acid, ethanol and ammonium carbonate. Yield: 56% of theory, C27H28N603 (484.57) R value: 0.34 (silica gel, dichloromethane / methanol = 5: 1) mass spectrum (EKA): (M + H) + = 485 (M + H + Na) ++ = 254
Example 60 l-Methyl-2-tN- (4-amidinophenyl) -aminomethyl] -5- [N- (ethoxycarbonylmethyl) -pyridin-2-yl-carbonylamino] benzimidazole Prepared analogously to Example le, starting from 1-me ti 1 - 2 - [N- (4-cyano f in i 1) - ami nome ti 1] - 5- [N- (ethoxycarbonylmethyl) -pyridin-2-ylca rboni 1 amino] -benz imide zol and acid ethanolic hydrochloride, ethanol and ammonium carbonate. Yield: 64% of theory, Rf value: 0.31 (silica gel, dichloromethane / methanol = 5: 1) mass spectrum (EKA): (M + H) + = 486 (M + H + Na) ++ 254.7
Example 61 l-methyl-2- [N- (4-amidinophenyl) -aminomethyl] -5- [N- (hydroxycarbonyl-yl) -n-bu-tannesulfonylamino] -benzimidazole. Prepared analogously to Example 3, starting from 1-methyl ti 2 - [N- (4-ami diene f eni 1) -aminomethyl] -5- [N- (ethoxycarbonyl-methyl) - n - bu tanosu 1 f on i 1 ami no] -be nc imi da zo 1 and lye of soda. Yield: 98% of theory, C22H28N6O4S (472.57) mass spectrum (EKA): (M + H) + = 473 (M + Na) + = 495 (M + 2Na) ++ = 259
The reaction was carried out using 62 l-methyl-2- [N- (4-amidinophenyl) -aminomethyl] -5- [N- (hydr oxy carbome ti 1) -ben zoi lamino] -benzimidazole. Prepared analogously to Example 3, starting from of 1 -me 1 1 - 2 - [N - (4-ami di no f in 11) -aminomethyl] -5- [N- (ethoxycarbonyl-methyl) -benzo 11 ami no] -b ene z and z soda lye. Yield: 69% of theory, C25H24N603 (456.51) mass spectrum (EKA): (M + H) + = 457 (M + 2Na) ++ = 251 (M + Na) + = 479
Use 63 l-methyl-2- [N- (4-amidinophenyl) -aminomethyl] -5- [N- (hydroxycarbonylmethyl) -pyr idin-2-yl-carbonylamino] -benzimidazole Prepared analogously to Example 3, starting from of 1 -me 111-2- [N - (4-ami di no-phen-11) -aminomethyl] -5- [N- (ethoxycarbonylmethyl) -p? r? d? n-2-? lc ar bon 11 ami no ] - benc imi da zo 1 and soda lye. Yield: 96% of theory, C2 H23 703 (457.50) mass spectrum (EKA): (M + H) + = 458 (M + Na) + = 480
e > 'I83íM £? R¿, S < rf¿3flte. ^ aMfefe ^ »M + H + Na = 240.6 M + 2Na = 251.6
EXAMPLE 64 l-Methyl-2- [(4-amidinophenyl) -oxymethyl] -5- (N-cyclohexyl-me tanosulfonylamino) -benzimidazole Prepared analogously to Example le, from 1-methyl 111 - 2 - [(4 - ci anus fen 11) -oxime 111] -5- (N-cyclohexyl-methanesulfonyl) -benzimidazole and ethanolic hydrochloric acid, ethanol and ammonium carbonate. Yield: 79% of theory, C23H29N503S (455.59) R value: 0.21 (silica gel, dichloromethane / ethanol = 4: 1) mass spectrum (EKA): (M + H) + = 456 (M + Na) + = 478
Example 65 l-methyl-2- [(4-amidinophenyl) -oxymethyl] -6- [N- (ethoxycarbonylmethyl) -benzenesulfoni-lamino-benzimidazole Prepared analogously to Example le, starting from l-met? L-2 [(4-C? Anophen? L) -oxymethyl] -6- [N- (ethoxycarbonylmethyl) -benzenesulfonylamino] -benzimidazole and hydrochloric acid, ethanolic, ethanol and ammonium carbonate. Yield: 45% of theory, C26H27N5O5S (521.6) mass spectrum (EKA): (M + H) + = 522 (M + H + Na) ++ = 272.7
Use 66 l-methyl-2- [N- (4-amidinophenyl) -aminomethyl] -5- (N-cyclopentylmethanesulfonylamino) -benzimidazole Prepared analogously to Example le, starting from 1 -me 111-2 - [N- (4 - c 1 ano f eni 1) - ami nome 111] -5- (N-cyclopentyl-methanesulfonyl) -benzimidazole and ethanolic hydrochloric acid, ethanol and ammonium carbonate. Yield: 89% of theory, C22H28N602S (440, 58) Rf value: 0.17 (silica gel, dichloromethane / ethanol
= 4: 1) mass spectrum (EKA): (M + H) + = 441 (M + Na) + = 463 E j psa 67 l-methyl-2- [(4-amidinophenyl) -oxymethyl-5- [ N- (N '- (ethoxycarbonylmethyl) -quinolin-8-sulfonylamino] -benzimidazole
»9 * a¡» -.
Prepared analogously to Example le, starting from l-methyl-2- [(4-cyanophenyl) -oxymethyl] -5- [N- (N '- (ethoxycarbonylmethyl) -aminocarbonylmethyl) -qu i not 1 in-8-su 1 f on i 1 ami no] -b ene imi da zo 1 and ethanolic hydrochloric acid, ethanol and ammonium carbonate. Yield: 49% of theory, C3iH3? N706S (629.7) mass spectrum (EKA): (M + H) + = 630 (M + 2H) ++ = 315.7 M + H + Na = 326.7
Example 68 l-methyl-2- [(4-amidinophenyl) -oxymethyl] -5- [N- (N '- (hydroxycarbonylmethyl) -aminocarbonylmethyl) -guinolin-8-sulfonylamino] -benzimidazole Prepared analogously to Example 3, from 1 -me ti 1 -2 - [(4 -ami di no f eni 1) -oxime ti 1] - 5 - [N- (N '- (ethoxycarbonylmethyl) -aminocarbonylmethyl) -quo 1 in-8 - his 1 f oni 1 ami no] -be nc imi da zo 1 and soda lye. Yield: 79% of theory, C29H27N706S (601.7) mass spectrum (EKA): (M + H) + = 602 (M + Na) + = 624
^ ZS ^. . ^? ^ ?. »-, J & amp; & & J8 .- ^ ----.« -.-. ¿-? Í-SM + 2H) ++ = 301,7 (M + H + Na) + + = 312.7
Example 69 5 l-methyl-2- [(4-amidinophenyl) -oxymethyl] -5- (N- (2-ethoxycarbonyl-ethyl) -qunolin-8-sulfonylamino] -benzimidazole Prepared analogously to Example le, from 1 -me 111-2- [(4-cyanophenol) -oxime 111] -5- (N-10 (2-ethoxycarbonyl-ethyl) -quinol-n-8-sulfon Lamino] - benzimidazole and ethanolic hydrochloric acid, ethanol and ammonium carbonate Yield: 62% of the theoretical, C3oH3oN605S (586.7) 15 mass spectrum (EKA): (M + H) + = 587 (M + 2H) ++ = 294 (M + H + Na) ++ = 305
E xample 70 20 2 - [N- (4-amidinophenyl) -aminomethyl] -3-methyl-6- [N- (ethoxycarbonylmethyl) -1, 2, 3, 4- tetrahydroquinone 1 in-8-sulfonylamino ] -benzofuran Prepared analogously to Example le, starting from 2 - [N - (4-cyano f in 11) - ami nome 111] - 3 -me 111-25 - [N- (ethoxycarbonylmethyl) -1, 2, 3, 4-tetrahydro-
'' .. qumolm-8-sulfon? Lam? No] -benzofuran (prepared analogously to Example 107) and ethanolic hydrochloric acid, ethanol and ammonium carbonate. Yield: 55% of theory, C3oH33N505S (575.70) R value: 0.25 (silica gel, dichloromethane / ethanol
= 4: 1) mass spectrum (EKA): (M + H) + = 576 (M + H + Na) ++ = 299.7
E xemplo 71 2- [N- (4-amidinophenyl) -aminomethyl] -3-meth? L-6- [N- (hydroxycarbonylmethyl) -1, 2, 3, 4 -tetrahydro -quinolin-8-sulfonylamino] -benzofuran Prepared analogously to Example 3, starting from 2 - [N- (4-amide f in 11) -ammome 111] -3-meth? l-6- [N- (ethoxycarbonylmethyl) - 1, 2, 3, 4-tetrahydrochlor 11 n - 8 - su 1 f on 11 ami no] -ben zofur ano and soda lye. Yield: 94% of theory, C28H29N5O5S (547, 65) mass spectrum (EKA): (M + H) + = 548 (M + Na) + = 570 (M + 2Na) ++ = 296.7
Example 72 2- [2- (amidinofentl) -ethyl] -4-methyl-7- [N-e-toxicarbonylmethyl) -quinolin-8-sulfonylamino] -quinol ina Prepared analogously to Example le, from 2 - [2 - (4 - cia no f in i 1) - eti 1] - 4 - me thi 1 - 7 - [N - (ethoxycarbonylmethyl) -quinolin-8-sulfonylamino] -quinoline (prepared analogously to Example 102) and acid ethanolic hydrochloric acid, ethanol and carbonate
amon i o. Yield: 50% of theory, C32H31N504S (581.6) R value: 0.18 (silica gel, dichloromethane / ethanol = 4: 1) 15 mass spectrum (EKA): (M + H) + = 582 ( M + 2H) ++ = 291.7 (M + H + Na) ++ = 302.7
Use 73 20 2- [2- (4-amidinophenyl) -ethyl] -4-methyl-7- [N- (hydroxycarbonylmethyl] -quinol in- 8-sulfonylamino] -quinoline Prepared analogously to Example 3, a starting from 2 - [2 - (4-amidi not f eni 1) - eti 1] - 4 -me 111 - 7 - [N -
(ethoxycarbonylmethyl) -quinolin-sulfonylamino] quinoline and soda lye. Yield: 38% of theory, C30H27N5? 4S (553.60) mass spectrum (EKA): (M + H) 554 (M + Na '= 576 (M + 2H + = 277.7
Example 74 1-methyl-1 - 2 - [2 - (4-amidinophen-1) -ethyl] -5- (N-quinoline-8-sulfonylamino) -indole hydrochloride a. (E) -4- [2- (1-methyl-indole-2-yl) ethenyl] benzonitrile 3.2S g (approximately 67 mmol) of a suspension of 50% sodium hydride in mineral oil is heated for 45 minutes up to 80 ° C in 70 ml of d ime ti 1 s ul f ox i do. After cooling to room temperature, an additional 140 ml of dimethyl ether and 1% of the mixture are added, and in portions, 18.2 g (44 mmol) of 4-cyanobenzene bromide 11 rifon 11 phosphonium. it is stirred for 90 minutes at room temperature. Then, 7.0 g (44 mmol) of 1-methyl-1-yl-1-carbale hydroxide (44%) were added dropwise (J. Org. Chem. 5, 2, 104 (1987). )) in 70 ml of 1-methyl ester and allowed to stir for 30 minutes at room temperature, for 20 minutes at 40 ° C and for 16 hours again at room temperature. The crude product is diluted with 200 ml of ethyl acetate, washed with 400 ml of 14% sodium chloride solution and the aqueous phase is extracted with 2 x 300 ml of ethyl acetate. The combined organic phases are dried with sodium sulphate, the solvent is distilled off in vacuo and the crude product is purified by flash chromatography (silica gel, petroleum ether, ethyl acetate = 9). :1) . Yield: 2.4 g (21% of theory), R value: O, 52 (silica gel, ethyl acetate / petroleum ether = 3: 7) b.4- [2- (l-methyl -indol-2-yl) ethyl] benzonitrile 2.3 g (8.9 mmol) of (E) -4 - [2 - (1-methyl) 1 -i do 1 - 2 - i 1) eteni 1] be The mixture is dissolved in 150 ml of methanol and 50 ml of methylene chloride and hydrogenated with 0.20 g of 10% palladium on carbon at a hydrogen pressure of 3 bar. vacuum and the white residue obtained is washed with a little diethyl ether and acetone Yield: 1.8 g (78% of theory), R value: 0.50 (silica gel, ethyl acetate / petroleum ether = 3 7)
a - * - i ^ -a &-? ^ * ^ k ^ c.4- [2- (l-Methyl-5-nitro-indol-2-yl) ethyl] benzonitrile In the space of 2 hours dissolve 1.7 g (6.53 mmol) of 4 - [2 - (1-methyl) 1-i ndol-2 -i 1) eti 1] be nz on itri 1 or in 20 ml of concentrated sulfuric acid at 15 ° C and then cooled to 2 ° C. Then, 0.66 g (6.53 mmol) of potassium nitrate are added in portions (increase in temperature to about 10 ° C). Stirring is continued for 30 minutes at 2-5 ° C and then poured on ice. The resulting yellowish precipitate is filtered off and washed with water. Yield: 2.0 g (100% of theory), Rf value: 0.24 (silica gel, ethyl acetate / petroleum ether = 3: 7) d.4- [2- (l-methyl-5 - amino-indol-2-yl) ethyl] benzonitrile 2.0 g (6.55 mmol) of 4 - [2 - (1-methyl-1 -5-nitr o-indol-2-y1) eti 1] benzonitri 1 or are dissolved in 200 ml of methanol and 200 ml of methylene chloride and hydrogenated with 0.20 g of 10% palladium on carbon at a hydrogen pressure of 3 bar. Next, the solvent is separated by
S &tissk distillation under vacuum and the residue is washed with a little methanol. Yield: 1.67 g (93% of theory) of an amorphous solid from beige to yellow, R value: 0.38 (silica gel, methylene chloride 1 ene / e t a nol = 19: 1) e. l-methyl-2- [2- (4-cyanophenyl) -ethyl] -5- (N-quino lin -8-sulfonylamino) -indole A solution of 1.57 g (5.7 mmol) of 4- [ 2- (1-me 111-5-ammo-i ndol-2-11) -e 111] ben z on 11 ri and 1.42 g (6.2 mmol) of qumol? N-8- acid chloride Sulfonic acid in 30 ml of pipdma is stirred for 1 hour at room temperature. The solvent is then removed in vacuo, the residue is taken up in 50 ml of methylene chloride, washed with 50 ml of saturated sodium hydrogen carbonate solution, dried with sodium sulfate and purified by flash chromatography. (silica gel, me 111 chloride and no / eta no 1 = 99: 1). Yield: 0.77 g (49% of theory), R value f: 0.39 (silica gel, me 111 chloride and no / e t a n 1 = 50: 1)
F. Hydrochloride of 1 -me t i 1 - 2 - [2 - (4-amidinofeni 1) -ethyl] -5- (N-quinolin-8-sulfoni l m no) - indole
- ^ 4SL & amp; amp; *. L ** > ^. ^. ^ '^ ^ S ^^ b ^^ ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^ - [2 - (4 - cia no feni 1) - eti 1] - 5 - (N -qu ino 1 in - 8 - su 1 f on i 1 ami no) - step 1 and ethanolic hydrochloric acid, ethanol and carbonate of ammonium. Yield: 39% of theory, C2 H25N502S (483, 6) Rf value: 0.29 (silica gel, me 111 ene / eta chloride no 1 = 4: 1 + some drops of acetic acid) mass spectrum (SKA ): (M + H) + = 484
Use 75 l-methyl-2- [2- (4-amidinophenyl) -ethyl] -5-fN- (ethoxycarbonylmethyl) -quinolin-8-sulfonylamino] -indole Prepared analogously to Example le, starting from 1 -me ti 1 - 2 - [2 - (4 - cia no f in i 1) - and 111] - 5 - [N - (ethoxycarbonylmethyl) -quinolin-8-sulfonylamino] -i ndo 1 and ethanolic hydrochloric acid, ethanol and carbonate of ammonium. Yield: 53% of theory, C31H3? N504S (569, 69) R value: 0.19 (silica gel, dichloromethane / ethanol = 4: 1)
mass spectrum (EKA 'M + H) + = 570 M + 2H 235.7 (M + H + Na 296.6
Use 76 5 l-methyl-2- [2- (4-amidinophenyl) -ethyl] -5-fN- (hydroxycarbonylmethyl) -quinolin-8-sulfonylamino) -indole Prepared analogously to Example 3, starting from 1 - me ti 1 - 2 - [2 - (4-amidi no f eni 1) -eti 1] - 5 - [N- (ethoxycarbonylmethyl) -quinolin-8-sulfonylamino] -indole 10 and soda lye. Yield: 96% of theory, C29H27 5O4S (541.63) mass spectrum (EKA): (M + H) + = 542 (M + Na) + = 564 15 (M + 2H) ++ = 271.7 ( MH) "= 540
Example 77 l-Methyl-2- (4-amidinobenzylamino) -5- (quinoline-8-20-sulphonylamino) -benzimidazole Prepared analogously to Example 1, from 1-methyl ti 2 - (4 - cian ob enci 1 ami no) - 5 - (qu i no 1 in - 8 - su 1 f on i 1 ami) -benc imi da zo 1 and ethanolic hydrochloric acid, ethanol and ammonium carbonate.
Performance: 85% of the theoretical,
C25H23N7O2S (485, 57) Rf value: 0.40 (silica gel, e 111 o / ethane 1 / ammon 1 aco = 50: 45: 5) mass spectrum (EKA): (M + H) + = 486 (M + H + Na) ++ = 254.7
Example 78 l-methyl-2- (4-midinobenzylthio) -5- (quinol? N-8-sulfonylamino) -benzimidazole Prepared analogously to Example le, starting from 1-me 111-2 - (4-cyanob) enc 1111 o) - 5 - (qu 1 not 11 n-8 - su 1 f on 11 ami no) -be nc ia 1 z and ethanolic hydrochloric acid, ethanol and ammonium carbonate. Yield: 69% of theory, C25H22N6O2S2 (502, 62) R value: 0.45 (silica gel, e 111 o / eta acetate 1 / ammon 1 to co = 50: 45: 5) mass spectrum ( EKA): (M + H) + = 503 (M + Na) ++ = 525
EXAMPLE 79 2 - [(4-Amidinophenyl) methyl thio] -5- (N-qu i no lin-8-sulfoni lamino) -benzothiazole hydrochloride a. 2 ~ \ (4-cyanophenyl) methylthio] -6-nitro-benzathiazole
. ^ - ». Kt-eaBSI uJfo: «- ** - * > - To a solution based on 1.5 g (7.06 mmol) of 2-me rc ap to -6-nitroben-zothiazo 1 0.37 g (7.7 mmol) of sodium hydride are added in portions. (50% in mineral oil) and then stirred for 30 minutes at 50 ° C. Then 1.45 g (7.4 mmol) of 4-b r omome t i lbe n z on i t r i 1 o is added dropwise and the mixture is stirred at 50 ° C. for a further hour. The reaction mixture is combined with 30 ml of ethyl acetate and 70 ml of 14% sodium chloride solution, after
which precipitates a large part of the compound of the statement in the form of a beige precipitate. The organic phase is concentrated in vacuo, the precipitated crude product is triturated with diethyl ether and the aqueous phase is separated. The solid obtained meets
with the beige precipitate. Yield: 1.3 g (56% of theory), Rf value: 0.52 (silica gel, ethyl acetate / petroleum ether = 3: 7) b. 2 - \ (4-cyanophenyl) -methylthio] -6-amino-benzothiazole 20 A suspension of 1.0 g (3.05 mmol) of 2- [(4-cyanophenyl) methylthio] -6-nitro-benzathiazole heat to boiling in 60 ml of acetic acid until a clear solution results. Next, 2.0 g (36 g) are added in two portions
mmol) of iron powder and boiled for 5 hours.
reflux minutes. It is filtered and the filtrate is concentrated in vacuo. The crude product is made alkaline by the addition of concentrated ammonia and purified by flash chromatography (silica gel, ethyl acetate / petroleum ether = 20:80 to 35:65). Yield: 0.22 g (24% of theory) of a beige amorphous solid, R value: 0.44 (silica gel, ethyl acetate / petroleum ether = 4: 6) c. 2- [(4-cyanophenyl) methylthio] -6- (N-quinolin-8-sulfonylamino) -benzothiazole A mixture based on 2.3 g (7.74 mmol) of
2 - . 2 - [(4-c? Anophen? L) methotthyl] -6-ammo-benzoth? Azole and 15 1.85 g (8.1 mmol) of cholino-8-sulfonic acid chloride stir for 2 hours at room temperature in 30 ml of pyridine. At room temperature, the solvent is distilled off in vacuo and the crude product is purified by flash chromatography (silica gel, methylene chloride / ethanol = 99: 1). Yield: 3.15 g (83% of theory) melting point: 106-108 ° C R value: 0.33 (silica gel; ethyl acetate / petroleum ether = 4: 6)
X & Ma ^ r ^^^^^^ b? I ^ & i ^ k! ^ h? ^) ^ i ^ X'í £ í.
d. 2 - [(4-Amidinopheni 1) methyl thio] -5- (N-quinolin-8-sulfonyl-lamino) -benzothiazole hydrochloride Prepared analogously to Example 1, from 2 - [(4-cyano-fe-ni-1) ) me ti 11 io] - 6 - (N - qu i no 1 in - 8 - su 1 f on i 1 ami no) - ben zotiazo 1 and ethanolic hydrochloric acid, ethanol and ammonium carbonate. Yield: 91% of theory, C24H? 9N502S, (505.64) R value: 0.34 (silica gel;
me t i 1 e no / e t a 1 = 4: 1 + some drops of acetic acid) Mass spectrum (SKA): (M + H) + = 506
EXAMPLE 80 15 Me z cy based on 2- (4-amidinophen-1) -ethyl] -1-methyl-6 - (quinoline-8-sulfonyl-1-amino) -imidazo hydrochloride. b] pyridine and 2- [2- (4-amidinophenyl) -ethyl] -3-methyl-6- (quinolin-8-sulfoni-lamino) -imidazo [4, 5-b] pyridine hydrochloride 20 a. 3 - (4-Cyanophenyl) -N- (3,5-di-tro-pyrid-2-yl) -propionic acid amide A solution based on 1.8 g (10 mmol) of 2-ami no-3, 5-din 11 ro -pyridine, 2.4 g (12 mmol) of 3- (cyanophenyl) propionyl chloride, 2.0 ml of
triethylamine and 0.1 g of dimethylamine in 35 ml of
Chlorobenzene is heated to 150 ° C for 3 hours. The solvent is then removed by distillation in vacuo and the residue is taken up in 50 ml of ethyl acetate. It is washed with 50 ml of water and 50 ml of saturated sodium chloride solution, dried with sodium sulfate and, after distilling off the solvent, purified by flash chromatography (silica gel, methylene chloride). . Yield: 2.2 g (65% of theory), Rf value: 0.67 (silica gel; me t i 1 e t i 1 c e t ona / xi 1 eno = 1: 1) b. 2 - [2 - (4-Cyanophenyl) ethyl] -6-phthalimido-imidazo [4, 5-b] pyridine A suspension based on 2.1 g (6.15 mmol) of 3 - ( 4 - ci an of in i 1) -N - (3, 5 -di nitro-pyrid-2-i 1) -pr op i ion icoy 0.50 g of 10% palladium on carbon in 50 ml of acetic acid glacial is reacted at 80 ° C at a hydrogen pressure of 3 bar. After cooling, the catalyst is filtered off, 1.1 g (7.4 mmol) of phthalic acid anhydride are added and the mixture is heated to boiling for 1 hour. The solvent is distilled off in vacuo and the crude product is taken up in 50 ml of methylene chloride, washed twice with saturated sodium hydrogen carbonate solution and purified by flash chromatography (silica gel; ileno / e tanol = 40: 1 to 19: 1). Yield: 0.95 g (41% of theory), Rf value: 0.50 (silica gel; acetate e t i 1 o / e t a no 1 / amo - ni a co = 90: 10: 1) c. Mixture of isomers based on 2 - \ 2 - (4-cyano-enyl) -ethyl] -l-methyl-6-f-talimido-imidazo [4, 5-b] pyridine and 2 - [2- (4-cyano-phenyl) -ethyl] -3-methyl-6-f amido-imidazo [4, 5-b] pyridine A mixture based on 0.80 g (2.0 mmol) of 2- [2- (4-cyano-phenyl) -ethyl] -6-phthalamido-imidazo [4, 5 - b) pyridine, 0.25 g (2.2 mmol) of potassium tert-butylate and 0.32 g (2.2 mmol) of methyl iodide are stirred in 10 ml of dimethylsulfox. i do for 1 hour at room temperature. It is then poured onto ice / water, extracted with 100 ml of ethyl acetate, dried over sodium sulphate and the solvent is distilled off in vacuo. Yield: 0.80 g (98% of theory), R value f: 0.56 (silica gel; acetate of t i 1 o / e t a n 1 / amo - n i a c o = 90: 10: 1) d. Mix of isomers based on 2- [2- (4-cyanophen-1) -ethyl] -l-methyl-6-imidazo [4,5-b] pyridine and
3iüfc > , & & St. «*. 2- [2- (4-cyanophenyl) -ethyl] -3-methyl-6-imidazo [4, 5-b] pyridine 0.80 g (2.0 mmol) of the mixture of isomers based on 2- [2- (4-c? Anophen? L) -et? L] -l-met? L-6- 5 phta 1 iodide of zo [4, 5-b] pi ri di na and 2- [ 2- (4-cyanophenyl) -ethyl] -3-met? L-6-? M? Dazo [4, 5-b] pipdine are stirred in 5 ml of 40% aqueous me 111 amine solution and 20 ml of ethanol for 1 hour at 40-60 ° C. Then, the solvent is separated by
After vacuum distillation, the crude product is taken up in 40 ml of ethyl acetate / ethanol (9: 1) and, subsequently, washed with water and saturated sodium chloride solution. After removing the solvent in vacuo, the residue is collected in
The reaction is carried out, and analogously to Example 79c, with 0.41 g (1.8 mmol) of the acid chloride qui no 11 n-8-suphonic acid, is processed and purified by chromatography. rapid resolution (silica gel, methylene chloride to chloride
me 111 e no / e t a no 1 = 19: 1). Yield: 0.50 g (54% of theory), Rf value: 0.63 + 0.50 (silica gel, e 111 e / e t a no 1 / ammon a co = 90: 10: 1)
«- &« - .. i.-jiAsar J e. Mixture of isomers based on 2- [2- (4-amidinophenyl) -ethyl] -l-methyl-6- (quinolin-8-sulfonylamino) imidazo [4, 5-b] pyridine hydrochloride and hydrochloride of 2 - 2 - (4-amidinopheni 1) -e ti 1] - 3 -me thi -6- (quinolin-8-sulfonylamino) -imidazo [4,5-b] -pyridine Prepared analogously to Example le, from mixture of isomers based on 2- [2- (4-cyanophenyl) -ethyl] -l-methyl-6- (quinolin-8-sulfonyl-ami no) -imido zo [4,5-b] pyridine and 2 - [2 - (4-cyano f eni 1) -ethyl] -3-methyl-6- (quinoline-8-sulfonyl-amino) -imino zo [4,5-b] pyridine and hydrochloric acid methanol, methanol and ammonium carbonate. Yield: 80% of the theoretical, C25H23N702S (485.57) RF value: 0.25 + 0.21 (silica gel; ethyl acetate 1 o / eta no 1 / amoni a co = 50: 45: 5) Spectrum of masses (SKA): (M + H) +, 486
Example 81 2- (4-amidinobenzyl thio) -6- [N- (methoxycarbonylmethyl) -guiny lin-8-sulfonyl lamino] -benzothiazole Prepared analogously to Example le, from 2 - (4-cyanobenzene) io) - 6 - [N - (methoxycarbonylmethyl) -quinolin-8-sulfonylamino] -
n ^ .. -r • benzathiazole and ethanolic hydrochloric acid, ethanol ammonium carbonate. Yield: 28, of the theoretical, C27H23 5? 4S3 (577.41) Rf value = 0.21 (silica gel; dichloromethane / ethanol
= 4: 1) Mass spectrum (EKA): (M + H) + = 578 M + H + Na = 300.7 E j us 82 Hydrochloride of 2 - [(4-amidinophenyl) oxime ti 1] - 5 - [N- (Toxiccarbonylmethyl) -quinolin-8-sulfonylamino] -benzothiazole a. Amide of (4-cyanophenyl) oxy-H- (5-nitro-2-mercapto-phenyl-1-acetic acid) A solution based on 1.05 g (6.5 mmol) of carb on i 1 di i -mi da The reaction mixture is heated to 50 ° C. for 30 minutes at 50 ° C. for 1 minute and 1.15 g (6.5 mmol) of tetrahydrofuran (4-cyanphene-1-oxyacetic acid). 1.0 g (5.9 mmol) of 2-methyl r cap-5-ni tr or i i na and heating for another 3 hours at 50 ° C. Filter, filter the filtrate in vacuo and extract the The crude product is purified by flash chromatography (silica gel, methylene chloride 1 and no / eta not 1 = 19: 1 to 4: 1).
"* -! *** Yield: 1.05 g (54% of theory), melting point: 274-276 ° C R value: 0.54 (silica gel; / ethane 1 = 19: 1 + some drops of ammonia 5 concentrate) b. 2- [(4-Cyanophenyl) oxymethyl-5-nitro-benzothiazole A solution based on 2.1 g (6.4 mmol) of amide of acid (4-cyano-phenyl-1-ox) is heated. - nitro - 2 -me rc ap tof in i 1) - a cetico in 20 ml of acid
glacial acetic acid for 1 hour at 80 ° C, diluted with ice / water and the precipitated crude product separated by filtration. After flash chromatography (silica gel, methylene chloride 1 e no / e t a no 1 = 99: 1), an amorphous solid is obtained
beige. Yield: 0.77 g (37% of theoretical), RF value: 0.56 (silica gel, me 111 chloride e no / e t a no 1 = 50: 1) c. 2 - \ (4-cyanophenyl) oxymethyl] -5-amino-benzothiazole A solution based on 0.62 g (2.0 mmol) of
2- [(4-Cyano-phenyl) oxymethyl] -5-nitro-benzothiazole in 20 ml of pyridine is mixed successively with 1.0 g (5.7 mmol) of sodium dithionite and 4 ml of water and stirred for 2 hours at 95 ° C. Then, the
The solvent is removed by distillation under vacuum and the
The residue is diluted with ice / water. It is filtered, and the filter residue is washed several times with a little cold water. Yield: 0.44 g (79% of theory), RF value: 0.37 (silica gel, methylene chloride 1 e n o / e t a no 1 = 50: 1) d. 2- [(4-cyanophenyl) oxymethyl] -5- (quinolin-8-sulfonylamino) -benzothiazole Prepared analogously to Example 79c, starting from 0.40 g (1.42 mmol) of 2- [(4-cyanopheni 1 ) ox ime ti 1] - 5 - ami no -be nzotiazo 1 and 0.34 g
(1.5 mmol) of acid chloride qu i no 1 i n - 8 - s or 1 f ón i c o.
The further purification is carried out by flash chromatography (silica gel, methylene chloride 1 and no / e t 1 = 99: 1). Yield: 0.41 g (61% of theory), R value: 0.49 (silica gel, methylene chloride 1 e no / e t a no 1 = 50: 1) e. 2 - [(4-cyanophenyl) oxymethyl] -5- [N- (ethoxycarbonyl-methyl) -quinone in-8-sulfonylamino] -benzothiazole A suspension based on 0.39 g (0.83 mmol) of 2- [(4-cyanophenyl) oxymethyl] -5- (quinolin-8-su 1 f on i 1 ami) -ben zothiazo 1, 0.23 ml (0.35 g, 2.1 mmol) of ethyl ester of acid br brn a cé ti co, 0.14 ml (0.14 g, 0.94 mmol) of 1.8-
fc. i £? 3á £: tt fcc. - > ~ - ^ fesafe ^ »^ diaz ab icic 1 or [5, 4, 0] unde c - 7 - e no and 0.60 g (4.1 mmol) of potassium carbonate in 30 ml of acetone s heated for 3 hours hours until boiling. It is then filtered, the solvent is distilled off in vacuo and the residue is purified by flash chromatography (silica gel, methylene chloride / t a no 1 = 99: 1). Yield: 0.41 g (61% of theory), Rf value 0.54 (silica gel;
me 111 e no / e t a no 1 = 50: 1 + some drops of ammonia)
F. 2 - [(4-Amidinophenyl-toxime-tl] -5- [N- (methoxycarbonylmethyl) -quinolin-8-sulfonylamino] -benzathiazole hydrochloride Prepared analogously to Example le, starting from 2 - [(4-cyanophen-11) oxy] me 111] - 5 - [N - (ethoxycarbonylmethyl) -qu? nol? n-8-sulfon? lam? no] -benzothiazole and methanolic hydrochloric acid, methanol and ammonium carbonate 20 Yield: 67% of theory, C27H23N505S2 ( 561.64) Rf value = 0.36 (silica gel, me 111 chloride and no / ethane 1 = 4: 1) Mass spectrum (SKA): (M + H) + = 562 25 (M + H + Na) ++ = 292.7
s.-3Ü? si & S > - JákwHJS & bkA. > ** < -Ject 83 l-methyl-2- (4-amidinobenzylthio) -5-fN- (methoxycarbonylmethyl) -quin 1 in-8-sulfonylamino] -benzimidazole Prepared analogously to Example le, from 1-me 111-2 - (4 - cia nobe nc 1111 o) - 5 - [- (methoxycarbonylmethyl) -qumol? N-8-sulfon? Lammo] -benzimidazole and methanolic hydrochloric acid, methanol and ammonium carbonate. Yield: 50% of theory, C28H26 604S2 (574.69) Rf value = 0.35 (silica gel, e 111 o / eta acetate 1 / ammonia co = 50: 45: 5) Mass spectrum (EKA ): (M + H) + = 575 (M + H + Na) ++ = 299
Example 84 1-methyl -2 - [4- (N-ethoxycarbonyl-amidino) -benzylthio] -5-N- (methoxycarbonylme il) -quinolin-8-sulfonylamino] -benzimidazole Prepared analogously to Example 31, starting from 1 -me 111-2- (4-amidi nobenc 1111 o) -5- [N- (methoxycarbonylmethyl) -qumo-l-n-8-sulfonamino] -benzimidazole and ethyl ester of citric acid 1 . Performance: 62% of the theoretical,
. ~ * v JS = .. .aA »A» ?. -1 C31H3oN606S2 (646.75) Rf value = 0.55 (silica gel; ethyl acetate 1 o / et ano 1 / ammonia = 50: 45: 5) Mass spectrum (EKA): (M + H) + = 647 (M + Na) + = 669
E j emplo 85 l-methyl-2- (4-amidinobenciltio) -5- [N- (hydroxycarbonylmethyl) quinolin-8- sulf onilamino] benzothiazole Prepared analogously to Example 3 from 1 'I ti 1 - 2 - (4-ami di nobe nc i 11 io) - 5 - [N - (methoxycarbonylmethyl) -quinino-8-sulfonylamino] -benzimidazole and sodium hydroxide solution. Yield: 61.5% of theory, C27H2 604S (560, 66) Rf value = 0.20 (silica gel; ethyl 1 or eti: eta 1: amon ia co = 50: 45: 5) Mass spectrum (EKA): (M + H) + = 561 (M + Na) + = 583
E xample 86 2- [(4-amidinofenyl) -oxymethyl] -5-fN- (hydroxycarbonylmethyl) -quinolin-8-sulfonylamino] -benzothiazole Prepared analogously to Example 3, starting from 2- [(4-amidinophenyl) ) -oxymethyl] -5- [N- (methoxycarbonylmethyl) -qu? nolm-8-sulfon? lammo] -benzothiazole and soda lye. Yield: 93% of theory, C26H21 5O5S2 (547.62) value Rf = 0.13 (silica gel; dichloromethane / ethanol
= 4: 1) Mass spectrum (EKA): (M + H) + = 548 (M + 2H) ++ = 274, 6 M + H + Na = 285, 6 (M + 2Na = 296, 6
Example 87 l-methyl-2- (4 - amidinobenci 1 thio) - 5 -benzoylamino -benzimidazole Prepared analogously to Example le, from 1 'I ti 1 - 2 - (4 - c 1 Anob Jan 1111 o) - 5 -b in zo 11 ami no - be nc imi da zo 1 and ethanolic hydrochloric acid, ethanol and ammonium carbonate. Yield: 54.8% of the theoretical, C23H2? N5OS (415.52) value Rf = 0.35 (silica gel; acetate of e 111 o / et ano 1 / ammon 1 to co = 50: 45: 5) Spectrum Mass (EKA): (M + H) + = 416
88
- • * ^ aS ^ - ^ J ^ -S-¿^ & '' the £ ¿gto »2-FN (4 - enyl amidinof) aminomethyl] -5-FN (ethoxycarbonylmethyl) quinolin- 8 -sulfoni lamino] benzothiazole Prepared analogously to Example le, from 2 - [N- (4 - ci f year eni 1) -ammome 111] - 5 - [N- (ethoxycarbonylmethyl) -qu non-l n? -8-sulphonyl] -benzothiazole and ethanolic hydrochloric acid, ethanol and ammonium carbonate. Yield: 80% of theory, C28H26Nd? 4S2 (574, 69) Rf value = 0.24 (silica gel, dichloromethane / ethanol = 4: 1) Mass spectrum (EKA): (M + H) + = 575 ( M + H + Na) ++ = 299
EXAMPLE 89 2- [N- (4-amidinophenyl) -aminomethyl] -5-fN- (hydroxy-carbonylmethyl) -quinolin-8-sulfonylamino] -benzothiazole Prepared analogously to Example 3, starting from 2 - [- ( 4 - ami di no f in 11) - ami nome 111] - 5 - [- (ethoxycarbonylmethyl) -qu? -nolm-8-sulfonamino] -benzothiazole and soda lye. Yield: 94% of theory, C26H = N6? 4S2 (546, 63) value Rf = 0.15 (silica gel; dichloromethane / ethanol
1) Mass spectrum EKA M + H) = 547 M + Na) + = 569 M + 2H) t = 274 M + H + Na = 285 M + 2Na) = 296 2M + 3Na 3 + = 387
Example 90 l-methyl-2- (4-amidinobenciltio) - 5 - [N- (ethoxycarbonyl-10-methyl) -benzoylamino] benzimidazole Prepared analogously to Example le, from 1 'I 111-2 - (4 - ci anobencyl 111 o) - 5 - [N- (ethoxycarbonylmethyl) -benzoylamino] -benzimidazole and ethanolic hydrochloric acid, ethanol and carbonate of
ammonium. Yield: 68.8% of theory, C3 H27N5? S (538.08) value Rf = 0.27 (silica gel, e-acetate 111 o / et an o 1 / amoni a co = 50: 45: 5) 20 Mass spectrum (EKA): (M + H ) + = 502 (M + H + Na) ++ = 262.8
Ie 91 l-methyl-2- (4-amidinobenzylthio) - 5 - [N- (hydroxycarbonylmethyl) -benzaylamino] -benzimidazole
Prepared analogously to Example 3, starting from 1 -me 111-2 - (4 -amy di nobenc 1111 o) - 5 - [N - (ethoxycarbonylmethyl) -benzoyl-ammo] -benzimidazole and sodium hydroxide solution. Yield: 79% of theory, C25H23N503S (473.53) Rf value = 0.21 (silica gel; ethyl acetate / ethanol / ammonia = 50: 45: 5) Mass spectrum (EKA): (M + H) + = 474 (M + Na) + = 496
EXAMPLE 92 2- [2- (4-Amidinophenyl) -ethyl] -3-methyl-6- [N- (ethoxycarbonylmethyl) -quinol in-8-sulfonylamino] -imidazole [4,5-b] pyridine a. 3, 5-di- [3- (4-cyanophenyl) propionylamido] -2 • -methyl-pyridine A solution of 3.8 g (19 mmol) of 3,5-din 11 ro - 2 -me 111 - ammo-p iri di na is hydrogenated in e-space of 2 hours in 90 ml of ethanol / methylene chloride (2: 1) at a hydrogen pressure of 5 bar with 1, 0 g of 10% palladium on carbon. The catalyst is separated by filtration and the solvent is distilled off in vacuo. The black oily crude product is dissolved in 50 ml of pyridine and mixed at 0 ° C with 7.0 g (36 mmol) of 3- (4-cyanophenyl) propionic acid chloride. After 2 hours, the solvent is distilled off in vacuo, the residue is taken up in 100 ml of ethyl acetate and washed with water and saturated sodium chloride solution. It is dried with sodium sulfate, the solvent is distilled off and the residue obtained is purified by flash chromatography (silica gel, methylene chloride / ethanol = 49: 1 to 19: 1). Yield: 4.8 g (59% of theoretical), R value f: 0.40 (silica gel; acetate of t i 1 o / e t a no 1 / amon a co = 90: 10: 1) b_. 3-Methyl-2- [2- (4-cyano-phenyl) -ethyl] -6- [3- (4-cyano-phenyl) -propioni-lamido] -imidazo [4, 5-b] -pyridine A solution of 1 is heated 6 g (3.5 mmol) of 3,5-di- [3- (4-cyanophenyl) propionylamido] -2-methylamino-pyridine in 30 ml of glacial acetic acid for 1 hour up to 100 ° C. The solvent is distilled off in vacuo, the residue is taken up in 80 ml of methylene chloride and neutralized with sodium bicarbonate solution. The organic phase is dried with sodium sulphate, the solvent is distilled off in vacuo and the crude product is evaporated. it is purified by chromatography
«1 rapid resolution (silica gel, methylene chloride / -ethanol = 49: 1 to 19: 1). Yield: 0.90 g (60% of theory), Rf value: 0.46 (silica gel; acetate ds eti 1 o / et ano 1 / ammonia co = 90: 10: 1) c.6-amino- 3-Methyl-2- [2- (4-cyanophenyl) -ethyl] -imidazo [4, 5-b] -pyridine 0.80 g (1.8 mmol) of 3-methyl-1 - 2 - [2 -] (4-cyano-phenyl) -ethyl] -6- [3- (4-cyanofenyl) propionyl-amido] -imidazo [4,5-b] -pyridine are heated for 2 hours to 100 ° C in 20 ml of hydrochloric acid 0.5 N. After cooling, it is made alkaline with ammonia and extracted with ethyl acetate. The organic phase is washed with saturated sodium chloride solution and the solvent is distilled off. Yield: 0.42 g (84% of theoretical), Rf value: 0.30 (silica gel, acetate of 111 o / e t ano 1 / amoni acó = 90: 10: 1) d. 2- [2- (4-cyanophenyl) -ethyl] -3-methyl-6- (quinolin-8-sulfonylamino) -imidazo [4, 5-b] pyridine Prepared analogously to Example 79c, from 0.40 g (1.4 mmol) of 6-ami no-3-methyl-1-2 - [2 - (4-cyanophen-1) -ethyl] -imidazo [4,5-b] pyridine with 0.39 g (1 , 6 mmol) of quinoline-8-sulfonic acid chloride.
- a ^^ b- AA ^ Silá & t2 »^. r¿ -».? l ^ Í. «. ^ Yield: 0.60 g (90% theoretical), R value: 0.74 (gel silica; ethyl acetate 1 o / et ano 1 / ammonia co = 90: 10: 1) e. 2- [2- (4-cyanophenyl) -ethyl] -3-methyl-6- [N- (ethoxycarbonylmethyl) -quinolin-8-sulfonylamino) -imidazo [4,5- b] pyridine Prepared analogously to Example 82e, a from 0.60 g (1.3 mmol) of 2- [2- (4-cyanophenyl) -ethyl] -3-methyl-6- (quinolin-8-sulfonylamino) -imi da zo [4, 5-b] ] pyridine with 0.33 g (1.5 mmol) of ethylester of ethylene broth. Yield: 0.70 g (98% of theory), R f value: 0.80 (silica gel; acetate of e t i 1 o / e t a o 1 / ammon i a c o = 90: 10: 1) f_. 2- [2- (4-amidinophenyl) -ethyl] -3-methyl-6- [N- (ethoxycarbonylmethyl) -quinolin-8-sullynylamino] -imldazo [4,5-b] pyridine Prepared analogously to the Example , from 2 - [2 - (4-cyano-en-1) -eti-1] -3-methyl-1-6 - [N- (ethoxycarbonylmethyl) -quinolin-8-sulfonylamino) -imi da zo [4, 5 -b] pir idina and ethanolic hydrochloric acid, ethanol and ammonium carbonate. Yield: 91% of the theoretical, C29, H29N7O4S (571, 66) value Rf = 0.22 (silica gel; acetate e 111 o / eta no 1 / ammonium co = 50: 45: 5) Mass spectrum (SKA): (M + H) + = 572 (M + H + Na) ++ = 297,
E n gn 93 93 2- [2- (4-amidinophenyl) -ethyl] -3-methyl-6- [N- (hydroxycarbonylmethyl) -quinolin-8-sulfonilamino] -imidazo [4,5-b] pyridine Prepared analogously to Example 3, starting from 2 - [2 - (4-ami di no phen 11) -e 111] - 3 -me 111-6 - [N - (ethoxycarbonylmethyl) -qu? nol? n-8-sulfon ? lam? no) -ími da zo [4, 5 - b] piri di na and lye of soda. Yield: 77% of theory, C27H25N7O4S (5 3.59) Rf value = 0.16 (silica gel; ethanol acetate / ammonia = 50: 45: 5) Mass spectrum (EKA): (M + H) + = 544 (M + H + Na) + + = 283.8
Use 94 l-methyl-2- [N- (4-amidinophenyl) -am nomethyl] -5- [N- (etoxycarbonylmethyl) -quinolin-8-sulfonylamino] -indole Prepared analogously to Example le, e from 1 -me 111-2 - [N - (4 - c 1 anophen 11) - am n ome 111] - 5 - [N- (ethoxycarbonylmethyl) -qu? nol? n-8-sulfon? lam? no ] - indole and ethanolic hydrochloric acid, ethanol and ammonium carbonate. Yield: 55% of theory, C30H30N6? 4S (570.68) R value: = 0.22 (silica gel, dic 1 or ometa no / eta no 1 = 4: 1) Mass spectrum (EKA): (M + H) + = 571 (M + 2H) ++ = 286 (M + H + Na) ++ = 297
Use 95 l-methyl-2- [N- (4-amidinophenyl) -aminomethyl] -5- [N- (hydroxycarbonylmethyl) -quinolin-8-sulfonylamino] -indole Prepared analogously to Example 3, from 1 -me 111 - 2 - [N- (4 -amidi no f eni 1) - ami nome 111] - 5- [N- (ethoxycarbonylmethyl) -qu? nolm-8-sulphon? lane] - indole and bleach soda. Yield: 97% of theory, C28H26N604S (542.62) mass spectrum (EKA): (M + H) + = 543 (M + Na) + = 565 (M + 2H) ++ = 272 (M + H + Na ) ++ = 283
(M + 2Na) ++ = 294 XH-NMR (d6-DMSO): d = 3.61 (s, 3 H); 4.50 (d, 2 H); 4.67 (s, 2 H); 6.20 (s, 1 H); 6.30 (d, 1 H); 6.70 (d, 2 H); 7.01 (d, 1 H); 7.29 (t, 1H); 7.38 (s, 1 H); 7.40-7.65 (m, 3 H); 7.77 (dd, 1 H); 8.03 (d, 1 H); 8.20 (d, 1 H); 8.42 (broad s, 2H); 8.55 (dd, 1H); 9.20 (dd, 1H) ppm
Use 96 l-methyl-2- [(4-amidinophenyl) -thiomethyl] -5- [N- (ethoxycarbonylmethyl) -quinolin-8-sulfonylamino] -benzimidazole Prepared analogously to Example le, starting from l-methyl- 2- [(4-cyanophenyl) -thiomethyl] -5- [N- (ethoxycarbonylmethyl) -quinolin-8-sulfonylamino] -benzimidazole and ethanolic hydrochloric acid, ethanol and ammonium carbonate. Yield: 84% of the theoretical, C29H28N6? 4S2 (588.71) R value: = 0.35 (silica gel; ethyl acetate 1 o / et ano 1 / amoni a co = 50: 45: 5) Spectrum of masses (EKA): (M + H) + = 589 (M + H + Na) ++ = 306
Example 97
»JS- & -. ".Ai.i?: - l-Methyl-2- [(4-amidinophenyl) -thiomethyl] -5- [N- (hydroxycarbonylmethyl) -quinolin-8-sulfonylamino] -benzimidazole Prepared analogously to Example 3, a from l-methyl-2- [(4-amidinofenyl) -thiomethyl] -5 - [N- (ethoxycarbonylmethyl) -quinolin-8-sulfonylamino] -benzimidazole and sodium hydroxide solution. Yield: 76% of theory, C27H2 604S (560, 66) R value: = 0.21 (silica gel, ethyl acetate / ethanol / ammonia = 50: 45: 5) spectrum. tables (EKA): (M + H) + = 56? (M + Na) + = 583
EXAMPLE 98 l-Methyl-2- [(4-amidinophenyl) -thiomethyl] -5- (quinolin-8-sulfonylamino) -benzimidazole Prepared analogously to Example LE, from 1-methyl-2 - [(4 - ci year f in 11) - 11 ome 111] - 5 - (qu i no 1 in - 8 - su 1 f on i 1 ami no) -be nc ia 1 z and ethanolic hydrochloric acid, ethanol and ammonium carbonate. Yield: 70% of theory, C25H22N602S2 (502, 62) R value: = 0.29 (silica gel, e 111 o / et ano 1 / amoni a co = 50: 45: 5) Mass spectrum ( EKA): (M + H) + = 503
Example 99 2- [(4-Amidinophenyl) -acetyl] -7- (quinoline-8-sulfonylamino) -1,2,4,4-tetrahydro-isoquinoline a.2- [(4-cyanophenyl) -acetyl] hydrochloride -7-nitro-l, 2, 3, 4- 10 tetrahydro-isoquinoline 4.0 g (22.5 mmol) of 7-n? Tro-l, 2, 3, 4- tetrahi dr o - iso - qu i Do not dissolve in 100 ml of chlorobenzene or mix with 4.24 g (25 mmol) of 4-cyanoalkyl chloride and dilute to heat.
Reflux for 2 hours. After cooling to room temperature, it is diluted with 1 liter of petroleum ether and filtered. The residue is dissolved in ethyl acetate and chromatographed on silica gel, eluting at the beginning with
Methylene and then with methylene chloride 1 e no / e t a no 1 (50: 1 and 25: 1). The desired fractions are combined and concentrated by evaporation. Yield: 3.80 g (53% of theory), R value f: = 0.50 (silica gel;
me 111 e no / e t a no 1 = 19: 1)
b.2- [(4-cyanophenyl) -acetyl] -7-amino-1,2,3-tetrahydro-isoquinoline Prepared analogously to Example Ib, starting from 2- [(4-cyanophenyl) -acetyl-7- nitro-l, 2,3,4-tetrahi dr o -iso qui no 1 i na ehi dr ge no no pa 1 a di o. Yield: 27% of theory, melting point: 186-188 ° C c. 2- [(4-cyanophenyl) -acetyl] -7- (quinolin-8-sulfonylamino) -1,2,4,4-tetrahydro-isoquinoline Prepared analogously to Example 1, from 2 - [(4-cyano) feni 1) - a ce ti 1] - 7 - ami not -1, 2, 3, 4 - tetr ah i dr o - is oqu i no 1 i na and quinolin-8-sulfonyl chloride. Yield: 80% of the theoretical, Rf value: = 0.55 (silica gel, chloride, methylene, ene / e, 1 = 19: 1) d. 2 - [(4-Amidinophenyl) -acetyl] -7- (quinoline-8-sulfonylamino) -1,2,4,4-tetrahydro-isoquinoline hydrochloride Prepared analogously to Example le, starting from 2 - [(4 - ci ano f in i 1) - aceti 1] - 7 - (qu i no 1 in - 8 - sulphonylamino) -1,2,3,4 - tetrahydro - isoquinoline and acid c 1 orh i dri co / ca r bona of ammonium in ethanol. Yield: 35% of theoretical, melting point: sintered from 173 ° C C27H25 503S (499.50) Mass spectrum: (M + H 500
EXAMPLE 100 2 - [(4-Amidinophenyl) -acetyl] -7-fN- (ethoxycarbonylmethyl) -quinolin-8-sulfonylamino] -1,2,3,4-e-trahydro-isoquinoline Prepared analogously to Example LE, starting from 2 - [(4 - cyan f eni 1) - a ce 111] - 7 - [N- (ethoxycarbonylmethyl) -quinolin-8-sulfonylamino] -1, 2, 3, 4 - tetrahi dr o - is oq i no 1 i na and ethanolic hydrochloric acid, ethanol and ammonium carbonate. Yield: 35% of the theoretical, C31H31N505S (585.68) Rf value: = 0.20 (silica gel, dic 1 or ome t an / et ano 1 = 4: 1) Mass spectrum (EKA): (M + H) + = 586 (M + 2H) ++ = 293.6 (M + H + Na) ++ = 304.6
Example 101 2- [(4-amidinophenyl) -acetyl] -7- [N- (hydroxycarbonyl-yl) -quinolin-8-sulfonylamino] -1,2,3,4-tetrahydro-o-isoquinoline Prepared analogously to Example 3 , from 2 - [(4-ami di no phen 11) -ace 111] -7 - [N - (ethoxycarbonylmethyl) -qu? nolm-8-sulfon? lam? no] -1, 2, 3, 4 - tetrahi dr o - is oqu i nol i na and soda lye. Yield: 49% of theory, C29H27N5O5S (557, 6) R value: = 0.17 (silica gel, dichloromethane / ethanol = 3: 2) Mass spectrum (EKA): (M + H) + = 558 ( M + Na) + = 580 (M + 2 H) ++ = 279.7 (M + H + Na) ++ = 290.7 (2M + H + Na) + + = 569
Example 102 2 - [(4-Amidinophenyl) -oxymethyl] -4-methyl-7- [N- (ethoxycarbonylmethyl) -quinolin-8-sulfonylamino] -quinoline hydrochloride a. 7-amino-2,4-dimethyl ti 1 -quinol ina 54.8 g (0.36 mol) of 3-a-111 amino-n-111 n, 38.0 g (0.38 mol) of a 111 to acetone and 32.5 ml of glacial acetic acid are stirred for 2 hours at 80 ° C. After cooling, the reaction mixture is poured onto ice / water and neutralized with sodium hydrogen carbonate solution.
After extraction for three times with ethyl acetate, the combined organic phases are washed with sodium chloride solution, dried over sodium sulfate and concentrated by evaporation. The crude product, thus obtained, is heated for 1 hour to 105 ° C with 200 ml of concentrated sulfuric acid. After cooling, the reaction mixture is poured onto ice / water and neutralized with ammonia solution.
After extraction with ethyl acetate three times, the combined organic phases are washed with sodium chloride solution, dried over sodium sulfate and concentrated by evaporation. The crude product is chromatographed on
silica gel, eluting at the beginning with methylene chloride and then with methylene chloride 1 e no / e t a n o 1
(50: 1, 25: 1, 19: 3 and 9: 1). The desired fractions are combined, concentrated by evaporation and mixed by triturating with petroleum ether. 20 Yield: 24.15 g (39% of theory), CnH12N2 (172.20) Mass spectrum: M + = 172 b. 7-f talimido-2,4-dimethyl-quinol ina 6.90 g (40 mmol) of 7-ami no-2,4-di me t 11-25 quinoline, 5.95 g (42 mmol) of anhydride of acid
Phthalic acid and 100 ml of glacial acetic acid are heated for 2 hours under reflux. After cooling, the reaction mixture is poured onto ice / water, the precipitated product is filtered with; 5 suction, wash with water and dry. Yield: 8.85 g (73% of theory), melting point: 203-205 ° C c .7-phthalimido-2,4-dimethyl-quinolin-1-oxide 4.25 g (14 mmol) of 7 - phta 1 imi do - 2, 4 - 10 d ime ti 1 - qu i no 1 i na dissolve in 500 ml of boiling methylene chloride After cooling to room temperature, 4.80 g of 3 - aq. c 1 or opbenbenic (approximately 50%). After 3 hours at room temperature, the
The reaction solution is washed in each case 1 × with sodium hydrogen chloride solution and sodium chloride solution, dried over sodium sulfate and concentrated by evaporation and recrystallized from ethanol. 20 Yield: 2.45 g (55% of theory), melting point: > 250 ° C d. 2-chloromethyl-4-methyl-phthalimido-quinoline 4.30 g (13.5 mmol) of 7-phtha 1 i mi-2, 4-d ime ti 1-qu i no 1 i-1-ox i do and 4.20 g (22 mmol) of
p-toluene sulfochloride are heated during
refluxing in 300 ml of methylene chloride. After cooling to room temperature, the reaction solution is washed once with sodium hydrogencarbonate solution and sodium chloride solution, dried over sodium sulfate and concentrated by evaporation. The residue is chromatographed on silica gel, eluting initially with methylene chloride and then with methylene chloride / ethanol (50: 1). The fractions
The desired compounds are combined, concentrated by evaporation and mixed by triturating with ether. Yield: 3.15 g (70, theoretical), melting point: 212-215 ° C e.2- [(4-cyanophenyl) -oxymethyl] -4-methyl-f-talimido-15-quinoline 895 mg (6, 2 mmol) of potassium tert-butethiol are dissolved in 50 ml of dimethyl ether 1 ml, mixed with 740 mg (6.2 mmol) of 4-hydroxybenzonitrile and stirred for 30 minutes. minutes to the
room temperature. After the addition of 2.0 g of 2-c 1 or ome thi 1 -4-methyl thi-7-phtha-1-imi do not, the reaction mixture is stirred for a further 12 hours at the room temperature. After the addition of ice / water, it is filtered with suction of the precipitate
formed, washed with water and dried.
? ~ j¡?) »> M8Sf? A & - t * .itá £ - »« • «. < H.H? l8§i .. ig & ¡ñÁá¡í? .f. d Yield: 2.20 g (89% of theory); melting point: 231-233 ° C f. 2- [(4-Cyanophenyl) -oxymethyl] -4-methyl-7-amino-quinoline 21.5 g (5.1 mmol) of 2- [(4-c? Anophen? L) -oxyethyl] -4 -met? l-7-phtal? could-qu? nol? na dissolve in 75 ml of 1 to no 1 (2: 1), mix with 7.5 ml of methylamine aqueous solution 40% and stir for 2 hours at room temperature. Then, the solution is concentrated by evaporation in a vacuum, the residue is stirred with 2N acetic acid, filtered with suction and dried. The crude product is chromatographed on silica gel, eluting initially with methylene chloride and then with methylene chloride and no / e t a n 1 (50: 1). The desired fractions are combined, concentrated by evaporation and mixed by triturating with ether. Yield: 1.05 g (71 'of theory), melting point: 192-194 ° C g. 2- [(4-cyanophenyl) -oxymethyl] -4-methyl-7- (quinino-8-sulfonylamino) -quinoline Prepared analogously to Example le, starting from 2 - [(4-cyano f-eni 1) - oxime 111] - 4 -me 111 - 7 -nanequino 1 inay and chloride of qu io 1 in - 8 - su 1 fon 11 o.
Yield: 67% of theory, melting point: 240-242 ° C h.2- [(4-cyanophenyl) -oxymethyl] -4-methyl-7- [N- (ethoxycarbonylmethyl) -quinolin-8-sulfonylamino] - quinoline Prepared analogously to Example Id, starting from 2 - [(4-cyano-en-1) -oxymethyl] -4-methyl-1 -7- (qu i no 1 in-8-su 1 f on i 1 ami no) - qu i no 11 na and ethyl ester of br omoa cé ti co acid. Yield: 92% of theoretical, melting point: sintered from 85 ° C i. 2 - [(4-Amidinophenyl) -oxime-tyl] -4-methyl-7- [N- (ethoxycarbonylmethyl) -quinolin-8-sulfonylamino] -quinoline hydrochloride Prepared analogously to Example le, starting from 2- [(4 -cyanophenyl) -ox? methyl] -4-methyl-7- [N- (ethoxycarbonylmethyl) -quinolin-8-sulfonylamino] -quinoline and hydrochloric acid / ammonium carbonate in ethanol. Yield: 49% of theoretical, melting point: sintered from 78 ° C C3? H29N505S (583.62) Mass spectrum: (M + H) + = 584 (M + H + Na) + = 303.7 (2M + H) + = 1167
3t? -Example 103 2 - [(4-amidi ofenyl) -oxymethyl] -4-methyl-7- [N- (hydroxycarbonylmethyl) -quinolin-8-sulfonylamino] -quinoline Prepared analogously to Example 3, from 2- [ (4-amidinophen? L) -oxymethyl] -4-methyl-7- [N- (ethoxycarbonylmethyl) -quinolin-8-sulfonylamino] -quinoline and soda lye. Yield: 19% of theory, C29H25 5OSS (555, 6) Mass spectrum (EKA): (M + H) + = 556 (M + Na) + = 578 (M + 2Na) ++ = 300 (M-H + 2Na) + = 600
EXAMPLE 104 2- [(4-amidinophenyl) -oxymethyl] -4-methyl-7- (quinolin-8-sulfonyl-amino) -quinoline Prepared analogously to Example le, starting from 2 - [(4-cyano-phenol 1 ) - oxime 111] - 4 -me ti 1 - 7 - (qu ino 1 in - 8 - su 1 f on i 1 ami no) - qu i no 11 na and ethanolic hydrochloric acid, ethanol and ammonium carbonate. Yield: 22% of the theoretical, C27H23N503S (97, 55) R value: 0.23 (silica gel, dichloromethane / ethanol = 4: 1) melting point: smtepza from 195 ° C Mass spectrum (EKA) : (M + H) + = 498
Example 105 2 - [N- (4-Aminophenyl) -aminomethyl] -6- (quinolin-8-sulfonylamino) -imidazo [1,2-a] pyridine hydrochloride a. 2-chloromethyl-5-nitro-imidazo [1,2-a] pyridine 12.6 g (0.1 mol) of 1,3-di c 1 or to ketone are heated to 105 ° C and mixed in portions with 8.25 g (60 mmol) of 2-ami no-5-n 11 ro -piri di na. After 10 minutes at 105 ° C, the reaction mixture is cooled, combined with 11 ene / eta no 1 (8: 2) chloride and chromatographed on silica gel, eluting at the beginning with methylene chloride and then with me 111 chloride and no / eta no 1
(25: 1, 19: 1 and 9: 1). The desired fractions are combined, concentrated by evaporation and mixed by triturating with ether. Yield: 4.35 g (34% of theory), melting point: 124-127 ° C b .2- [N- (4-cyanophenyl) -aminomethyl] -6-nitro-im dazo [1, 2-a] ] pyridine
3.0 g (25.4 mmol) of 4-ami nobe nz on itri 1 o melt at 120 ° C and mix in portions with 1.30 g (6.3 mmol) of 2-c 1 or ome ti 1 - 5 - nitro-imi da zo [1,2-a] pipdin. After 30 minutes at 120 ° C, the reaction mixture is cooled, combined with methylene chloride 1 ene / eta no 1 (8: 2) and chromatographed on silica gel, eluting at the beginning with methylene chloride. and then with methylene chloride 1 and no / eta no 1 (50: 1, 25: 1 and 15: 1). 10 The desired fractions are combined and concentrated by evaporation. Yield: 0.71 g (39% of theory), R value: 0.50 (silica gel, methylene chloride 1 and no / ethane 1 = 19: 1) 15 c .2- [N- (4 -cyanomethyl) -aminomatill-6-amino-imidazo [1, 2-a] -pyridine Prepared analogously to Example Ib, starting from 2 - [N - (4-cyanophen-1) -ami nome ti 1] - 6 - nitro-imidazo [1,2-a] pyridine and hydrogen or palladium. 20 Yield: 75% of the theoretical, R f value: 0.20 (silica gel, methylene chloride 1 e n o / e t a n o 1 = 9: 1) d. 2- [N- (4-cyanophenyl) -aminomethyl] -6- (quinolin-8-sulfonylamino- = imidazo [1,2-a] pyridine
Prepared analogously to Example 1, from 2 - [N - (4-cyano-phenyl-1) - ami-nome-thi] - 6 -amino-noniimido [1,2-a] pyridione and chloride quinolin-8-sulfonyl. Yield: 35% of theory, value R f: 0.78 (silica gel, chloride of me t i 1 e no / e t a n o 1 = 4: 1 + glacial acetic acid) e. 2- [N- (4-amidinophenyl) -aminomethyl] -6- (quinoline-8-sulfonylamino) -imidazole [1,2-a] pythine hydrochloride Prepared analogously to Example le, starting from 2 - [N- ( 4-cyclohexphi 1) - ami nome ti 1] - 6 - (quinolin-8-sulfonylamino) -imidazo [1,2-a] pyridine and c 1 -hydrochloride / ammonium cation. Yield: 51% of theory, Rf value: 0.15 (silica gel, methylene chloride 1 and no / eta no 1 = 4: 1 + glacial acetic acid) C24H27N7O2S (471.48) Mass spectrum: (M + H) = 472
Example 106 2- [N- (4-amidinophenyl) -aminomethyl] -6- [N- (ethoxycarbonylmethyl] -quinolin-8-sulfonylamino] -imidazo 1,2-] pyridine Prepared analogously to Example LE, starting from 2 - [N - (4-cyano-phenyl-1) -amino-111] -6- [N - (ethoxycarbonylmethyl] -qumol? N-8-sulphon? Lane] -imino-zo [1, 2-a 1 pyridine and ethanolic hydrochloric acid, ethanol and ammonium carbonate Yield: 11% of theory, C28H2 N7O4S (557, 65) Mass spectrum: (M + H) + = 558 (M + Na) + = 580
EXAMPLE 107 2 - [N- (4-Amidinophenyl) -aminomethyl] -3-methyl-6- [N- (ethoxycarbonylmethyl) -quinolin-8-sulfonylamino] -benzofuran hydrochloride a. 4-Acetylamino-2-hydroxy-acetophenone 16.5 g (0.10 mol) of 3-methyl-1-acetyl anhydride are dissolved in 40 ml of dichloroethane and, after the addition of 19.6 g. (0.25 mol) of acetyl chloride are mixed in portions at 5 ° C with 42.0 g (0.32 mol) of aluminum chloride. After 2 hours at room temperature, the reaction mixture is heated at reflux for a further 2 hours. After cooling to room temperature, ice is added,
A ^ MS ^ f ^^^ fl ^ ^ itetaaaaa - ^. A ^. ^ BK ^ > .
The formed precipitate is filtered off with suction, washed with water and dried. Yield: 14.8 g (77% of theory), R value: 0.40 (silica gel, ether of 5 p e t r o 1 e o / a c e t t o of ethyl = 1: 1) b. 4-amino-2-hydroxy-acetic acid 10.0 g (52 mmol) of 4-acetyl-1-ami-2-hydroxy-1-hydroxypropyl ester and 100 ml of 18% hydrochloric acid are heated for 15 minutes. reflux minutes.
After cooling to room temperature, the formed precipitate is filtered off with suction, washed with ice / water and dried. The filtrate is concentrated by evaporation, taken up in water and mixed with concentrated ammonia. He
The precipitate formed is filtered off with suction, washed with ice / water, dried and combined with the first precipitate. Yield: 7.6 g (97% of theory), R value: 0.65 (silica gel;
pe t r o 1 eo / a ce t a t o de etil = 1: 1) c. 4-phthalimido-2-hydroxy-acetophenone Prepared analogously to Example 102b, starting from 4-ami no-2-h i dr ox i-a c e t or fona none and phthalic acid anhydride. 25 Performance: 75% of the theoretical,
R f value: 0.55 (silica gel; ethyl ether / ethyl acetate = 1: 1) d. 4- [(2-carboxy) -benzoylamino] -2-carboxymethyloxy-acetophenone 18.9 g (67 mmol) of 4-phtha1-im-2-hydroxy-1-acetophenone, 16.5 g (99 mmol) of ethyl bromoacetic acid ester and 40.0 g (0.3 mol) of potassium carbonate are taken up in 100 ml of acetone and refluxed for 6 hours. After cooling to room temperature, the formed precipitate is filtered off with suction and dried. The filtrate is concentrated by evaporation, taken up in water and extracted 3 times with ethyl acetate. The combined organic extracts are washed with water and dried. The combined crude products are dissolved in 50 ml of ethanol, mixed with 50 ml of 3N sodium hydroxide solution and stirred for 30 minutes at room temperature. After addition of 100 ml of water and acidification with 6N hydrochloric acid, the precipitate formed is filtered off with suction, washed with cold water and dried. Yield: 19.4g (81% of theory), Rf value: 0.30 (silica gel, methylene chloride / ethanol = 7: 3)
e. 3-methyl-6-phthalimido-benzofuran A mixture of 36.0 g (0.1 mol) of 4- [(2-carboxy) -benzoylamino] -2-carboxymethyloxy-acetophenone, 30 g (0.37 mol) of acetate of sodium, 5 770 ml of acetic acid and 153 ml of glacial acetic acid are heated at reflux for 2.5 hours. The reaction mixture is concentrated by evaporation, the residue is triturated with water, filtered with suction, washed with water and dried.
Yield: 21.6 g (77% of theory), Rf value: 0.85 (silica gel, methylene chloride + 2.5% ethanol) f .2- [N- (4-cyanophenyl) -aminomethyl) 1] -3-methyl-6- f such imido-benzofuran 15 5.68 g (20 mmol) of 3-methyl-1-6-phtha-1-imidobenzofuran are dissolved in 150 ml of methylene chloride, mixed with 5.0 g of hydrofluoride 1 and 20 g of thionyl chloride and stir for 60 hours at room temperature. The mixture of
The reaction is concentrated by evaporation, dissolved twice in methylene chloride and concentrated again by evaporation to dryness. The crude product is dissolved in 150 ml of toluene, mixed with 5.1 g (43 mmol) of 4-ami nobe n z on i t r i 1 and 20 g
of aluminum oxide and heated to reflux
SHkA «= iáíÉiafe I for 6 hours. The reaction mixture is concentrated by evaporation, the residue is taken up in methylene chloride and chromatographed on silica gel.
(methylene chloride). The desired fractions are combined, concentrated by evaporation and mixed by triturating with ether of oil or 1 ml of methanol. Yield: 6.0 g (68% of theory), R value: 0.30 (silica gel, methylene chloride) 10 g. 2- [N- (4-cyanophenyl) -aminomethyl] -3-methyl-6-aminobenzofuran. Prepared analogously to Example 102f, starting from 2 - [N - (4 - cyano f in i 1) - ami nome 111] - 3 -me 111 - 6 - phta 1 imi do -be nzof ur ano and methylamine. 15 Yield: 65% of theory, value R f: 0.25 (silica gel; methylene chloride) h. 2- [N- (4-cyano-phenyl) -aminomethyl] -3-methyl-6- (quinolin-8-sulphonylamino) -benzofuran Prepared analogously to Example le, starting from 2 - [N - (4-cia) eni 1) - ami nome ti 1] - 3 -me ti 1 - 6 - ami no -be nzofur anus and quinolin-8-sulfonyl chloride. Yield: 97% of the theoretical, Rf value: 0.65 (silica gel, 25 me t i 1 chloride and no / e 1 = 95: 5)
i. 2- [N- (4-cyanophenyl) -aminomethyl] -3-methyl-6- [N- (ethoxycarbonylmethyl) -quinolin-8-sulfonylamino] -benzofuran. Prepared analogously to Example Id, from 2 - [N - ( 4 - ci ano f eni 1) - ami nome 111] - 3 -me 111 -6 - (qu i no 11 n - 8 - su 1 f on 11 ami no) - benzofur anus and ethyl ester of bronze a cé you co Yield: 99, of the theoretical, Rf value: 0.70 (silica gel; chloride of me 111 e no / e t a no 1 = 95: 5) j. 2- [N- (4-amidinophenyl) -aminomethyl] -3-methyl-6- [N- (ethoxycarbonylmethyl) -q-inol-8-sulfonylamino] -benzofuran hydrochloride Prepared analogously to Example 1, from 2 - [N - (4 - ci ano f eni 1) - ami nome 111] - 3 -me 111 -6- [N- (ethoxycarbonylmethyl) -qu? Nol? N-8-su 1 f on i 1 ami no ] -be nzofur ano and acid c 1 orhi dr ico / car bona to ammonium. Yield: 32% of the theoretical, R f value: 0.21 (silica gel, methylene chloride 1 ene / et ano 1 = 4: 1 + glacial acetic acid) C30H29N5? 5S (571.67) Mass spectrum: (M + H) + = 572 (M + 2H) ++ = 286.7-
z & ^ &r? &% (M + fi + N a) + + = 2 9 7, 7
E n g lish 1 0 8 2- [N- (4-amidinophenyl) -aminojttte tl] -3-methyl-6- [N- (hydroxycarbonylmethyl) -quinolin-8-sulfonylamino] -benzofuran Prepared analogously to Example 3, from 2 - [N - (4-ami di no phen 11) - ami nome 111] - 3 -met? l-6- [N- (ethoxycarbonylmethyl) -qumol? n-8-su 1 f on i 1 ami no] - b in zof ur ano and soda lye. Yield: 94% of theory, C28H25N5O5S (543.61) Rf value: 0.12 (silica gel; d chloromethane / ethanol = 4: 1 + glacial acetic acid) Mass spectrum: (M + H) + = 544 ( M + 2H) ++ = 272.7 (M + H + Na) ++ = 283.6 (M + 2Na) ++ = 294.7
Example 109 2- [N- (4-amidinofenyl) -am nomethyl] -3-methyl-6- (quinolin-8-sulfonium lamino-benzofuran) Prepared analogously to Example le, starting from 2 - [N - (4 - c 1 year f in 11) - ami nome 111] - 3 -me 111 -6 - (qu 1 not 11 n - 8 - su 1 f on 11 - ami no) - be nzofuranoy acid
jf JSLjh reo
ethanolic hydrochloride, ethanol and ammonium carbonate. Yield: 17% of theory, C26H2 N503S (485.58) • "* Rf value: 0.17 (silica gel, me 111 eno / et 1 = 4: 1 + glacial acetic acid) Mass spectrum ( EKA): (M + H) + = 486
Example 110 2 - [(4-amidinophenyl) -oxymethyl] -4-methyl-7- [N- (ethoxycarboni 1-methyl] -ben zoi lamino] -quinoline Prepared analogously to Example le, starting from 2- [(4 -cyanophenyl) -ox? met? l] -4-met? l-7- [N- (ethoxycar bon i lme ti 1] -ben zo 11 ami no] - qui no nay ethanolic hydrochloric acid, ethanol and carbonate of ammonium Yield: 64% of theory, C29H28N O4S (496, 6) Mass spectrum: (M + H) + = 497 (M + H + Na) ++ = 260
S J & amp; amp; amp; amp; Use 111 2 - [N- (4-amidinophenyl) -amomethyl] -4-methyl-7- [N- (ethoxycarbonylmethyl) -quinolin-8-sulfonylamino] -quinoline Prepared analogously to Example 1, from 2 - [N - (4 - ci ano f in 11) - ami nome 111] - 4 -me 111 -7- [N- (ethoxycarbonylmethyl) -qumolm-8-su 1 f on 11 ami no] - qu i no 1 i na and ethanolic hydrochloric acid, ethanol and ammonium carbonate. Yield: 63% of the theoretical, C31H3oN604S (582.69) Rf value: 0.15 (silica gel, dichloromethane / ethanol = 4: 1 + glacial acetic acid) Mass spectrum (EKA): (M + H) + = 583 (M + H + Na) ++ = 303
Example 112 2- [N- (4-amidinophenyl) -aminomethyl] -4-methyl-7- [N- (hydroxycarbonylmethyl) -quinolin-8-sulfonylamino] -quinoline Prepared analogously to Example 3, starting from 2 - [ N - (4-ami di no phen 11) - ami nome 111] - 4 -met? L-7- [N- (ethoxycarbonylmethyl) -qu? Nol? N-8-su 1 f on i 1 ami no] - What a nol i na and lye of soda. Yield: 49% of theory, C29H26N6O4S (554, 64) Mass spectrum (EKA M + H) = 555 M + Na-) + = 577 M + 2Na) ++ = 300 2M + 3Na 3 + 392.6
Example 113 2 - [(4-Amidinophenyl) -oxymethyl] -4-methyl-7- [N- (hydroxycarbonylmethyl] -benzoyl inol -quinoline Prepared analogously to Example 3, starting with 2- [(4-am? dmofen? l) -ox? met? l] -4-met? l-7- [N- (ethoxycarbonylmethyl) -benzoylamino] -quinoline and sodium hydroxide. Yield: 26% of theory, Mass Spectrum (EKA): ( M + H) + = 469
E xample 114 2- [2- (4-amidinophenyl) -ethyl] -3-methyl-6- [N- (ethoxycarbonylme il) -quinolin-8-sulfonilamino] -benzofuran Prepared analogously to Example le, from 2 - [2 - (4 - c 1 ano f in 11) - e 111] - 3 -me 111 - 6 - [N - (ethoxycarbonylmethyl) -qumol? N-8-sulphon? Lammo] -benzofuran and ethanolic hydrochloric acid , ethanol and ammonium carbonate. Yield: 84% of theory, C3? H30N4? 5 (570, 68) R value: 0.24 (silica gel, dichloromethane / ethanol = 4: 1 + glacial acetic acid) Mass spectrum (EKA): (M + H) + = 571 (M + H + Na) ++ = 297
EXAMPLE 115 2- [N- (4-amidinophenyl) -aminomethyl] -3-methyl-6- [N- (ethoxycarbonyl-benzenesulfonylamino] -benzofuran) Prepared analogously to Example le, starting from 2 - [N - (4 - cyan f in 11) - amy nome 111] - 3 -me 111 - 6- [N- (ethoxycarbonylmethyl) -benzenesulfonylamino] -benzofuran and ethanolic hydrochloric acid, ethanol and ammonium carbonate Yield: 36% of the Theoretical value R f: 0.22 (silica gel, dichloromethane / ethanol
= 4: 1 + glacial acetic acid) Mass spectrum (EKA): (M + H) + = 521
iBi j »aj & < B6 ¿Sa * fe.- 'Jfe ¿xe? *! ÉsB? Example 116 vff 2- [2- (4-amidinophenyl) -ethyl] -3-methyl-6- [N- (hydroxycarbonyl-methyl) -quinolin-8-sulfonylamino] -benzofuran Prepared analogously to Example 3 , from 2 - [2 - (4-ami di no pheni 1) - eti 1] - 3 -methyl 1-6 - [N - (ethoxycarbonylmethyl) -quinolin-8-sulfonylamino] -benzofuran and soda lye . Yield: 87% of theory, C29H26N4O5S (5 2, 63) Rf value: 0.13 (silica gel, dichloromethane / ethanol = 4: 1 + glacial acetic acid) Mass spectrum (EKA): (M + H) + = 543 (M + Na) + = 565
E xample 117 2- [N- (4-amidinophenyl) -aminomethyl] -3-methyl-6- [N- (hydryloxycarbonylmethyl) -benzenesulfonylamino] -benzofuran Prepared analogously to Example 3, starting from 2 - [ - (4-ami di no feni 1) - ami n ome ti 1] - 3 - methyl-6- [N- (ethoxycarbonylmethyl) -benzene not its 1 f on i 1 ami] -be nzofuranoy lye of soda. Yield: 79% of theory, C25H24N4O5S (492.57)
Rf value: 0.12 (silica gel, dichloromethane / ethanol = 4: 1 + glacial acetic acid) Mass spectrum (EKA): (M + H) + = 493 (M + Na) + = 515 M + 2Na 269
Example 118 2 - [N- (4-amidinophenyl) -aminomethyl] -3-methyl-6- [N- (N '- (ethoxycarbonylmethyl) -aminocarbonylmethyl) -quinolin-8-sullynylamino] -benzofuran Prepared analogously to the Example , from 2 - [N - (4 - cyano f in i 1) - ami nome 111] - 3 -me ti 1 -6- [N- (N '- (ethoxycarbonylmethyl) -aminocarbonylmethyl) -quo n-8 - its 1 f on i 1 ami no] -ben zofura and ethanolic hydrochloric acid, ethanol and ammonium carbonate. Yield: 81% of theory, C32H32N606S (628, 72) Mass spectrum (EKA): (M + H) + = 629 (M + H + Na) ++ = 326
E xemployment 119 2- [N- (4-amidinophenyl) -aminomethyl] -3-methyl-6- [N- (Nf (1 H - te trazol - 5 - i 1) -aminocarbonylmethyl) -quinolin-8-sulfoni lamino] -benzofuran
• te * ft > .t ». ^ Ta-gay -j? -aia = -agfc- ".
to . 2- [N- (4-cyanophenyl) -aminomethyl] -3-methyl-6- [N- (N '(1 H -tetrazol-5-yl) -amcarbonylmethyl) -quinolin-8-sulfonylamino] - benzofuran 0.53 g (1.0 mmol) of 2 - [N - (4-cyano-phen-1) -5-ammomethyl] -3-meth? -6-carbox? met? l-qu? nolm-8- its 1 f on i 1 ami no] - be nzof ur ano dissolve in 20 ml of tetrahydrofuran, mix with 0.2 5 g (1.2 mmol) of car bon 11 di i zo zo 1 and 0, 1 g (1.0 mmol) of 5-ami non-tetrazole 1 and heated at reflux for 5 hours.
hours. The reaction mixture is concentrated by evaporation, the residue is dissolved in ethanol and chromatographed on silica gel (methylene chloride + 2.5, ethanol). The desired fractions are combined and concentrated by evaporation.
Yield: 0.11 g (19% of theory), C29H23N9O4S (593, 64) R value: 0.18 (silica gel, me 111 chloride and no / eta no 1 = 9: 1) Mass spectrum : (MH) "= 592 20 b. 2- [N- (4-amidinophenyl) -aminomethyl] -3-methyl-6- [N- (N '- (1H-tetrazol-5-yl) -aminocarbonylmethyl) - quinoline-8-sulfonylamino] -benzofuran Prepared analogously to the Example le, a
from 2 - [N - (4 - c 1 ano f in 11) - ami nome 111] - 3 -me 111 -
< ¡& amp; * B ~ M. *, .s-Á¡ & «J8.-V 6- [N- (N '- (lH-tetrazo-5-yl) -aminocarbonylmethyl) - qu i not 11 n - 8 - su 1 f on i 1 ami nó] -be nzofura no and acid c 1 orhidri co / car bona to de ammonium. Yield: 97% of theory, C29H26N10? 4S (610, 67) Mass spectrum (EKA): (M + H) + = 611 (M + Na) + = 633 (M + H + Na) ++ = 317
EXAMPLE 120 2- [N- (4-amidinophenyl) -aminomethyl] -3-methyl-6- [N- (1 H -tetrazol-5-yl) -methyl] -quinolin-8-sulfonylamino] -benzofuran a. 5-Bromomethyl-1- (2-cyanoethyl) -tetrazole 1.50 g (7.85 mmol) of bromoacetic acid (2-cyan oe ti 1) -amide are dissolved in 50 ml of methylene chloride and mixed with 508 mg (7.85 mmol) of sodium acidide. At 0 ° C a solution of 2.20 g (7.85 mmol) of trifluoroacetic acid anhydride in 5 ml of methylene chloride is added dropwise. After 22 hours at room temperature, add a saturated sodium hydroxide solution and extract 3 times with methylene chloride. The combined organic phases are dried over sodium sulfate and
concentrate by evaporation. The crude product is chromatographed on silica gel, eluting initially with methylene chloride and then with methylene chloride 1 and no 1 (50: 1). The desired fractions are combined and concentrated by evaporation. Yield: 505 mg (30% of theory), C5H6BrN3 (216.06) Mass spectrum (EKA): M + = 215/217 (Br) b .2- [N- (4-cyanophenyl) -aminomethyl] -3- methyl-6- [Nl- (2-cyano-ethyl) -tetrazol-5-yl) -methyl) -quinolin-8-sulfonylamino] -benzofuran. Prepared analogously to Example Id, starting from 2 - [N - (4 - cyano f in i 1) - ami n ome ti 1] - 3 -me ti 1 -6 - (qu ino 1 in - 8 - su 1 f on i 1 ami no) -be nzofur anus and 5-bromomethyl-1- (2-cyanoethyl) -tetrazole. Yield: 98% of the theoretical, R f value: 0.45 (silica gel; methylene chloride 1 ene / eta no 1 = 95: 5) c .2- [N- (4-cyanophenyl) -aminomethyl] - 3-Methyl-6- [N- (1H-tetrazol-5-ylmethyl) -quinolin-8-sulfounilamino] -benzofuran 0.5 g (0.83 mmol) of 2 - [N - (- cyano) f eni 1) -aminomethyl] -3-methyl-6- [N- [1- (2-cyanoethyl) -tetrazol-5-yl-methyl] -qu? nolin-8-sulfonylamino] -benzofuran are dissolved in 50 ml of methylene chloride, it is 9
mix with 0.28 g (2.5 mmol) of potassium tert-butoxide and stir for 90 minutes at room temperature. The reaction mixture is concentrated by evaporation, the residue is dissolved in water and acidified with glacial acetic acid. The precipitate formed is separated by filtration, washed with water and dried. The crude product is chromatographed on silica gel (methylene chloride + 1-2% ethanol). The desired fractions come together
and concentrate by evaporation. Yield: 110 mg (24% of theory), R value: 0.43 (silica gel, dichloromethane / ethanol
= 9: 1) d. 2- [N- (4-amidinophenyl) -15-aminomethyl] -3-methyl-6- [N- (lH-tetrazol-5-yl) -methyl] -quinolin-8-sulfonylamino] -benzofuran hydrochloride Prepared analogously to Example 1, from 2 - [N - (4-cyano-phenyl-1) - ami nome ti 1] - 3 -me 111 -6- [N- (l-tetrazol-5-yl-methyl) -qu? nolin-8- 20 su 1 f on i 1 ami no] - ben zof ur ano and acid 1 ammonium bicarbonate. Yield: 97% of theory, C28. H25N9, 03S (567.66) Mass spectrum (EKA): (M + H) + = 568 25 (M + Na) + = 590
M + H + Na 295, 6 M + 2 Na) + + = 306.7
EXAMPLE 121 2- [2- (4-amidinophenyl) -ethyl] -3-methyl-6- [N- (N '- (and oxycarbonylmethyl) -aminocarbonylmethyl) -quinolin-8-sulfonylamino] -benzofuran Prepared analogously to Example le, from 2- [2- (4-c? anophen? l) -et? l] -3-met? l-6- [N- (N '- (ethoxycarbonylmethyl) -aminocarbonylmethyl) -quot; 11 n - 8 - su 1 f on 11 ami no] -ben zofur ano and ethanolic hydrochloric acid, ethanol and ammonium carbonate. Yield: 61% of the theoretical, C33H33N506S (627.73) R value: 0.25 (silica gel, dichloromethane / ethanol = 4: 1 + glacial acetic acid) Mass spectrum (EKA): (M + H) + = 628 (M + 2H) ++ = 314.7 (M + H + Na) ++ = 325.7
Example 122 2- [N- (4-amidinophenyl) -aminomethyl] -3-methyl-6- [N- (N '(hydroxycarbonylmethyl) -aminocarbonylmethyl) -quinolin-8-sulfonyl] -benzofuran
*., & x &jJ &tJe'i j. ~ "*, ia / k ~~ Prepared analogously to Example 3, starting from 2 - [N - (4 - ami di no feni 1) - ami ome ti 1 ] - 3 - met? L-6- [N- (N '- (ethoxycarbonylmethyl) -aminocarbonylmethyl) -quinolin-8-sulfonylamino] -benzofuran and sodium hydroxide solution Yield: 69% of theory, C30H28N6O6S (600.67) Mass spectrum EKA M + H) + = 601 M + Na) + = 623 10 M + 2 H) ++ = 301 M + H + Na 312 M + 2 Na = 323
Example 123 15 2- [2- (4-amidinophenyl) -ethyl] -4-methyl-7- [N- (lH-tetrazol-5-yl-methyl) -quinolin-8-sulfonylamino] -quinoline Prepared analogously to Example LE, starting from 2 - [2 - (4-cyano-phenyl-1) -eti-1] -4-methyl-1-7 - [N-20 (lH-tetrazol-S-yl-methyl) -quinolin -8-sulfonylamino] -quinoline and c 1 or hydride i co-eta n 1 i co, ethanol and ammonium carbonate. Yield: 31% of theory, C30H27N9O2S (577.67)
Rf value: 0.15 (gel itself.) me * ce; dichloromethane / ethanol = 4: 1 + glacial acetic acid) Mass spectrum (EKA): (M + H) - + = 578 (M + Na) + = 600 (MH) "= 576
Example 124 L-methyl-2- [N- (4- (Nn-exoxyloxycarbonyl amidino) phenyl) -aminomethyl] -5- [N- (ethoxycarbonylmethyl) -quinolin-8-sulfonylamino] -benzimidazole Prepared analogously to Example 31 , from 1 -me 111-2 - [N - (4-ami diene f in 11) -aminomethyl] -5- [N- (ethoxycarbonylmethyl) -qu? nol? n-8-su 1 f on 11 ami no] - benzium zo 1 and n-hexyl ester of acid c 1 orofo rmi co. Yield: 61% of theory, C36H4iN706S (699.84) Rf value: 0.60 (silica gel, dichloromethane / methanol = 9: 1) Mass spectrum (EKA): (M + H) + = 700 (M + Na) + = 722 (M + H + Na) ++ = 361, 8 Example 125? l-methyl-2- [N- (4- (Nn-octyloxycarbonylamido) phenyl) -aminomethyl] -5- [N- (ethoxycarbonylmethyl) -quinolin-8-sulfonylamino] -benzimidazole Prepared analogously to Example 31, from 1 -me ti 1 - 2 - [N - (- amidí no f eni 1) - aminomethyl] -5- [N- (ethoxycarbonylmethyl) -quinolin-8- su 1 f on 11 ami no] -b ene imi da zo 1 and sternium-octyl 1-acidic acid. Yield: 65% of theory, C38H45N706S (727.89) Rf value: 0.58 (silica gel, dichloromethane / methanol = 9: 1) 15 Mass spectrum (EKA): (M + H) + = 728 (M + Na) + = 750 (M + H + Na) ++ = 375.8
E n g lish 126 20 l-methyl-2- [N- (4- (Nn-bu ti loxycarbonylamino) phenyl) -aminomethyl] -5- [N- (ethoxycarbonylmethyl) -quinolin-8-sulfoni lamino] -benzimidazole Prepared analogously to Example 31, starting from 1 -me ti 1 - 2 - [N - (4-ami di no f in i 1) -
.S »£ j & & "tS £ L᧠.. ^ .: SSík. Itesgí aminomethyl] -5- [N- (ethoxycarbonylmethyl) -quinolin-8- its 1 f on i 1 ami no] -benz imi da zo 1 and é Sulfuric acid ionic acid cyclophosphoric acid yield: 64% of theory, C34H37N706S (671, 78) R value: 0.57 (silica gel, dichloromethane / methanol
= 9: 1) Mass spectrum (EKA): (M + H) + = 672 (M + Na) + = 694 10 (M + H + Na) ++ = 347.8
Example 127 L-methyl-2- [N- (4-amidino-2-methyl-toxophenyl) -aminomethyl] -5- (N-methyl-benzenesulfonylamino) -benzimidazole Prepared analogously to Example le, starting from 1-methyl 1 - 2 - [N - (4-cyano-2-methoxy-1-pheny1) -ammomethyl] -5- (N-methyl-benzenesulfonylamino) -benzimidazole and ethanolic hydrochloric acid, ethanol and ammonium carbonate. 20 Yield: 57% of theory, C24H26N603S (478.6) Mass spectrum (EKA): (M + H) + = 479 (M + Na) + = SOI
.i88S3 »< muk > EXAMPLE 128 l-Methyl-2- [N- (4-amidinophenyl) -ammomethyl] -5- (N-methyl-phenyl-acetylamino) -benzimidazole Prepared analogously to Example le, from 1 - I 111 - 2 - [N - (4 - cia no fen 11) - ami nome 111] - 5 - (N -me 111 - fen 11 - a ce 111 ami no) - be nc ími da zo 1 and ethanolic hydrochloric acid , ethanol and baby carbonate. Yield: 54% of theory, C25H26N60 (426.53) R value: 0.27 (silica gel, dichloromethane / methanol = 5: 1) Mass spectrum (EKA): (M + H) + = 427 (M + 2H) + + = 214
Example 129 L-Methyl-2- [N- (4- (N-benzoy-lamidino) -phenyl) -aminomethyl] -5- [N- (ethoxycarbonylmethyl) -quinolin-8-sulfonylamino] -benzimidazole Prepared analogously to Example 31, from 1 -me 111-2 - [N - (4-amidi not f eni 1) -ammomethyl] -5- [N- (ethoxycarbonylmethyl) -qu? nol? n-8-su 1 f on i 1 ami no] -beneficium zo 1 and benzoyl chloride. Yield: 54% of theory, C36H33 705S (675.77)
'? ^% .. ^, - ^ * -, ^ - ** ¿,. . ^ ..t ^ üfe ifeáw .. *** -. »Mass spectrum: (M -?) + = 676 (M + Na) + = 698
EXAMPLE 130 1-methyl-2 - [N- (4 - (N-benzoylamidino) -phenyl) -aminomethyl] -5- [N- (n-propyloxycarbonylmethyl) -quinino-8-sulfonylamino] -benzimidazole Prepared analogously to Example 31, from 1 -me 111-2 - [N - (4-ami di-phen-11) -aminomethyl] -5- [N- (n-propyloxycarbonylmethyl) -qumolm-8-sulfon-lammo] - benzimidazole and benzoyl chloride. Yield: 52% of theory, C37H35N705S (689.77) Mass spectrum: (M + H) + = 690. (M + Na) + = 712
E-use 131 Dry ampoule with 75 mg of active ingredient per 10 ml C ompo s i c on: Active ingredient 75.0 mg Mannitol 50.0 mg Water for injection purposes up to 10.0 ml
Preparation
*. ^? ^ X2r ^, - The active principle and mannitol dissolve in water. After filling, it is lyophilized. The solution for making the solution ready for use is made with water for injection purposes.
Example 132 Dry ampule with 35 mg of active ingredient per 2 Compo s i c on: 10 Active ingredient 35.0 mg Mannitol 100.0 mg Water for injection purposes up to 2.0 ml
Preparation: 15 The active principle and mannitol dissolve in water. After filling, it is lyophilized. The solution for giving the ready-to-use solution is made with water for injection purposes.
E n g lis 133 Tablet with 50 mg of active ingredient Compo s i c ons: 25 (1) Active ingredient 50.0 mg
2) Lactose • 98.0 mg 3) Corn starch 50.0 mg 4) Po 11 vi n i lp i r r 11 11 dona 1 15 15 mg 5) Magnesium stearate 2.0 mg 215.0 mg
Preparation: (1), (2) and (3) are mixed and granulated with an aqueous solution of (4). The dried granulate is added by mixing (5). Compressed, biplanes, faceted on both sides and dividing notch on one side are pressed from this mixture. Diameter of the tablets: 12 mm.
E xemplode 134 Tablet with 350 mg of active ingredient C ompo sition: (1) Active ingredient 350.0 mg (2) Lactose 136.0 mg (3) Corn starch 80.0 mg (4) Po 11 vi ni lp irro 11 don 30.0 mg (5) Magnesium stearate 4.0 mg 600.0 mg
Preparation
? Íjí &t; Ot? Is & ? i
(1), (2) and (3) are mixed and granulated with an aqueous solution of (4). The dried granulate is added by mixing (5). Compressed, biplanes, faceted on both sides and dividing notch on one side are pressed from this mixture. Diameter of the tablets: 12 mm.
E n g lis 135 Capsule with 50 mg of active ingredient C ompo sition: (1) Active ingredient 50.0 mg (2) Dried corn starch 58.0 mg (3) Powdered lactose 50.0 mg (4) Stearate magnesium 2, 0 mg 160.0 mg Preparation: (1) mix by grinding with (3). This crushed mixture is added, under intense mixing, to the mixture based on (2) and (4). This powder mixture is introduced into a capsule packing machine into hard gelatin plug-in size 3 capsules.
eÜStueste fcSfe & assss E 3 emplo 136 Capsules with 350 mg of active ingredient C omp osition: (1) Active ingredient 350.0 mg (2) Dried corn starch 46.0 mg (3) Powdered lactose 30.0 mg (4) Magnesium stearate 4.0 mg 430.0 mg Preparation: 10 (1) is mixed by grinding with (3). This crushed mixture is added, under intense mixing, to the mixture based on (2) and (4). This powder mixture is introduced into a capsule filling machine in plug-in capsules of size 0 gelatin aura.
E -jus 137 Suppositories with 100 mg of suppository active ingredient contains: 20 Active ingredient 100.0 mg Polyethylene glycol (MW 1500) 600.0 mg Polyethylene glycol (MW 6000) 460.0 mg Polyethylenesorbitan monostearate 840.0 mg 25 2 0 0 0, 0 mg
-;;, - - at at at at at at at at at at at at at at at Preparación Preparación Preparación Preparación:::::::::::: at at at at at at at at at at at at at at at at at at at at at at at at at at at at at at at at at at at at at at at at at at at at at at at at at at at at at at at at at at at at at at at at at at at at at at at at at at at at at at at at at at at at at at at at at at at at at at at at at at at at at at at at at at at at at at at at at at at at at at at at at at at at at at at at at at at at at at at at at at at at at at at at at at at at at at at at at at at at at at at at at at at at At 40 ° C, the milled active substance is dispersed homogeneously in the melt. It is cooled to 38 ° C and poured into weakly cooled suppository molds beforehand.
* VkM¡tHÍ¡ ÍL
Claims (12)
1. Bicyclic disubstituted heterocycles of the general formula Ra-Het-B-Ar-E, (I) wherein B means an ethylene group, optionally substituted with one or two C? -3 alkyl groups, a methylene group may be replaced of the ethylene group, which is linked with the radical Het or Ar, by an oxygen or sulfur atom, by a sulfinyl, sulfonyl, carbonyl or -NRi group, Ri representing a hydrogen atom or a C? -6 alkyl group, or B also means a linear chain C al5 alkylene group, in which a methylene group, which is not linked to the radical Het or to the radical Ar, is replaced by a group NRi, in which Ri is defined as mentioned above, E means a cyano group or RbNH-C (= NH), wherein Rb represents a hydrogen atom, a hydroxy group, a C i _ 3 alkyl group or a radical cleavable in vivo, Ar means a phenylene group or naphthylene, optionally substituted with a fluorine, chlorine or bromine atom, with a trifluoromethyl group, C 1 -C 3 alkyl or C 1 -C 3 alkoxy, means a thienylene, thiazolylene, pyrid, and not pyrimidine group, pyridinylene or pyridinium, optionally substituted on the skeleton of carbons with an alkyl group C i -. , Het means a bicyclic heterocycle of the f or rmu 1 a wherein X represents a nitrogen atom or a methino group, optionally substituted with a C? _3 alkyl group, and Y represents an amino group, optionally substituted with a C 1-5 alkyl or C3_7 cycloalkyl group, an oxygen or sulfur atom or X represents a nitrogen atom and Y represents a group im not substituted with a C 1-5 alkyl or C 3-7 cycloalkyl group, the alkyl and cycloalkyl substituent being substituted in each case with a carboxy group or with a transformable group m alive in a group carboxy, being able to be replaced in one of the above-mentioned heterocycles ad 1 c 1 on a non-angular methine group by a nitrogen atom, or Het means a group of the f or rmu la. Rx being defined as mentioned above, and Ra, means a phenyl-C3-alkoxy group, an amino group, a C3_3-amino alkyl group which is substituted at the nitrogen atom additionally with a phenyl group 1 - to 1 qu and 1 or C? -3, a group R3-CO-R4N or R3-SO2-R4N, in which R3 represents a C1-5 alkyl group, phenyl 1 - a 1 qu i 1 or C? _3, C3-7 cycloalkyl, phenyl, naphthyl, pyridyl, quinolyl, isoquinolyl, tetr ah i dr oqu i no 1 i 1 ootetr ah i dr ois oqu i no 1 i 1 o and R4 represents a hydrogen atom, a C1- alkyl group. 5 or phenyl-C 1 _ 3 alkyl, which in each case is substituted on the alkyl part with a group which can be transformed in vivo into a carboxy group, with a carboxy or tetrazolyl group, with an ami nocarbon on 11 oo alkyl C? The ammonia is either substituted, or in each case substituted at the additional nitrogen atom with a transformable group m in a carboxy-C C-3 alkyl group, or with a carbohydrate group. xi represents a C2-5 alkyl group substituted in terminal position with a di- (C3_3) alkyl group -amino, or a C3_7 cycloalkyl group, their tautomers, their stereoisomers and their salts.
2. Bicyclic heterocycles di sust 1 tu 1 do s of the general formula I according to claim 1, wherein B means an ethylene group, optionally substituted with one or two methyl groups, and a methylene group of the ethylene group, which is linked, can be replaced. with the radical Het or Ar, by an oxygen or sulfur atom, by a carbonyl group or -NRi, Ri representing a hydrogen atom or a methyl group, or B also means an n-propylene group, in which the methylene group central is replaced by a group ~ NR ?, in which R1 is defined as mentioned above, E means a cyano group or RbNH-C (= NH), in which R represents a hydrogen atom, an alkyloxy group C? -B, -carbonyl, a cyc 1 or a 1 qu group 11 oxyC 5 _ -carbon 11 o, benzoyl, nicotinoyl or 1 s on 1 co 11 not 11 o, Ar means a phenylene group, optionally substituted with a fluorine, chlorine or bromine atom, with a tr 1 f 1 or ome 111 or, methyl or methoxy, or a thienylene group, optionally substituted with a methyl group, Het means a bicyclic heterocycle of formula X represents a nitrogen atom or a methine group, optionally substituted with a methyl group, and Y represents an amino group optionally substituted by a C 1-3 alkyl or C 3-7 cycloalkyl group, an oxygen or sulfur atom, or X represents a nitrogen atom and Y represents a group imino substituted with a C 1-3 alkyl group, the alkyl part being substituted ad 1 c 1 ona with a carboxy or C 1 -C 3 alkyloxy group or, or Het means a group of the formulas I Ri being defined as mentioned above, and R2 represents an alkyl group C1-3 substituted with a carboxy or C ?3-carbonyl alkoxy group, and Ra, means a benzyloxy group, an amino group, a C alqu --.-3-amino alkyl group which is further substituted at the nitrogen atom with a group benzyl, a group R3-CO-R4N or R3-S02-R4N, in which R3 represents a C4_4 benzyl, C5.7 cycloalkyl, phenyl, pyridyl, quinolyl, isoquinolyl, tetr ah idr oqu i no 1 i 1 alkyl group ootetrahydroiso qu i no 1 i 1 o and R4 represents a hydrogen atom, a C1-3 alkyl group, which is substituted with a carboxy group, C1-3 alkoxycarbonyl, tetrazolyl, aminocarbonyl or Ci -3 alkyl-ami noc ar bon i 1, the aminocarbonyl and C 1-3 alkyl amyl groups being unsubstituted or, in each case at the nitrogen atom, additionally substituted with a car box group i - a 1 qui 1 or C1-3 or C 1 -3-alkoxy-carbon-1-C 1 -alkyl, or a C 2-3 alkyl group substituted in terminal position with a di- (C 1-3 -alkyl) -amino group, its isomers and us salts.
3. Bicyclic di substituted heterocycles of the general formula I according to claim 1, wherein B means an ethylene group optionally substituted with one or two methyl groups, a methylene group of the ethylene group, which is linked to the radical Het, can be replaced. or Ar, for an oxygen or sulfur atom, for a group < ¡Ft »sS5?» Afe - ..,., »-. ,, & < The carbonyl or -NRlf representing Ri a hydrogen atom or a methyl group, or B also means an n-propylene group, in which the central methylene group is replaced by a group - NRi, in which Ri is defined as mentioned above, E means a group R NH-C (= NH), in which R represents a hydrogen atom, an alkyloxy group Ci-β, -carbonyl, a group 1 or 1 i i axi C 5 -7 - carboni 1 oo benzoyl, Ar means a phenylene group, optionally substituted by a fluorine, chlorine or bromine atom, with a tr 1 f 1 or r ome th 1 or methyl group or methoxy, or a thienylene group, optionally substituted with a methyl group in the carbon skeleton, Het means a bicyclic heterocycle of the formula X represents a nitrogen atom or a methine group, optionally substituted with a methyl group, and Y represents an imino group, optionally substituted with a C1-3 alkyl group or C-7 cycloalkyl, an oxygen or sulfur atom, or X represents a nitrogen atom and Y represents an imino group substituted with a C 1-3 alkyl group, the alkyl part being further substituted with a carboxy or C 1-3 alkyloxy group, and R a benzyloxy group, an amino group, a C 1 -C 3 alkyl group -amino which is substituted at the nitrogen atom by addition with a benzyl group, a group R3-CO-R4N or R3-SO2-R4N, wherein R3 represents a C1-4 alkyl group, benzyl, C5-7 cycloalkyl, phenyl, pyridyl, quinolyl, isoquinolyl, tetrahi dr oqu i no 1 i 1 oo 10 tetrahi dr ois oqu i no 1 i 1 o and R4 represents a hydrogen atom, a C? -3 alkyl group, which is substituted with a carboxy group, C 1 _ 3 -carbonyl, tetrazolyl, aminocarbonyl or C 1 alkyl alkoxy - ami no car bon i 1 o, the groups being replaced 15 ami ocar bon 11 oy alkyl C 1 - 3 - ami nocarboni 1 or, in each case at the nitrogen atom, additionally with a carboxy - a 1 qu i 1 or a C1-3 or a C 1 --3 alkoxycarbonyl group - C1-3 alkyl, or a C2-3 alkyl group substituted terminally with di- (C 1-3 alkyl) -amino group, 20 and its isomers and their salts.
4. Bicyclic heterocycles di s t i t u i s of the general formula I according to claim 3, in which Ra in position 5 means a group R3-CO-25 R4N or R3-SO2-R4N, which R3 and R4 are defined - é® & amp; amp; as mentioned above, their isomers and their salts.
5. Bicyclic heterocycles di s t i t u i t s of the general formula wherein X means a methino group or a nitrogen atom, B means an ethylene group, the methylene group being replaced by Ar being replaced by an oxygen atom or an imino group, Ar means a group 1, 4-fe ni 1 e no, E means an amidino group, Rx means a methyl group and Ra, means a group R3-CO-R4N or R3-SO2-R4N, R4 representing a methyl group substituted with a carboxy group, C 1 -3 alkoxy - car bon i 1, carox ime ti 1 ami no - ca r bon i 1 oo alkoxy Ciscar bon i lme ti 1 ami no ca rbon i 1, and R3 represents a group is oqu i no 1 in - 8 - i 1 o, and its isomers and their salts.
6. Bicyclic heterocycles di s t i t u i s of the general formula according to claim 5, in which Ra represents a group R 3 -CO-R 4 N, its isomers and its salts.
7. The following di-substituted bicyclic heterocycles of the general formula according to claim 5 are: (a) 1-methyl 1 - 2 - [(4-ami di no f in i 1) -oxymethyl] -5- [N- (hydroxycarbonylmethyl) -quinolin-8-su 1 foni 1 ami no] -be nc imi da z ol, (b) l-methyl-2- [2- (4-amidinophenyl) -ethyl] -5- [N- ( NT- (hydroxycarbonylmethyl) -aminocarbonylmethyl) -qui no 1 in-8-su 1 f on i 1 ami no-be nc imi da zo 1, (c) 1-met? L-2- [N- (4 -amidinofenyl) -aminomethyl] -5- [N - (hydroxy-carbonylmethyl) -quinolin-8-sulfonylamino] -benzimidazole and (d) 1 -methyl-2 - [N- (4 -amino dino f eni 1 ) -ammomethyl] -5- [N- (hydroxycarbonylmethyl) -quinolin-8-su 1 f on i 1 ami] - i ndo 1, as well as its salts.
8. Physiologically compatible salts of the compounds according to claims 1 to 7.
9. A medicament containing a compound according to at least one of claims 1 to 7, in which E represents a group R NH-C (= NH), or a salt according to claim 8 together with optionally one or more support substances and / or inert diluent agents.
10. Use of a compound according to at least one of claims 1 to 7 in which E represents a group RbNH-C (= NH), or a salt according to claim 8 for the preparation of a medicament with a thrombin time-prolonging effect , an inhibitory effect of thrombin and a 10 inhibiting effect on related problems.
11. Process for the preparation of a medicament according to claim 9, 15 characterized by the fact that, by non-chemical route, a compound according to at least one of claims 1 to 7, in which E represents a group RR NH-C (= NH), or a salt according to the rei indication 8 is incorporated in one or several 20 support substances and / or inert diluents.
12. Process for the preparation of the compounds according to claims 1 to 8, 25 characterized in that a. for the preparation of a compound of the general formula I, in which E means a group RbNH-C (= NH), in which Rb represents a hydrogen atom, a hydroxy group Or C1-3 alkyl, a compound, optionally formed in the reaction mixture, of the general formula Ra-Het-B-Ar-C (= NH) -Z 1, (II) wherein B, Ar is reacted , Het and Ra are defined as mentioned in claims 1 to 7 and Zi represents an alkoxy, aralkoxy, alkylthio or aralkylthio group, with an amine of the general formula H2N-Rb ', (III) in which Rb' represents a hydrogen atom, a hydroxy group or C1-.3 alkyl or, b. for the preparation of a compound of the general formula I, in which the group Ra and E are defined as in claims 1 to 7, with the proviso that the group Ra contains a carboxy group and E is defined as in the claims 1 to 7, or the group Ra is defined as in the claims 1 to 7 and E represents a NH2-C group (= NH), or the group Ra contains a carboxy group and E represents a group NH2-C (= NH), a compound of the general formula is transformed Ra '- Het - B - Ar - E', (IV) in which A, B, Ar and Het are defined as in claims 1 to 7 and the group Ra 'and E' possess the meanings mentioned in the claims 1 to 7 for the group Ra, and E, with the proviso that the group Ra ', contains a group transformable in a carboxyl group by hydrolysis, treatment with an acid or base, 10 thermolysis or hydrogenolysis, and E is defined as in claims 1 to 7, or E 'represents a group which can be transformed into an NH2-C group (= NH) by hydrolysis, treatment with an acid or base, thermolysis or hydrotreatment. isisy the group Ra, present The meanings mentioned in claims 1 to 7 for the group Ra, or the group Ra ', contain a group which can be converted to a carboxyl group by hydrolysis, treatment with an acid or base, thermolysis or hydrothogen i i s, and E' 20 represents a group which can be converted into an NH2-C group (= NH) by hydrolysis, treatment with an acid or a base, thermolysis or hydrogenolysis, by hydrolysis, treatment with an acid or base, thermolysis or hydrogenolysis in a compound 25 of the general formula I, in which the group Ra, and E a »& 3SSg-S« ^ ja are defined as mentioned in claims 1 to 7, with the proviso that the group Ra contains a carboxy group and E is defined as in claims 1 to 7, or the group Ra, present the meanings mentioned in claims 1 to 7 and E represents a group NH2-C (= NH), or the group Ra, contains a carboxy group and E represents a group NH2-C (= NH) or c. for the preparation of a compound of the general formula I, in which the group Ra contains one of the ester groups mentioned in claims 1 to 7 in the definition of the group Ra a compound of the general formula Ra "- Het - is reacted B - Ar - E, (V) in which B, E, Ar and Het are defined as claims 1 to 7 and the group Ra "has the meanings mentioned in claims 1 to 7 for the group Ra, with the proviso that that the group Ra "contains a carboxyl group or a group transformable in a corresponding ester group by an alcohol, with an alcohol of the general formula HO-R8, (VI) in which Rs represents the alkyl part of one of the said in vivo cleavable radicals claim 1, with excision of the group R5 -CO-0- (R5CR7) for a-, carboxyl group, or with their formamidoacetals or with a compound of the general formula Z2-R9, (VII) wherein Rg represents the alkyl part of one of the radicals in vivo separable mentioned claims 1 to 7, with the exception of the group R5-CO-O- (R5CR7) for a carboxyl group and Z2 represents a leaving group, or d. for the preparation of a compound of the general formula I, in which Rb represents an in vivo cleavable radical, a compound of the general formula Ra-Het-B-Ar-C (= NH) -NH2 is reacted, (VII ) wherein Ra, Het, B and Ar are defined as claims 1 to 7, with a compound of the general formula Z3-Rio, (IX) wherein R10 means an in vivo cleavable radical and Z3 means a leaving group nucleofuge, or e. for the preparation of a compound of the general formula I, in which Ra represents an amino group and E represents a cyano group, a nitro compound of the general formula N02 - Het - B - Ar - CN, (X) is reduced wherein B, Ar and Het are defined as mentioned in claims 1 to 7, of. for the preparation of a compound of general formula I, in which Ra represents an amino group and E represents a cyano group, a protective radical for an amino group of a compound of the general formula Ra "'- Het - is removed B - Ar - CN, (XI) 10 in which B, Ar and Het are defined as mentioned in claims 1 to 7 and Ra "? means an amino group protected by a protective radical, or g. for the preparation of a compound of the general formula I, in which Ra represents a group R3-CO-R4N or R3-S02-R4N and E represents a cyano group, a compound of the general formula R4NH-Het is reacted - B - Ar - CN, (XII) in which R4, Het, B and Ar are defined as mentioned in claims 1 to 7, with a compound of the general formula R3 - X - Z4, (XIII) wherein R3 is defined as mentioned in claims 1 to 7, X means a carbonyl or sulfonyl group and Z4 means a gi ^ íg | ^^ jgttKgte nucleophilic labile group or also, in the case that X represents a carbonyl group, means, together with another hydrogen atom of the contiguous nitrogen atom, another bond car bond - n 11 r oge no, or h. for the preparation of a compound of the general formula I, in which Ra represents a group R -CO- R 4 N or R 3 -SO 2 -R 4 N and E represents a cyano group, wherein R 4 is defined as mentioned above; 7, except for the atom Hydrogen, a compound of the general formula R3-X-NH-Het-B-Ar-CN is reacted, (XIV) wherein R3, Het, B, Ar and X are defined as mentioned 15 claims 1 to 7, with a compound of the general formula R4 '- Z5, (XV) in which R4' possesses, with the exception of the hydrogen atom, the meanings mentioned 20 claims 1 to 7 for R4 and Z5 means a nucleophilic leaving group, or i. for the preparation of a compound of the general formula I, in which R 4 represents a C 1-5 alkyl group or f e n i 1 - a 1 q i 1 or C 1-3, which is substituted in each case in the 25 of alkyl with a group which can be converted into a ^^? ítJSs «? ¿¿i¡ ^ & üs¡h. carboxy group, with a tetrazolyl group, with an aminocarbonyl group or an optionally substituted C.sub.1 -C.sub.3 -amino group, which in each case are substituted on the nitrogen atom, additionally, with a transformable group m alive in a group car box i - a 1 qu i 1 or C? -3, and E represents a cyano group, a compound of the general formula R3-X-NR4 '- Het - B - Ar - CN, (XVI) is reacted in wherein R3, Het, B, Ar and X are defined as mentioned in claims 1 to 7 and R4 'means a C1-5 alkyl group of 1 to 1 to 1 to 1 to 1 to 3 in each case, is substituted on the alkyl part with a group which can be converted in vivo into a carboxy group, with a tetrazolyl group, with an aminocarbonyl group or a C 1 -3-amino alkyl group or which, in each case, is substituted at the nitrogen atom, additionally, with a group transformable in vivo in a car box group i-a 1 qu i 1 or C 1-3, or its derivatives reactive with a compound of the formula Rn-H, (XVII) in which R4 'has the meanings mentioned in claims 1 to 7 for R4, with the exception of the hydrogen atom, and Rn represents a substituent mentioned in claims 1 to 7 in the definition of the radical R4, of the alkyl group C5.5 ofen 11 - to 1 qu1 1 or C3_3, which is linked to the radical Rn through a carbonyl group, oj. for the preparation of a benzothiazolyl or benzoxazolyl benzothiazolyl compound of the general formula I, in which B represents an ethylene group, a compound, optionally formed in the reaction mixture, is reacted the general formula in which (XVIII) Ra and Y are defined as mentioned in claims 1 to 7, with a compound of the general formula HO-CO-B '-Ar-E, (XIX) in which Ar and E are defined as mentioned claims 1 to 7 and B 'means an ethylene group, optionally substituted with one or two C1-3 alkyl groups, or k. for the preparation of a compound of the general formula I, which contains one of the tetrahydric or non-1-one or isoquinoline radicals mentioned in claims 1 to 7, a compound of the general formula I containing one is hydrogenated. of the quinolha or isoquinoline radicals mentioned in claims 1 to 7 and, if necessary, then a protection is separated for reactive groups optionally present, used in the reactions described above, and / or if desired, then a compound of the General formula I, thus obtained, is separated into its stereoisomers and / or a compound of general formula 1, thus obtained, is transformed into its salts, in particular into its physiologically compatible salts.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19834751.0 | 1998-08-01 |
Publications (1)
Publication Number | Publication Date |
---|---|
MXPA01000399A true MXPA01000399A (en) | 2001-11-21 |
Family
ID=
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6469039B1 (en) | Disubstituted bicyclic heterocycles, the preparation and the use thereof as pharmaceutical compositions | |
US6121308A (en) | Disubstituted bicyclic heterocycles, the preparation thereof and their use as pharmaceutical compositions | |
US6414008B1 (en) | Disubstituted bicyclic heterocycles, the preparation thereof, and their use as pharmaceutical compositions | |
US6300342B1 (en) | Antithrombotic phenylalkyl derivatives | |
EP1140903B1 (en) | Aromatic amides | |
AU742593B2 (en) | Disubstituted bicyclic heterocycles, their production and use as medicaments | |
EP1140881B1 (en) | Antithrombotic amides | |
TWI393708B (en) | Hydroxamate compounds, use thereof and synthesizing method for the same | |
HUT61984A (en) | Process for producing condensed imidazole derivatives and pharmaceutical compositions comprising same | |
CA2510846A1 (en) | New carboxylic acid amides,the preparation thereof and their use as pharmaceutical compositions | |
IL166584A (en) | Prodrugs of 1-methyl-2(4-amidinophenylaminomethyl)-benzimidazol-5-yl- carboxylic acid -(n-2-pyridyl-n-2-hydroxycarbonylethyl)-amide, pharmaceutical compositions containing them , use thereof in preparation of pharmaceutical compositions and processes to prepare them | |
DE19753522A1 (en) | Substituted indoles, their preparation and their use as pharmaceuticals | |
SK15962001A3 (en) | Heterocyclically substituted benzimidazoles, the production and application thereof | |
EP3585772B1 (en) | 1, 4, 6-trisubstituted-2-alkyl-1h-benzo[d]imidazole derivatives as dihydroorotate oxygenase inhibitors | |
US6593355B2 (en) | Benzimidazoles with antithrombotic activity | |
US6288061B1 (en) | Imidazole derivatives | |
DE19816983A1 (en) | New bicyclic heteroaromatic amidine or nitrile compounds, used as thrombin inhibitors, antithrombotic agents or intermediates | |
US20020183519A1 (en) | Antithrombotic carboxylic acid amides | |
DE19718181A1 (en) | New aryl-substituted bi:cyclic heterocyclic compounds | |
DE19804085A1 (en) | New benzo-condensed heterocyclic compounds useful in treatment of thrombosis and prevention of vascular occlusion | |
MXPA01000399A (en) | Disubstituted bicyclic heterocycles having, in particular, a thrombin inhibitive effect | |
WO1999029670A2 (en) | Aminocarbonyltetralin and dihydronaphtalene derivates as thrombin inhibitors | |
DE19706229A1 (en) | New aryl-substituted bi:cyclic heterocyclic compounds | |
MXPA00005785A (en) | Five-membered, benzo-condensed heterocycles used as antithrombotic agents | |
DE19751939A1 (en) | New aryl-substituted bi:cyclic heterocyclic compounds |